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ABSTRACT
Because of the hazards of inhalational agents to both patients 
and theatre staff, investigations of the hypothesis that total 
intravenous anaesthetic techniques might provide equally satisfactory 
anaesthesia for patients either breathing spontaneously or requiring 
mechanical ventilation compared with conventional inhalational based 
techniques were carried out. A review of the literature suggested 
that etomidate and later propofol might be suitable agents for this 
purpose.
The investigations were carried out in two stages. Firstly 
their properties as induction agents were investigated to determine 
their potential suitability for infusion. After these studies were 
completed, the infusion studies were carried out. Supplementary 
analgesia was provided by the infusion of fentanyl.
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SUMMARY
INVESTIGATIONS OF ETOMIDATE AND PROPOFOL 
FOR THE INDUCTION AND MAINTENANCE OF ANAESTHESIA
This thesis investigates the hypothesis that total intravenous 
anaesthetic techniques involving the infusion of etomidate or 
propofol could provide adequate anaesthesia for fit patients 
undergoing a variety of routine operations requiring either 
spontaneous or assisted ventilation.
The initial studies of the bolus administration of etomidate 
for the induction of anaesthesia were carried out in outpatients 
undergoing cystoscopy premedicated only with atropine. The first 
two studies of etomidate with sodium phosphate/biphosphate dissolved 
in sterile water as diluent showed it to be a potent, short acting 
hypnotic with cardiovascular and respiratory stability, superior 
to that of propanidid. A high incidence of pain on injection and 
muscle movement was found.
Reformulation in polyethylene glycol (Study Three) and 
propylene glycol (Study Four) did not appear to alter its potency 
or physiological characteristics. In both formulations the incidence 
of pain on injection, but not muscle movement, was reduced.
Alfentanil given intravenously immediately before an induction 
dose of etomidate was found to reduce the incidence of pain on 
injection and muscle movement without affecting the speed of
recovery (Study Five).
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Investigation of propofol in Study Six as an induction agent 
in patients undergoing minor general and gynaecological surgery 
showed it to have similar cardiovascular properties to thiopentone, 
but with a higher incidence of apnoea and pain on injection. The 
incidence of pain on injection was reduced when administered via 
a vein in the antecubital fossa, but not by the prior intravenous 
injection of lignocaine.
The continuous infusion of etomidate and fentanyl was found 
to provide adequate anaesthesia for most patients in all the 
etomidate studies. Cardiovascular and respiratory stability was 
well maintained. Induction of anaesthesia using a bolus of etomidate 
(Study Seven) was found to be unsatisfactory due to pain on injection 
and muscle movement. The substitution of thiopentone (Study Eight) 
provided an excellent induction of anaesthesia but was associated 
with a prolonged recovery time. The use of a pre-determined two 
stage infusion scheme of etomidate with a separate variable infusion 
of fentanyl (Study Nine) was found to give a smoother induction 
compared with Study Seven, faster recovery than that found in 
Study Eight, and reduced the amount of etomidate infused over a 
period of time. A wide variation in infusion rates for fentanyl 
was found in all the studies.
The effects of these infusion techniques on hepatic and 
renal function (Study Ten) in patients undergoing simple abdominal 
hysterectomy were found to be similar to those of a standard 
inhalational based anaesthetic technique.
Using a predetermined infusion scheme with a separate variable
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infusion of fentanyl as analgesic (Study Eleven), propofol provided 
a smooth induction of anaesthesia following an opiate premedication. 
Maintenance of anaesthesia was satisfactory in ventilated patients , 
but spontaneously breathing patients became apnoeic. Although 
arterial blood systolic and diastolic pressures and heart rate 
tended to fall during induction, this was not clinically significant 
and soon returned to pre-induction levels. Recovery was rapid and 
the incidence of side effects was low. Administration over two 
to three hours (Study Twelve) was associated with progressive 
prolongation of the duration of action of bolus increments of 
vecuronium, but not atracurium. The variability of the fentanyl 
infusion rates were found to be similar to those of the etomidate 
studies.
The conclusions of these studies were that etomidate and 
propofol offer advantages of rapid recovery and (for etomidate) 
cardiovascular stability. For general use^ their side-effects 
reduce their potential advantages over other currently available 
induction agents. Total intravenous anaesthetic techniques are 
possible with both etomidate and propofol supplemented with 
fentanyl, but better methods of assessing the requirements of 
individual patients are required before such techniques are suitable 
for widespread use in clinical anaesthesia.
The conclusions of this thesis do not fully support the 
hypothesis.
CHAPTER ONE
INTRODUCTION
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Hypothesis
This thesis explores the hypothesis that total intravenous 
anaesthetic techniques could provide equally satisfactory anaesthesia 
for patients either breathing spontaneously or requiring mechanical 
ventilation, compared with inhalational agents.
Hazards of Inhalational Agents to Patients
Although in widespread use for many years, problems have 
recently been attributed to the use of the inhalational agents.
With the exception of carbon tetrachloride (Powell, 1945) the 
concept that anaesthetic agents such as ether (Haggard, 1924) 
were eliminated unchanged was not challenged until the 1960's.
Using radio-isotopes, chloroform and carbon tetrachloride (Paul 
and Rubenstein, 1963), ether, halothane and methoxyflurane 
(Van Dyke, Chenoweth and Van Poznack, 1964) were found to be 
metabolised. During the late 1960's and 70's these findings 
took on greater significance when a series of clinical reports 
appeared, implicating inhalational anaesthetic agents as posing 
potential hazards both to patients and to theatre personnel.
Methoxyflurane is metabolised to oxalic acid and fluoride 
ions, which can cause nephrotoxicity and renal failure (Panner 
et al, 1970; Taves et al, 1970; Mazze, Trudell and Cousins,
1971). Halothane hepatotoxicity has been a controversial issue 
but appears to be a complex clinical entity (Van Dyke, 1983;
Cousins, Plummer and Hall, 1984; Neuberger and Williams, 1984)
This topic has recently been reviewed again when further problems
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associated with its use have been described (Blogg, 1986; Brown 
and Gandolfi, 1987).
Nitrous oxide can cause problems by diffusion into gas 
loculi. This may occur in intestinal obstruction, pneumothorax 
(Eger, 1980) or middle ear surgery (Mann, Woodsford and Jones,
1985). Nitrous oxide can also affect the haematological system 
causing lecuopenia, acute aplasia (Lassen et al, 1956), megaloblastic 
haemopoesis (Amess et al, 1978) and myeloneuropathy (Layser, 1978) 
resulting from the inhibition of the production of methionine 
synthetase (Koblin et al, 1982; Nunn, 1987). The time of exposure 
required may be as short as two hours in seriously ill patients 
(Amos et al, 1982). Nitrous oxide may also affect cell mediated 
immunity (Nunn and O ’Morain, 1982). The degree of liver damage 
associated with hypoxia (Fassoulaki et al, 1984) may be increased 
by nitrous oxide and it may also affect metabolic pathways in the 
liver (Black, Virayotha and Tephily, 1984).
Hazards of Inhalational Agents to Theatre Staff
The chronic inhalation of volatile and gaseous anaesthetic 
agents may reduce psychomotor performance (Bruce and Bach, 1976) 
but such effects have not been found by other investigators 
(Smith and Shirley, 1977; Frankhuizen et al, 1978). Higher 
sub-anaesthetic levels found in patients after operation (Cook 
et al, 1978) have been shown to cause impairment of psychological 
function and decision making (Bentin, Collins and Adam, 1978).
Early concern about the effect of theatre pollution on staff
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was expressed by Werthmann (1949) who found haematological 
changes in theatre personnel chronically exposed to ether. He 
suggested the venting of gases out of the operating theatre and 
the filtering of theatre air. Later studies suggested that 
there was an increased incidence of miscarriage and congenital 
abnormality in theatre personnel (Cohen, Belville and Brown, 1971; 
Knill-Jones et al 1972) although not in the wives of exposed males 
(Knill-Jones, Newman and Spence, 1975).
Other suggested hazards have been an increase in carcinoma 
(Bruce et al, 1968; Corbett et al, 1973), and altered drug 
metabolism in anaesthetists (Harman et al, 1978; Duvaldestine 
etal, 1981). Jaundice attributable to halothane sensitivity has 
been described (Klatskin and Kimberg, 1969).
The amount of disease potential has been widely discussed 
and the consensus of opinion would appear to be that there is 
an increased risk of abortion in theatre staff (Vessey and Nunn,
1980; Mazze, 1983; Buring et al, 1985) possibly due to nitrous 
oxide (Lane et al, 1979; Cohen et al, 1980; Brodsky, 1983).
This has been supported by animal studies which have shown that 
nitrous oxide may be foetotoxic (Vieira, 1979; Vieira, Cleaton-Jones 
and Moyes, 1983) and that the administration of folinic acid partially 
reduced this teratogenic effect (Keeling et al, 1986). In contrast, 
prolonged exposure to volatile anaesthetic agents has been shown 
to be without adverse effect on rats (Plummer et al, 1986).
Reduction of theatre pollution has become official policy of the 
Association of Anaesthetists of Great Britain and Ireland
(Association of Anaesthetists, 1978). A recent review has suggested
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that these environmental problems may not be as significant 
as previously suggested (Spence, 1987).
Possible Solutions
Scavenging Systems
The most common solution has been the introduction of 
scavenging systems, both active and passive. Such systems are 
not always efficient (Railton and Fisher, 1984) and cannot 
compensate for ill fitting face masks (Torda, Jones and Englert, 
1978). Closed circuit anaesthesia using oxygen and halothane 
without nitrous oxide has been advocated (Burns, 1980; Hughes, 
1980). Nitrous oxide, in particular, can cause problems of 
gaseous homeostasis and gas uptake (Conway, 1982), with the 
accumulation of nitrogen (Barton and Nunn, 1975).
At best, these solutions reduce the dangers of pollution 
to the theatre staff, but not to the patients. Apart from the 
pharmacological dangers described earlier, hazards may arise 
from anaesthetic equipment (Ward, 1985) often attributable to 
inconvenient or poorly designed equipment (Rendell-Baker, 1982).
Bulk storage supplies of oxygen and nitrous oxide may be mis- 
connected with potentially fatal results (Feeley and Hedley-Whyte, 
1976; Carley, Houghton and Park, 1984). Vapourizers (Kelly, 1985; 
Hogan, 1985) and scavenging systems (Tavakoli and Habeeb, 1978; 
Seymour, 1982) can also give rise to unexpected hazards.
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Total Intravenous Anaesthesia
Total intravenous anaesthetic techniques offer potential 
advantages of non-hypoxic oxygen and air mixtures combined 
with a total absence of the hazards of inhalational agents to 
both patients and theatre staff. Such techniques require the 
provision of hypnosis and analgesia and the ability to infuse 
small volumes of drugs, with a high degree of accuracy.
Historical Survey of Total Intravenous Anaesthesia
The technique was first described by Ore"' in 1874. He administered 
two bolus injections of 9 gm. of chloral hydrate intravenously on 
February 9th 1874 to anaesthetise a 52 year old male for exploration 
of a crushed finger which had caused tetanus (Ore/, 1874, a). A 
similar anaesthetic for the removal of a testicular tumour was carried 
out in August of that year (Ore/, 1874, b). The technique failed to 
find general acceptance. In the early 1900fs the use of I.V. ether 
(Burkhardt, 1909; Kummel, 1912) and hedonal (Federoff, 1912) was 
described. The techniques were difficult and time consuming, although 
shocked patients seemed to benefit from the administration of 
large amounts of fluid (Rood, 1911). Intravenous paraldelyde 
(Noel and Souttar, 1913) and magnesium sulphate (Peck and Meltzer,
1916) were also investigated. Later alcohol (Constantine, 1929;
1930) and intravenous tribromoethanol (avertin), (Kirschner, 1930) 
were also investigated as potential intravenous anaesthetics, but 
again without success.
Intratracheal anaesthesia was developing at the same time
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(Cotton and Boothby, 1913; Kelly, 1913) based on the work of 
Meltzer and Auer (1909). These techniques soon became superior 
to intravenous techniques (Shipway, 1913).
Review of Intravenous Hypnotic Agents
One of the major advances in anaesthesia was the introduction 
of the intravenous hypnotic agents. They provide a rapid, smooth 
induction of anaesthesia compared with the prolonged and sometimes 
stormy inhalation inductions associated with the use of ether or 
chloroform. The first drugs used in this way were the barbiturates 
of which thiopentone, pioneered by Lundy (1936; 1942) and later 
methohexitone, remain in everyday use in Britain. The introduction 
of thiopentone allowed minor operations to be done with intravenous 
anaesthesia alone (Lundy, 1942), but this was soon superceded by 
the use of a combination of thiopentone, nitrous oxide and oxygen 
(Organe and Broad, 1938).
The barbiturates have disadvantages of cardiovascular and 
respiratory depression. Recovery is due principally to redistribution 
(Dundee and Clarke, 1980) and cummulation occurs on repeated 
injection (Dundee, 1955). Methohexitone is more rapidly metabolised 
than thiopentone (Vickers, Wood-Smith and Stewart, 1978).
Both thiopentone and methohexitone have been used as infusions 
during neurosurgical operations (Hunter, 1972, a; b). However 
the problems of cummulation, and delayed recovery have meant'that 
these techniques have also not become widely used.
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During the last twenty years various induction agents 
have been introduced which are metabolised more rapidly than 
the barbiturates. None of these has been entirely successful. 
Ketamine has an effect described as "dissociative anaesthesia" 
(Corssen and Domino, 1966) but has been found to be associated 
with a high incidence of hypertension, delirium and hallucinations 
during the recovery period (Knox et al, 1970). Alcohol has been 
investigated but has not been found to be as reliable for induction 
as the barbiturates or eugenols (Dundee et al, 1970). Minaxolone 
has been shown to be a satisfactory induction agent (Punchihewa 
et al, 1980) but has been withdrawn due to toxicological findings 
(Morgan and Dawson, 1984). Benzodiazepines have also been used 
but they have a marked variability in effect and delay in hypnotic 
action (Dundee et al, 1985).
Several intravenous induction agents are highly lipophilic 
and virtually insoluble in water. A polyoxyethylated castor oil, 
Cremophor E.L. is a detergent which until recently was commonly 
used as a solubilising agent. Although the mechanisms are not 
clear (Watkins et al, 1976; Glen et al, 1979; Benoit et al, 1983) 
anaphylactic reactions to propanidid, althesin and di-isopropyl 
phenol (Briggs, Clarke and Watkins, 1982) have been associated 
with the use of Cremophor. As a result of these problems propanidid 
(Pharmaceutical Journal, 1983) and althesin (Lancet, 1984) have 
been withdrawn from use. Di-isopropyl phenol has been reformulated 
in a soya bean emulsion formulation, now re-released as propofol.
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Etomidate and Propofol 
Etomidate
Early animal work (Janssen et al, 1971; 1975) suggested
that etomidate (R-(l)-ethyl-l-(a methy1-benzyl) imidazole-5 
carboxylate) was a potent hypnotic of rapid onset, with a high 
safety margin. Metabolism was mainly by hydrolysis in the liver 
(Meuldermans, Lauwers and Heykants, 1976) and over seventy six 
per cent was protein bound (Meuldermans and Heykants, 1976).
Much of the early clinical work on etomidate was reported by 
Doenecke and his group. Reviewing his experience he concluded 
(Doenecke, 1974) that an induction dose of 0.15 mg.kg. ^ was 
inadequate, but that 0.3 mg.kg. ^ of etomidate was better than 
5 mg.kg. ^ of thiopentone, and that etomidate possessed marked 
cardiovascular and respiratory stability with few side-effects 
and no serious complications. The capacity of etomidate to release 
histamine was found to be very much less than that of althesin 
or propanidid (Doenecke et al, 1973).
Other clinical studies confirmed its properties of 
cardiovascular stability (Brlickner et al, 1974; Kettler et al, 
1974; Hemplemann et al, 1974, a), and respiratory stability 
(Hemplemann et al, 1974, b). All these studies described a 
lack of analgesia, pain on injection and myoclonic movements as 
significant disadvantages.
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Propofol
2,6 di-isopropylphenol is one of a series of alkylphenols.
Early animal work in several species showed it to be a potent 
hypnotic (James and Glen, 1980). Being insoluble in water,
Cremophor E.L. was used as a solvent and the compound was 
investigated as disoprofol. Although found to be a satisfactory 
induction agent (Kay and Roily, 1977, b); Briggs et al, 1981), 
concern over possible anaphylactic responses to Cremophor E.L.
(Briggs, Clarke and Watkins, 1982) led to reformulation in an 
emulsion formulation - Propofol. This consists of di-isopropyphenol 
1% w/v. in an aqueous emulsion containing 10% w/v. soya bean oil,
1.2% w/v. egg phosphatide and 2.25% w/v. glycerol. No adverse 
effects were produced when repeatedly injected into mini-pigs and 
no evidence of histamine release has been demonstrated (Glen and 
Hunter, 1984; Doenecke et al, 1985). The most important change 
clinically was an increase in the required induction dose to 2.5 mg.kg. 
(Cummings et al, 1984).
Scope of the Thesis
The hazards of inhalational agents to both patients and 
theatre staff have been outlined. Reviewing the properties of 
etomidate and propofol suggested that these drugs could possibly 
be used as the hypnotic component of a total intravenous anaesthetic 
technique.
This thesis describes several studies designed to evaluate 
the potential of etomidate and propofol to provide hypnosis by
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infusion. The studies were carried out in two stages. The first 
stage was their administration as a single bolus for the induction 
of anaesthesia. Studies One and Two investigated the use of 
etomidate when dissolved in sodium phosphate/biphosphate 
in sterile water as diluent. Study Three assessed its use when 
reformulated in polyethylene glycol. Study Four investigated its 
use when formulated in propylene glycol and Study Five investigated 
the effect of alfdntanil on.the induction characteristics of etomidate. 
Study Six investigated the effects of the administration of 
propofol. These studies allowed an assessment of the cardiovascular 
and respiratory stability, rapidity and quality of induction and 
recovery and the presence of any side-effects of the two drugs.
The second stage evaluated their infusion as the hypnotic 
component of a total intravenous technique. Study Seven investigated 
the effect of a bolus injection of etomidate followed by a combined 
infusion of etomidate and fentanyl. In Study Eight, anaesthesia 
was induced with thiopentone, then maintained by an infusion of 
etomidate and fentanyl. In Study Nine the effect of a predetermined 
infusion rate of etomidate combined with a variable infusion rate 
of fentanyl was investigated. Study Ten described an investigation 
of the effects of the infusion techniques of Studies Eight and 
Nine on hepatic and renal function. Study Eleven described the 
initial infusion study of propofol and fentanyl and Study Twelve 
described the effects of their infusion over a longer ( 2 - 3  hours) 
period of time. These studies were particularly concerned with 
the safety of the technique, the rates of infusion, any effects on 
cardiovascular and respiratory stability and the quality of
anaesthesia both for patients and theatre staff.
The results are discussed, and conclusions drawn.
CHAPTER TWO
METHODOLOGY OF THE INDUCTION 
AND INFUSION STUDIES
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Patient Selection
All the etomidate induction and infusion studies were granted 
Clinical Trial Certificates before being carried out. The licencing 
system was then changed slightly and the alfentanil study and the 
propofol induction and infusion studies were carried out after having 
been granted Clinical Trial Exemption Certificates. All studies 
also had prior approval from the Victoria Infirmary Ethical Committee.
All patients in the studies were A.S.A. Grade One or Two. All 
patients were weighed pre-operatively. Patients were excluded 
from any study who gave a history of previous adverse reaction to 
anaesthesia, who were possibly pregnant, or who were greater than 
10% over their expected body weight. Before taking part, the study 
was discussed in detail with each patient. Their right to refuse 
to participate was specifically pointed out before their final 
agreement was obtained. Oral consent was obtained for all the 
etomidate studies and written consent obtained for all the propofol 
studies. Separate oral consent was obtained for taking blood for 
arterial blood gas measurements or for liver function tests. Oral 
confirmation of the patient’s willingness to participate in a 
study was obtained immediately before the induction of anaesthesia.
Organisation of the Investigating Teams
All drugs were given by a member of the investigating team for 
that particular study. A senior member of the team (a Consultant 
or Senior Registrar) was always present and was the anaesthetist 
with full clinical responsibility for that patient. It was their
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responsibility to obtain valid patient consent, to prepare and 
to administer the anaesthetic. The anaesthetist was allowed to make 
any decision that was clinically necessary. The anaesthetist 
also supervised the patient’s recovery and measured the time to 
early recovery when this measurement was required. The anaesthestist 
was also responsible for visiting the patient in the ward, or before 
they left hospital, and recording any complications which occurred 
in the post-operative period.
There was always a second anaesthetist present who was also 
a member of the investigating team. Their function was to record 
all complications and when necessary, their duration, which occurred 
during the induction and maintenance of anaesthesia, to make and 
record all measurements of pulse rate and systolic and diastolic 
blood pressures, to take all arterial blood gas samples when 
required, to record the times of starting and ending anaesthesia 
and to record all changes in infusion rates.
Methodology
The studies described in this thesis fall into two distinct 
groups. The studies described in Chapters Three to Six are concerned 
with the investigation of etomidate and propofol as induction 
agents only. The later chapters, Seven to Nine, describe their 
use by infusion to produce hypnosis. For clarity, the methodology 
of each group of studies will be described separately.
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Methodology of the Induction Studies 
Groups of Patients Studied
The groups of patients investigated varied from study to 
study. Studies One to Four (the initial etomidate induction studies) 
were carried out in day stay patients undergoing cystoscopy. This 
procedure was chosen because it represents a relatively uniform 
surgical procedure of short duration. Study Five (etomidate and 
alfentanil) was carried out in patients undergoing diagnostic 
dilatation and curettage, or termination of pregnancy of less than 
ten weeks duration. This group of patients was chosen because the 
procedures also represent a short, relatively uniform surgical 
stimulus, but unlike patients undergoing cystoscopy patients 
undergoing minor gynaecological surgery in this hospital remain 
overnight in the ward after surgery. Study Six (induction with 
propofol) was carried out on in-patients undergoing a range of minor 
surgical and gynaecological procedures.
Allocation of Patients to Groups within each Study
In the etomidate induction studies (Studies One - Five) 
patients were randomly allocated to different groups. A table 
of random numbers was used to produce a code by which patients 
were randomly assigned to one group in each study. In Study Six, 
patients were randomly allocated according to a code supplied by 
I.C.I. Pic.
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Anaesthetic Techniques
All patients received atropine 0.6mg. I.M. as premedication, 
except for forty nine patients in the second study who received no 
premedication. All patients in Studies One to Four were placed 
supine on the cystoscopy operating table before any preparation for 
anaesthesia was carried out. In Studies Five and Six, patients 
were anaesthetised in the anaesthetic room and not transferred 
into theatre until anaesthesia had been satisfactorily established.
After the attachment of a blood pressure cuff, the arterial 
systolic and diastolic blood pressures and the pulse rate were 
measured. Once the intravenous injection of: the appropriate hypnotic 
induction agent had been completed, patients received oxygen 33% 
and nitrous oxide 67% via a Mapleson "A" circuit. Manual ventilation 
was carried out on all patients who remained apnoeic for 60 seconds 
or longer. Any supplementary volatile or intravenous anaesthetic 
agent required, was added after a minute had elapsed in the etomidate 
studies. This was extended to two minutes in the propofol study.
Anaesthesia was supplemented with halothane 0.5 - 2% as 
required (except in the alfentanil group in Study Six) to provide 
satisfactory induction of anaesthesia. The induction of anaesthesia 
was judged to be satisfactory when the patient was lying still with 
all cardiovascular parameters within 20% of their pre-induction 
values, breathing adequately with a quiet, unobstructed respiratory 
pattern and an absent eye-lash reflex. Thereafter the patients 
were transferred on to the operating table unless they were already 
lying there and then positioned as required for surgery.
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During maintenance anaesthesia the inspired concentration of 
halothane was set at 1% and was maintained at this level throughout 
the operation. This level was increased up to a level of 4% if the 
patient moved during surgery, the arterial systolic blood pressure 
or the pulse rate rose to a level 20% or higher compared with the 
pre-induction levels, or if the respiratory rate rose above a rate 
of 20 breaths per minute. The inspired concentration of halothane 
was reduced or switched off if the arterial systolic blood pressure 
or the pulse rate fell to a level 20% or lower compared with the 
pre-induction levels, or if the respiratory rate fell to a rate 
lower than 10 breaths per minute.
Observations Made
The following observations were made in all patients in the 
induction studies.
Quality of Induction and Maintenance of Anaesthesia
The quality of anaesthesia during the induction and maintenance 
of anaesthesia was observed. Of particular interest during the 
induction period was the presence or absence of pain on injection 
or muscle movement. Patients were not specifically asked about the 
presence of pain during injection, but only whether their hand and 
arm remained comfortable. If a patient complained of pain or discomfort 
they were asked to describe the sensation more fully. Muscle 
movement was classified as severe (generalised muscle spasm), 
moderate (contraction of a group of muscles), or mild (slight 
twitching of one or more limbs).
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The ease of transition from the induction of anaesthesia to 
the maintenance of anaesthesia was noted. In particular, the 
response of the patients to the insertion of the cystoscope, the 
cervix being dilated, or the skin being incised (as appropriate) 
was observed.
The presence or absence of cutaneous flushing, peripheral 
vasodilatation, angioneurotic oedema, or other manifestations of 
histamine release, such as bronchospasm, were looked for and their 
occurrence noted.
Cardiovascular System
The arterial systolic and diastolic blood pressures and the 
pulse rate were measured immediately before induction and one minute 
afterwards, before the introduction of halothane. Further measurements 
were made during and after the operations at times which are 
described in detail in the specific studies. In Studies One to Four 
the pulse rate was counted by palpation of the radial pulse. In the 
later induction studies (Five and Six) a continuous E.C.G. and heart 
rate monitor (Diascope D.S. 521, Simonsen and Weel, Denmark) was 
used to provide a continuous display of the E.C.G. throughout the 
induction and maintenance of anaesthesia. The arterial systolic 
and diastolic blood pressures were measured using an oscillotonometer 
in Studies One to Five. A Dinamap 845 (Criticon Inc.) was used to 
measure systolic and diastolic arterial blood pressures and pulse 
rate in Study Six.
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Respiratory System
The presence or absence of respiratory upsets such as cough, 
hiccough, bronchospasm, or laryngospasm were noted. Apnoea 
was defined as the absence of respiration and its duration 
was timed. Manual assistance of ventilation was carried out, if 
required, after the elapse of 60 seconds. Apnoea lasting 60 seconds 
or longer was defined as being prolonged.
Recovery
Once surgery had ended, the nitrous oxide and halothane were 
switched off and the patients breathed 100% oxygen. This point was 
taken to be the end of anaesthesia and the start of the recovery 
period. The time was recorded. The patients were then taken down 
from the lithotomy position when this was necessary and transferred 
by trolley to the recovery area. Transfer of the patients was 
complete within 1 - 2  minutes. A nurse was allocated to supervise 
the recovery of each patient until they had fully recovered consciousness 
All patients in Studies Five and Six breathed air enriched with 
4.1 min. ^ of oxygen via a Hudson mask until they were about to be 
sent back to the ward.
All patients in Studies One to Five were asked to open their 
eyes, raise their head on command and move their left thumb at 
thirty second intervals after the end of anaesthesia by the 
anaesthetist. The time when the patient could achieve all three 
of these objectives was taken to be the time of early recovery 
and was recorded. Patients undergoing cystoscopy remained lying
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on their trolley until they could stand unaided. The time taken 
to achieve this was recorded in Study Two by the attendant nurse 
and was taken to be the time to achieve late recovery. Patients in 
Studies Five and Six were returned to the ward after the
anaesthetist had seen them and had judged them to be fit to do so.
All patients in Studies One to Four were seen by the anaesthetist 
before they were allowed to leave the hospital. Patients remaining 
in hospital overnight (Studies Five and Six) were visited several 
hours after their operation and revisited 24 hours after operation 
by the anaesthetist. The patients were asked about the presence or 
absence of nausea, vomiting or headache, and their opinion of the 
anaesthetic they had received. In particular, the presence of pain
on injection or other unpleasant sensation was asked about. During
this visit, the injection site was inspected for signs of venous 
damage. Redness and tenderness over the injection site was defined 
as phlebitis. The, presence of hardness alone was defined as 
thrombosis and the combination of both was defined as thrombophlebitis.
Methodology for the Infusion Studies
Groups of Patients Studied
Studies Seven, Eight, Nine (infusion of etomidate and
fentanyl) and Eleven (infusion of propofol) were carried out on
in-patients undergoing a range of common surgical and major
gynaecolgoical procedures. A range of procedures was chosen so
that the advantages and disadvantages of such techniques when used
in routine clinical practice could be assessed. Study Ten (effect 
of etomidate on hepatic and renal function) was carried out in
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patients undergoing simple abdominal hysterectomy. Study Twelve 
(longer infusion of propofol) was undertaken in patients undergoing 
peripheral vascular or surgery for the correction of Dupuytren*s 
contracture of the hand.
Allocation of Patients to Groups within Each Study
In Studies Eight and Nine, patients were not randomly allocated 
to control or infusion groups. A deliberate attempt was made to 
reduce the number of possible confounding variables by matching 
patients in the infusion and control groups for age, weight, sex 
and operation undergone. In all the studies the operations were 
carried out whenever possible, by the same surgeons. In Study Ten, 
patients were randomly allocated to one of the three groups using 
a code derived from a random number table similar to that used to 
allocate patients in the induction studies. In Study Twelve, 
patients were randomly allocated to one of two groups according to 
a code supplied by I.C.I. Pic.
Administration of Oxygen and Air
To allow the administration of an oxygen/air mixture using 
the available anaesthetic equipment, a Barnett air compressor was 
connected by a T piece to the back bar of a standard Northwick 
Park anaesthetic machine, as shown in Figure One. By this means 
an infinitely variable oxygen/air mixture could be administered 
to patients either breathing spontaneously or being ventilated 
without further modification of the anaesthetic equipment. An 
overall view of the equipment used is shown in. Figure Two. The
FIGURE ONE
INSERTION OF THE T PIECE FROM THE AIR COMPRESSOR 
INTO THE BACK BAR OF THE ANAESTHETIC MACHINE.
FIGURE TWO
GENERAL VIEW OF THE ANAESTHETIC EQUIPMENT 
INCLUDING THE AIR COMPRESSOR.
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flows of oxygen and air were adjusted to provide a concentration 
of 40% oxygen in the inspiratory limb of the breathing circuit 
throughout these studies. This concentration was periodically 
checked during the studies using a mass spectrometer (Medishield 
Multi-gas Monitor M.S.2).
Preparation of the Infusion Solutions
Because of the concern about the amount of propylene glycol 
solvent which would have to be infused with the etomidate, a specially 
concentrated solution of etomidate (125 mg. of etomidate dissolved 
in 1 ml. of absolute alcohol, Janssen Pharmaceutical) was used. This 
was diluted with normal saline to provide a 2.5 mg.ml. ^ solution 
of etomidate. In Studies Seven, Eight and in one group of Study 
Ten, a combined solution of 2.5 mg.ml. ^ etomidate and 7 meg.ml.  ^
of fentanyl was prepared by removing 16 ml. of fluid from a 100 ml. 
bag of normal saline (Viaflex, Travenol). This volume of fluid 
was replaced by 2 ml. (250 mg.) of concentrated etomidate and 14 ml. 
(700 meg.) of fentanyl. In Study Nine and in another group in 
Study Ten, when fentanyl was infused separately, etomidate was 
diluted to a 2.5 mg.ml. ^ solution by removing 2 ml. of fluid 
from a 100 ml. bag or normal saline and adding 2 mis. of concentrated 
etomidate solution.
When infused separately, fentanyl was diluted to a 
30 meg.ml. ^ solution by the addition of 20 cc. of normal 
saline to 30 ccs. (1500 meg) of fentanyl which had been drawn up 
in a 50 cc. syringe (Plastipak, Becton Dickinson). The formulation 
of propofol used for infusion in Studies Eleven and Twelve has
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already been described on page 38 and was identical to that used 
in the induction study. This was drawn up undiluted in a 50 cc. 
syringe.
Administration of the Infusion Solutions
The combined etomidate and fentanyl solutions used in Studies 
Seven, Eight and Ten and the etomidate solutions used in Studies Nine 
and Ten were administered via a Treonic D.C.2 rotary pump. A 
special administration set (A 27, Avon Medical) designed for use 
with this rotary pump was used. This administration set has a 
portion of soft plastic which is intermittently compressed by 
the roller, thus injecting small frequent boluses of fluid.
Fentanyl was infused separately in Studies 9 - 1 2  from a 
50 cc. syringe attached to a 100 cm. manometer line (Portex) 
using a Treonic I.P.3 volumetric syringe pump to drive the syringe. 
Propofol was infused in Studies Eleven and Twelve from a 50 cc. 
syringe connected to a 100 cm. manometer line using an Injectomat 
Syringe Pump (Dylade Medical, Runcorn, Cheshire) which is also a 
volumetric pump. The precise means of connecting the infusion 
sets to the intravenous cannulae varied in different studies and 
are described in detail in each study.
Calibration of the Infusion Pumps
The Treonic D.C.2 rotary pump is essentially a drop counter,
As drop size, and therefore the volume of fluid infused, may be
altered by the surface tension of the solution, the pump was
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calibrated before each study. Solutions of normal saline (the 
control solution), etomidate in normal saline and a mixture of 
etomidate and fentanyl in normal saline, in the volumes and concentratior 
which were to be used clinically, were prepared. The infusion sets 
and the infusion pump were set up as if in clinical use. The pump 
was set to deliver fluid at different drop rates and for different 
lengths of time so that the total volume delivered should have been 
10 mis. The volumes were measured in a dry test tube calibrated 
to 0.1 ml. Each combination of drop rate and time was repeated 
twenty five times. The results are shown in Table One. The mean 
volume of the control solution (saline) delivered was 1 0 . 0 + 0 . 0 3  ml.
For etomidate in saline the mean volume delivered was 9.0 + 0.03 ml. 
and for etomidate, fentanyl and saline the mean volume delivered 
was 8.5 +_ 0.03 ml. These results are highly significantly different 
from each other (p 0.001). The amounts of etomidate and fentanyl 
quoted in the chapters describing the infusion studies have been 
corrected to take account of these calibration results.
The Treonic I.P.3 and Injectomat Syringe Pumps are volumetric 
pumps. Similar calibration studies to those described for the 
Treonic D.C.2 pump showed that using 50 cc. syringes and 100 cm. 
manometer lines, both pumps were accurate to + 2% when infusing 
either fentanyl or propofol over the rates of infusion used in 
these studies.
Anaesthetic Technique for the Infusion Groups
All patients received intramuscular premedication sixty 
minutes before operation. All patients over sixty years of age received
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morphine lOmg. and atropine 0.6 mg. Male patients under sixty years of 
age received omnopon 20 mg. and hyoscine 0.4 mg. and female patients 
under sixty years of age received omnopon 15 mg. and hyoscine 0.3 mg. 
Patients were brought to the anaesthetic room 10 - 20 minutes before 
the induction of anaesthesia. A continuous E.C.G. and heart rate 
monitor (Diascope D.S. 521, Simonsen and Weel, Denmark) and a 
blood pressure cuff were attached. At this time, the patient’s 
agreement to take part in any study was finally confirmed.
Immediately before the induction of anaesthesia, venous 
access was established via a vein in the dorsum of the non-dominant 
hand under local analgesia, through which all injections and infusions 
of hypnotics and analgesics were administered. Local analgesia 
for the venepuncture was provided by the subcutaneous injection of 
1 ml. of 1% lignocaine without adrenaline over the proposed puncture 
site. Induction began with the injection of 1.3 meg. kg. ^ of 
fentanyl intravenously. After the elapse of 1 - 2 minutes, the 
hypnotic appropriate to that particular study was injected or infused. 
Once the eyelash reflex had disappeared, intubation of the trachea, 
if required, was facilitated with 100 mg. of succinylcholine except 
in Studies Eleven and Twelve, when a dose of 1 mg.kg. ^ of 
succinylcholine was used. The position of the endotracheal tube 
was confirmed by observation of the movement of the patient’s chest 
wall and by auscultation of their chest and abdomen. The infusion 
of the hypnotic under study was commenced immediately thereafter.
All patients breathed 100% oxygen during the induction of anaesthesia.
If apnoea occurred in patients who were to breathe spontaneously,, manual 
ventilation was carried out until spontaneous respiration returned.
The induction of anaesthesia was judged to be satisfactory
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when the patient was lying still with all cardiovascular parameters 
within 20% of their pre-induction values and either-breathing adequately 
with a quiet, unobstructed respiratory pattern, or being adequately 
ventilated after a satisfactory intubation, and an absent eye-lash 
reflex.
Once the induction of anaesthesia had been satisfactorily 
completed, the patients were moved from the anaesthetic room 
and transferred to the operating theatre. At this point the 
patients had to be disconnected from the anaesthetic equipment for 
a period of 30 - 60 seconds. The Treonic D.C.2 infusion pump was 
connected to an electrical socket in the operating theatre by an 
extension cable, and the Injectomat Syringe .Pump was both battery 
and electrically powered. This meant that neither the infusion of 
etomidate nor of propofol was interrupted during transfer of the 
'patients.
The patients were then connected to the modified anaesthetic 
machine and the correct functioning of the monitors and the infusion 
pumps was rechecked. At this point, the infusion of analgesia was 
commenced (unless it had been combined with the etomidate). The 
initial infusion rates of the hypnotics and analgesics were three 
to four times the estimated maintenance infusion rates. The aim was 
to gradually reduce these rates during surgery unless the protocol 
for a particular study required a fixed rate of infusion.
If the systolic arterial blood pressure and the pulse rate
remained within a range of 20% above and below the pre-operative
values and the respiratory rate remained between 10 - 20 breaths 
per minute (in spontaneously breathing patients), then the rate of
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infusion of etomidate and fentanyl or fentanyl alone was 
gradually reduced throughout the operation to as low a rate as 
possible.
If the systolic arterial pressure and the pulse rate rose 
above the upper limit, or if the patient began to sweat or to 
lachryraate then the rate of infusion of etomidate and fentanyl or 
fentanyl alone (depending on the protocol) was increased until 
these variables had returned to within the desired range . Other 
indications for increasing the rate of infusion in spontaneously 
breathing patients were a respiratory rate greater than 20 breaths 
per minute or if the patient began to move during surgery. If 
increasing the infusion rate did not produce an adequate response, 
then 33% oxygen in nitrous oxide was substituted for the inspired 
oxygen/air mixture, halothane was added and the total intravenous 
anaesthetic technique was abandoned. Other measures which were 
thought to be clinically necessary could be carried out at the 
discretion of the anaesthetist in charge of the case.
If the systolic arterial pressure, pulse rate or respiratory 
rate fell below the lower limit, the rate of infusion of etomidate 
and fentanyl or fentanyl alone (depending on the protocol) was 
decreased until an adequate response was obtained. If decreasing 
the rate of infusion did not produce an adequate response then the 
protocol could be broken and other measures be taken at the discretion 
of the anaesthetist in charge of the case.
When mechanical ventilation was required, the ventilator was 
adjusted to produce an expired tidal volume of 8 - 9 ml.kg.
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This was checked by a Wright's respirometer inserted into the 
expiratory limb of the ventilatory circuit. The minute volume flow 
was adjusted to produce a respiratory rate of 12 - 15 breaths per 
minute. Neuromuscular blockade was continued in Studies 7 - 1 0  with 
tubocurarine 0.5 mg.kg. ^ administered intravenously. This was 
administered after the return of diaphragmatic movement had been 
observed and confirmed by movement of the reservoir bag of the 
anesthetic machine. Further increments of tubocurarine 0.25 mg.kg.  ^
were given in response to muscle movement during surgery. In 
Studies Eleven and Twelve, bolus doses of atracurium or vecuronium 
were administered intravenously as required to provide neuromuscular 
blockade. In Study Eleven an initial dose of 400 meg.kg. ^ of 
atracurium was given with further increments of 200 meg.kg. ^ given 
in response to patient movement or tightening of the abdominal 
muscles during surgery. In Study Twelve bolus increments of atracurium 
190 meg.kg. ^ or vecuronium 45 meg.kg. ^ were administered when 
there was a palpable response to the second stimulus of a "train of 
four" series of supramaximal stimuli delivered to the ulnar nerve 
in the forearm delivered from a Myotest Mark 2 peripheral nerve 
stimulator.
Anaesthetic Technique for the Control Groups
Anaesthesia for the control groups in Studies Eight, Nine 
and Ten was kept as similar to that of the infusion groups as 
possible. The important differences were that for all patients in
-1
the control groups anaesthesia was induced with thiopentone 5 mg.kg. 
and maintained by the inhalation of 33% oxygen in nitrous oxide.
This was supplemented with halothane in the spontaneously breathing
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groups, or morphine 0.7 mg.kg.-^ in the ventilated groups. The 
inspired concentration of halothane varied from 0.5 - 2% and was 
altered using the same criteria as described for the infusion 
groups. Halothane 0.5% was administered to the ventilated 
patients if increases in systolic arterial blood pressure or pulse 
rate occurred which were greater than 20% above the pre-induction 
levels, or if sweating or lachyrmation was1 observed.
Observations Made
Quality of Induction and Maintenance of Anaesthesia
Observations were made of the presence or absence of pain on 
injection or infusion and muscle movement. Patients were not 
specifically asked about the presence of pain during injection, but 
only whether the hand and arm were comfortable. The extent of muscle 
movement was classified as described for the induction studies on 
page 46 . The quality of the maintenance of anaesthesia, particularly 
in response to surgical incision and the ease of maintenance of 
anaesthesia was noted.
The presence or absence of cutaneous flushing, peripheral 
vasodilatation, angioneurotic oedema, or other manifestations 
of histamine release, such as bronchospasm, were looked for and 
their occurrence noted.
Cardiovascular System
The E.C.G. was continuously monitored from before induction
S9
until the end of anaesthesia, using a Diascope D.S. 521. Measurements 
of arterial systolic and diastolic blood pressures were made 
immediately before induction, one minute after induction, and at 
various intervals as described in each study until anaesthesia and 
surgery were satisfactorily established. Thereafter, measurements 
were made at five minute intervals until the end of surgery, unless 
more frequent measurements were clinically required. In the etomidate 
studies, arterial systolic and diastolic blood pressures were measured 
using an oscillotonometer and the pulse rate was measured by 
palpation. In the propofol studies, a Dinamap 845 (Criticon Inc.) 
was used to measure the arterial systolic and diastolic blood pressures 
and the heart rate.
Respiratory System
Every five to ten minutes, measurements of the respiratory 
rate were made visually over a two minute period in all the 
spontaneously breathing patients. Severe respiratory depression 
was defined as a respiratory rate of less than six breaths per 
minute. In these circumstances,ventilation was manually assisted 
and the infusion rate reduced until adequate spontaneous respiration 
was re-established. Complications such as cough, hiccough, 
laryngospasm and bronchospasm were looked for and their occurrence 
noted.
In all the etomidate infusion studies which involved patients 
being allowed to breathe spontaneously, arterial blood samples, 
usingaheparinised syringe connected to a 23 S.W.G. needle, were taken 
from the radial artery at the wrist of the non-dominant arm of
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twenty suitable patients in both infusion and control groups for 
the measurement of arterial carbon dioxide tension. Samples were 
not taken from any patient if Allen*s test suggested that the collateral 
circulation was inadequate. The control sample was taken under local 
analgesia, after the patient had been in the anaesthetic room for 
10 minutes and after the attachment of any monitoring equipment, 
but before the insertion of an intravenous cannula. Local analgesia 
for the arterial puncture was provided by the subcutaneous injection 
of 1 ml. of 1% lignocaine without adrenaline over the proposed 
puncture site. A further sample was taken once a steady state of 
anaesthesia had been achieved for at least 20 minutes. The third 
sample was taken under local analgesia in the recovery area, 15 
minutes after the end of anaesthesia. Samples were not taken from 
any patient during anaesthesia or during the recovery period if a 
steady respiratory state was not achieved during anaesthesia.
If a complete set of results was not obtained from any patient the 
patient was withdrawn from this part of the study and the next 
suitable patient was substituted.
Recovery
The hypnotic agents (infused or inhaled) were switched off when 
wound closure was complete. This point was taken to be the end of 
the operation and the start of the recovery period. The time was 
noted. In the ventilated patients, residual neuromuscular blockade 
was antagonised with neostigmine 2.5 mg. (combined with atropine 
1.2 mg.). The patients were extubated once adequate spontaneous 
respiration had been re-established.
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The patients were then transferred to a trolley and returned 
to the recovery area. Transfer of all patients was completed within 
two minutes. Their recovery was supervised by a nurse whose sole 
responsibility was the care of that patient. All patients breathed 
air enriched with 4.1 min ^ of oxygen via a Hudson mask throughout 
their stay in the recovery area. At thirty second intervals after 
the end of anaesthesia, patients were asked by the anaesthetist to 
open their eyes, raise their head on command and move their left 
thumb. The time when the patients could achieve these three objectives 
was taken to be the time of early recovery and was recorded. In the 
propofol infusion studies, patients were also asked their name and 
address. Patients remained in t'he recovery area until they had fully 
recovered consciousness for at least fifteen minutes. They were 
then reassessed by the anaesthetist who decided whether they should 
return to the ward, or remain for a longer period of time in the 
recovery area.
Patients were visited in the ward by the anaesthetist several 
hours after their operation and revisited 24 - 48 hours after 
operation. As in the induction studies, the patients were asked 
about the presence or absence of pain on injection, nausea, vomiting 
or headache, and their opinion of the anaesthetic they had received.
, Particular attention was paid to trying to determine whether any 
episodes of awareness had occurred during anaesthesia. This was 
done by asking specific questions as to what patients remembered 
from leaving the ward until their post-operative visit by the 
anaesthetist. Patients were also asked whether they had had any 
dreams or other memories associated with this period. During this 
visit, the infusion site was inspected for signs of venous damage.
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The extent of venous damage was classified as described on page 48 
Analysis of Data
One of the major statistical problems of the infusion studies 
was how to quantify the changes in infusion rates and cardiovascular 
parameters. This was done by calculating the coefficient of 
variation. The coefficient of variation is defined as th^ standard
i
deviation of a series of numbers divided by their mean, expressed 
as a percentage. In the infusion studies, changes in infusion 
rates and cardiovascular parameters occurring during the course of 
an individual anaesthetic were quantified by calculating the 
appropriate coefficient of variation for each parameter. The 
variation of the infusion rates and the cardiovascular parameters 
for each group was estimated by calculating from the values 
obtained from each patient, the mean coefficient of variation and 
the standard error of the mean for each variable.
Statistical Analysis
Data such as patient’s age and weight, arterial systolic and 
diastolic blood pressures, pulse rate, arterial carbon dioxide 
tension, infusion rates and duration of action of neuromuscular 
blocking agents were regarded as being normally distributed.If 
three or more groups were being compared, then the one-way F test 
was used; otherwise Student’s t test, either paired or unpaired 
as appropriate, was used.
The time to recovery, urea and electrolytes and liver function
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test results were regarded as being non parametric in distribution.
For paired data the Wilcoxon matched pairs signed-ranks test 
was used, if unpaired, the Mann-Whitney U test.
The incidence of pain on injection, apnoea and muscle movement wen
regarded as binomial data. The Chi squared test with the Yates 
correction for small numbers was used with the appropriate degrees 
of freedom.
The following statistical text books were consulted.
Haber A. and Runyon R.P. (1973) General Statistics. Second Edition.
Pub. Addison Welsey Company.
Siegel S. (1956) Nonparametric Statistics for the Behavioural 
Sciences. Pub. McGraw-Hill.
CHAPTER THREE
STUDIES ONE AND TWO
ETOMIDATE IN PHOSPHATE BUFFER FOR
THE INDUCTION OF ANAESTHESIA
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Study One
Effects of Different Rates of Injection 
Introduction
Etomidate was first supplied for intravenous administration in 
a vial of 20 mgs. of etomidate powder with a separate vial of sodium 
phosphate 27 mgs. and sodium biphosphate 44 mgs. also in powder 
form^as diluent. This second vial was made up to a 20 ml. solution 
with sterile water and added to the vial of etomidate to produce a 
1 mg.kg. ^ solution of etomidate. The solution was used as soon 
as possible after preparation. The aim of this study was to assess 
the effects of different rates of injection of etomidate in this 
solvent on the quality of induction and maintenance of anaesthesia.
Patients and Methods
Ninety eligible patients were randomly allocated to one of three 
groups. Each group was to be induced with etomidate 0.3 mg.kg. ^ 
administered over 15, 30 or 60 seconds. Due to a misunderstanding 
of the protocol, two patients received etomidate over 60 seconds 
instead of the intended 30 seconds. Premedication and preparation 
of patients for the induction of anaesthesia was carried out as 
described in Chapter Two. After the measurement of pulse rate and 
arterial systolic and diastolic blood pressures, etomidate was 
injected via a 21 S.W.G. needle inserted into a vein in the ante- 
cubital fossa or in the dorsum of the non-dominant hand. Maintenance
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anaesthesia and recovery of the patients, as well as observations 
of the quality of induction and maintenance of anaesthesia were 
carried out as described in Chapter Two. Measurements of arterial 
systolic and diastolic blood pressures and pulse rate were made
immediately before the induction of anaesthesia, at one minute
after induction, before the administration of halothane and again 
five minutes after induction. In this study, the times tp early and
late recovery were not recorded.
Results
Composition of the Groups
Patient details are shown in Table Two. The groups were very 
similar in weight and sex distribution. These differences were not 
statistically significant. However the group receiving etomidate 
over 30 seconds was younger than the other two groups. This 
difference was statistically significant (p <  0.02).
Quality of Induction and Maintenance
Anaesthesia was successfully induced in all patients.
Induction was rapid and without apnoea, laryngospasm or bronchospasm. 
There was no evidence of histamine release in any patient.
Maintenance of anaesthesia was satisfactory in all patients in 
each group. The complications found are discussed later in the 
chapter.
TABLE TWO
DETAILS OF PATIENTS
IN THE FIRST ETOMIDATE INDUCTION STUDY
INJECTION
RATE
NO. OF 
PATIENTS
MEAN AGE 
'(YRS)
+ S.E.M.
MEAN WT.
(Kg.)
+ S.E.M.
60 SECS.
21M
32
11F
60 + 3 61 + 1
30 SECS.
17M
28
11F
52 + 3 * 60 + 1
15 SECS.
23M
30
7F
61 + 2 59 + 1
* SIGNIFICANTLY (P <  0.02) LOWER THAN THE OTHER 
TWO GROUPS.
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Cardiovascular Changes
The mean values of the measurements of the arterial systolic 
and diastolic blood pressures and the pulse rates in each group 
with their associated standard errors of the mean are shown in 
Figure Three. There were no statistically significant changes in 
arterial systolic and diastolic pressures in any group during the 
induction of anaesthesia. There was a rise in pulse rate in all 
three groups during the induction of anaesthesia, but this was not 
clinically or statistically significant.
Study Two
Comparison with Propanidid
The aim of this study was to compare the cardiovascular 
effects and quality of anaesthesia of different rates of 
injection of etomidate with a fixed rate of injection of propanidid.
Patients and Methods
One hundred and sixty eligible patients were randomly allocated 
to one of four groups. The preparation of etomidate used was the 
same as that used in the first study. One group was to receive 
propanidid 7 mg.kg. ^ over 30 seconds. The other groups were to 
receive etomidate 0.3 mg.kg. ^ administered over 15 or 30 seconds.
In one group who was to receive etomidate 0.3 mg.kg. ^ over 15 
seconds, atropine premedication was omitted.
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Due to a misunderstanding of the protocol by one of the 
investigators, nine patients received fentanyl immediately before 
induction and were eliminated from the trial. Another nine patients 
were allocated to the wrong group. The final number of patients 
in each group is shown in Table Three.
Premedication and preparation of patients for the induction 
of anaesthesia was carried out as described in Chapter Two. After 
the measurement of pulse rate and arterial systolic and diastolic 
blood pressures, etomidate or propanidid was injected via a 21 S.W.G. 
needle inserted into a vein in the antecubital fossa or in the 
dorsum of the non-dominant hand. Maintenance of anaesthesia and 
recovery of the patients as well as observations of the quality of 
induction and maintenance of anaesthesia and the time to early and 
late recovery were carried out as described in Chapter Two. 
Measurements of arterial systolic and diastolic blood pressures 
and pulse rate were made immediately before the induction of 
anaesthesia, at one minute after induction, before the administration 
of halothane, again on insertion of the cystoscope and also at the 
end of anaesthesia. The time to achieve early recovery was noted 
and further measurements of arterial systolic and diastolic blood 
pressures and pulse rate were made at that time. The time to 
late recovery was also noted.
Results
Composition of the Groups
The composition of the groups is shown in Table Three.
TABLE THREE
DETAILS OF PATIENTS
IN THE SECOND ETOMIDATE INDUCTION STUDY
NO. OF 
PATIENTS
MEAN AGE 
(YRS.)
+ S.E.M.
MEAN WT.
(Kg.)
+ S.E.M.
PROPANIDID
24M
40
16F
58 + 2 64 + 22
ETOMIDATE 
(30 SECS.)
20M
30
10F
55 + 2 62 + 2 .
ETOMIDATE 
(15 SECS.)
22M
32
10F
61 + 3 63 + 2
ETOMIDATE 
(15 SECS.)
(ATROPINE
OMITTED)
37M
49
12F
53 + 2 69 + 2
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There were no statistically significant differences between the 
groups.
Quality of Induction and Maintenance
Anaesthesia was successfully induced in all patients. The 
induction of anaesthesia was rapid without apnoea, laryngospasm 
or bronchospasm. There was no evidence of histamine release in any 
patient. Maintenance of anaesthesia was satisfactory in all 
patients in each group. The complications found are discussed 
later in the chapter.
Cardiovascular Changes
The mean values of the measurements of the arterial systolic 
and diastolic blood presures and the pulse rates in each group with 
their associated standard errors of the mean are shown in Figure 
Four. There were no statistically significant changes in_the arterial 
systolic and diastolic pressures or pulse rates in the two groups 
receiving etomidate and atropine. There was a statistically 
significant fall (p <  0 .0 1) in the mean arterial systolic pressure 
during induction in the control group receiving propanidid which 
rapidly returned to control levels. There were no statistically 
significant changes in the mean arterial diastolic pressures and 
pulse rates in any group during the induction and maintenance of 
anaesthesia. The omission of atropine resulted in a lower mean pulse 
rate in that etomidate group prior to induction. The mean pulse rate 
rose after induction but remained lower than the corresponding 
group which had received atropine premedication. These differences
Fig. 4
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were all statistically significant (p < 0 .01).
Recovery
The times of early and late recovery were comparable in the 
four groups as shown in Table Four. There were no statistically 
significant differences between the groups, except that the mean 
time to respond was faster when etomidate (with atropine premedication) 
was administered over 15 seconds compared with its administration 
over 30 seconds. This difference was statistically significant 
(p <  0.05). The overall incidence of nausea and vomiting was 7.5%.
Two patients had hallucinations, another, a known epileptic, suffered 
an epileptiform fit.
Complications
The incidence and severity of pain on injection and muscle 
movement of all patients receiving etomidate and atropine were 
pooled and compared with those found with propanidid. The results 
are shown in Table Five. The overall incidence of pain with 
etomidate (24%) was greater than that of propanidid (0%). This 
difference was statistically significant (p <  0.0001). Increasing 
the rate of injection to 15 seconds from 30 or 60 seconds reduced 
the incidence of pain from 32% to 13%. This difference was 
statistically significant (p < 0.025). The pain could be extreme
and three patients refused to be re-anaesthesed with etomidate as 
a result of their experience.
The overall incidence of muscle movement with etomidate (29%)
TABLE FOUR
DETAILS OF RECOVERY TIMES
IN THE SECOND ETOMIDATE INDUCTION STUDY.
PATIENT
NOS.
MEAN TIME 
TO RESPOND 
(MINS.) + S.E.M.
MEAN TIME 
TO STAND 
(MINS.) + S.E.M.
PROPANIDID AO 7 + 0.1 17 + 0.6
ETOMIDATE
30 8 + 0.8 19 + 1.2
(30 SECS.)
ETOMIDATE
32 6 + O.A 18 + 1.0
(15 SECS.)
ETOMIDATE
(15 SECS.) 49 6 + 0.6 18 + 1.0
(ATROPINE.
OMITTED)
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was greater than that found with propanidid (0%). This difference 
was,, statistically significant (p <  0.0001). Injection of etomidate 
0.3 mg.kg. ^ over 15 seconds reduced the incidence of involuntary 
muscle movements to 14.5%, compared with the 43% found when injected 
over 30 seconds. This difference was statistically significant 
(p <  0.01). This incidence just failed to reach statistical 
significance at the 0.05 level when compared with the 31% found 
when etomidate was injected over 60 seconds. The movements soon 
ceased when halothane was introduced and the time to insertion of 
the cystoscope was not unduly prolonged. Patients did not complain 
of muscular pain post-operatively.
Conclusions
The conclusions of these initial studies were that etomidate 
was a short acting induction agent with excellent cardiorespiratory 
stability. There was a high incidence of pain on injection and 
involuntary muscle movements, reduced by the rapid injection of 
etomidate. The muscle movements were easily controlled by the 
administration of halothane.
Compared with propanidid, etomidate produced a greater degree 
of cardiovascular stability; but the incidence of pain on injection 
and muscle movement was significantly higher.
ETOMIDATE
CHAPTER FOUR
STUDIES THREE AND FOUR
IN POLYETHYLENE AND PROPYLENE GLYCOL
FOR THE INDUCTION OF ANAESTHESIA
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Introduction
From the results of the studies described in Chapter Three 
and from other similar studies (Morgan, Lumley and Whitwam, 1975; 
Holdcroft et al, 1976), it became clear that the incidence of 
side effects with the original formulation of etomidate was 
unacceptably high. In an attempt to reduce these side-effects, 
the solvent was changed to first polyethylene glycol (P.E.G. 1000) 
and then to propylene glycol. Table Six shows how changing the 
solvent considerably raised the osmolality and pH of the etomidate 
preparations. The values for methohexitone and diazepam are shown 
for comparison. Changes in solvent can affect the potency of a 
drug due to changes in drug solubility or to synergistic or 
antagonistic effects of the solvent itself (Walsh, 1984). Studies 
Three and Four assessed the effects of these changes of formulation 
of etomidate on cardiovascular stability and the incidence of 
side-effects.
Study Three
Polyethylene Glycol as Solvent
Polyethylene glycol 1000 is a macrogol with an average 
molecular weight of 1000 (Walsh, 1984). The aim of this study 
was to evaluate the effects of two different rates of injection 
of etomidate dissolved in polyethylene glycol 1000 on potency, 
cardiovascular stability, and quality of anaesthesia.
TABLE SIX
EFFECT OF DIFFERENT SOLVENTS ON pH 
AND OSMOLALITY OF ETOMIDATE *
pH AT 37°C OSMOLALITY 
(mOs/Kg.)
ETOMIDATE (PHOSPHATE) 3.46 254
ETOMIDATE (PEG) 5.21 550
ETOMIDATE
(PROPYLENE GLYCOL) 8.10 4640
METHOHEXITONE 9.94 78
DIAZEPAM (VALIUM)
INJECTION 6.38 7800
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Patients and Methods
Fifty eligible patients were randomly allocated to one 
of two groups. Each group was to receive etomidate 0.3 mg.kg. ^ with 
polyethylene glycol as sol vent, administered over 15 or 30 seconds. 
Premedication and preparation of patients for the induction of 
anaesthesia was carried out as described in Chapter Two. After the 
measurement of pulse rate and arterial systolic and diastolic blood 
pressures,etomidate was injected via a 21 S.W.G. needle inserted 
into a vein in the dorsum of the non-dominant hand. Maintenance 
of anaesthesia and recovery of the patients as well as observations 
of the quality of induction and maintenance of anaesthesia and the 
time to early recovery were carried out as described in Chapter Two. 
Measurements of arterial systolic and diastolic blood pressures 
and pulse rate were made immediately before induction and at one 
minute after induction, before the administration of halothane.
The time to achieve early recovery was noted and a further 
measurement of arterial systolic and diastolic blood pressures and 
pulse rate was made at that time.
Results
Composition of the Groups
The composition of the two groups is shown in Table Seven.
There were no statistically significant differences between the 
groups.
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Quality of Induction and Maintenance
Anaesthesia was successfully induced in all patients. No 
respiratory upsets, apnoea, or hiccough were observed. The 
incidence of pain on injection and myoclonia are shown in 
Table Seven. The incidence of pain on injection and muscle movement 
was very similar in both groups. This difference did not reach 
statistical significance.
Maintenance of anaesthesia was satisfactory in all patients 
in each group. No patient in either group showed any evidence of 
histamine release.
Cardiovascular Changes
The mean values of the measurements of the arterial systolic 
and diastolic blood pressures and the pulse rates in each group with 
their associated standard errors of the mean are shown in Figure 
Five. There were no statistically significant changes in the mean 
arterial systolic or diastolic pressures or pulse rates during the 
induction of anaesthesia or recovery in either group.
Recovery
Early recovery time when the etomidate was injected over 
15 seconds was slightly faster when compared with its injection over 
30 seconds (Table Seven). This difference was not statistically 
significant. Two patients in each group felt nauseated or were
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physically sick. All patients were willing to receive etomidate 
again.
Potential Toxicity of Polyethylene Glycol
Polyethylene glycol is a term for a wide range of glycols 
with molecular weights ranging from 200 to 6000. One of their 
pharmaceutical uses is to solubilise poorly water soluble drugs 
(Walsh, 1984). For many years these substances have been regarded 
as being biologically unreactive (Wilson and Thomas, 1984). It 
was in this climate of opinion about the safety of the polyethylene 
glycols that the study of etomidate in polyethylene glycol 1000 
was carried out in 1975 - 1976.
The pharmacological properties of the polyethylene glycols 
have recently been reviewed (Wilson and Thomas, 1984) and the 
assumptions about the biological inactivity of the glycols were 
questioned. The conclusions of this review were that the 
polyethylene glycols do show physicochemical and biochemical 
interactions with cells, and concluded that such interactions could 
be important.
These interactions could explain some isolated examples 
of possible toxicity associated with the use of polyethylene 
glycol 300. In a study of thirty two patients in which a preparation 
of nitrofurantoin and polyethylene glycol 300 had been infused for 
eight hours a day for five days, seven patients developed renal 
failure and two died. The histological appearances of the kidneys
of the dead patients showed changes similar to those found with
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ethylene glycol poisoning (McCabe, Jackson and Grieble, 1959). This 
suggested that the renal damage may have been linked with the use 
of polyethylene glycol 300.
As the low molecular weight polyethylene glycols are mainly 
excreted unchanged, and the remainder are not metabolised to 
ethylene glycol, the findings described by McCabe, Jackson and 
Grieble (1959) were attributed to deterioration of the polyethylene 
glycol 300 before infusion (Walsh, 1984). In retrospect, the 
review by Wilson and Thomas (1984) would suggest that this was 
perhaps an over simplistic explanation.
In view of the uncertainty surrounding the use of 
polyethylene glycols, it was decided to review all the patients who 
had participated in the study. Because of the length of time which 
had elapsed from the date of the study (ten years) and the apparent 
rapidity and severity of the reactions described by McCabe,
Jackson and Grieble (1959), it was felt that a review of the case- 
sheets of the patients concerned should be carried out first. If 
there was any evidence that any patient had suffered from cardiac 
or renal illness within a six month period of the administration 
of the preparation then these patients would be reviewed in person, 
if at all possible. No such evidence was found.
If these doubts about the safety of polyethylene glycol had 
been appreciated at the time of the study, it w o u l d  not have been
carried out. The study is included in this thesis because it 
represented a logical step in the investigation of etomidate. At
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the same time it is felt that these doubts about the safety of 
the study should be recorded.
Study Four
Propylene Glycol as Solvent
After the previous study had been completed, the solvent used 
for etomidate was changed to propylene glycol. This was done for 
pharmaceutical reasons as propylene glycol can be manufactured on 
a large scale more easily than polyethylene glycol.
This study compared the cardiovascular effects and complications 
of etomidate in propylene glycol with those of methohexitone. 
Methohexitone was chosen as the control hypnotic in preference to 
propanidid because of concern about the safety of Cremophor E.L.
(Watkins et al, 1976).
Patients and Methods
A hundred eligible patients were randomly allocated to one of
-1
two groups. Each group was to receive either etomidate 0.3 mg.kg. 
with propylene glycol as solvent or methohexitone 1.5 mg.kg. ^
Both drugs were to be injected over 30 seconds. Premedication and 
preparation of patients for the induction of anaesthesia was 
carried out as described in Chapter Two. After the measurement of 
pulse rate and arterial systolic and diastolic blood pressures, etomidate 
or methohexitone was injected via a 21 S.W.G. needle inserted into a
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vein in the dorsum of the non-dominant hand. Maintenance of 
anaesthesia and recovery of the patients as well as observations 
of the quality of induction, maintenance and time to early recovery 
were carried out as described in Chapter Two. Measurements of 
arterial systolic and diastolic blood pressures and pulse rate were 
made immediately before induction and at one minute after induction, 
before the administration of halothane. The time to achieve early 
recovery was noted and further measurements of arterial systolic 
and diastolic blood pressures and pulse rate were made at that time.
Results
Composition of the Groups
Patient details are shown in Table Eight. Age, weight and 
sex distributions were similar in both groups and were not 
statistically significantly different.
Quality of Induction and Maintenance
Anaesthesia was successfully induced in all patients.
No respiratory upsets, apnoea, or hiccough were observed. The 
incidence of myoclonic movements and pain on injection are shown 
in Table Eight. There was no statistically significant difference 
in the incidence of pain between the two groups but the incidence 
of myoclonia was greater in the etomidate group. This difference 
was statistically significant (p <  0 .0,1).
TA
BL
E 
E
I
G
H
T
2: •M >HQ00S os EhO w>
o
CO
55 CJ :sM w O< OS l-lOh EhCJ
o I=DPh H QO
W
SM
W 2CJ H W2 H Eh
pq <flQ OM Q l-lCJ Z 22 < oM
H*'
Eh
W
+• !SCO pq as
H 2 EhS w 05w > CDM o o
H< 2 P-<
Oh w pq>-q ffiPh CJ Eh
o CO
§co M
>-•
/
05
W
>
O
CJ CO COH /•—v • • •
OS • 2 o o
CO •
O as w + 1 + 1Eh 1—1 •
2 CO m o
w •
2 + Nf
IH
Eh
Eh
2
pq W
hJ 2
CJ w iH o
CO > i-H
£ o
2 s
2
o
ss m
O Eh
CJ
25 W
M l—) eg CO
< 2s
Ph 1— 1
CN rH
/-N W + | + |
2 • •
< o o c o i"- CO
w w , vD vO
■2 ^  +|
w
CD 2 CO CO< /-N •
• w + | + 1
s: c o  •
< OS CO r- vO
W >H m m
2  ^ +|
CO
Eh 2  P h 2  Po
P h 2 c o  r » CN 0 0
O W CO iH CO rH
H
Eh
O < O O
2; O h m in
pq
s
o
Eh
pq M
Eh X!
< pq
Q ffiM O
2 0 0
O EhEh pq
W 2
80
Maintenance of anaesthesia was satisfactory in all patients 
in each group. No patient in either group showed any evidence of 
histamine release.
Cardiovascular Changes
The mean values of the measurements of the arterial systolic 
and diastolic blood pressures and the pulse rates in each group 
with their associated standard errors of the mean are shown in 
Figure Six. No statistically significant differences were found 
between the groups, both groups showing minimal changes in their 
mean systemic arterial systolic and diastolic arterial pressures 
and pulse rates during the induction of anaesthesia and during 
recovery.
Recovery
Early recovery from methohexitone was slightly faster compared 
with etomidate as shown in Table Eight. This difference was not 
statistically significant. Three patients in the etomidate group 
felt nauseated or were sick compared with two in the methohexitone 
group. All patients were willing to receive etomidate again.
Conclusions
The potency, short duration of action and the cardiovascular 
stability of etomidate remained unchanged despite changes of solvent. 
The incidence of pain on injection was greatly reduced compared with
Fig. 6
CARDIOVASCULAR CHANGES DURING THE FOURTH 
ETOMIDATE INDUCTION STUDY
Etomidate
Methohexitone
81
the incidence of pain in the groups receiving the original formulation 
of etomidate. In contrast, the incidence of myoclonic movements 
remained unchanged. In these two studies, no patient refused to 
be re-anaesthetised with etomidate as a result of their experience.
Etomidate formulated in propylene glycol was found to have 
a similar degree of cardiovascular and respiratory stability to 
that found with methohexitone. The incidence of pain on 
injection was similar with both drugs, but the incidence of muscle 
movement was much higher with etomidate.
CHAPTER FIVE
STUDY FIVE
ETOMIDATE AND FENTANYL 
FOR THE INDUCTION OF ANAESTHESIA
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Introduction
Chronologically this study was carried out after the etomidate 
infusion studies and was designed partly as a prelude to further 
infusion studies with etomidate. These proposed studies were 
abandoned after the effect of etomidate on adrenal function became 
known (Fellows et al, 1983). However, since the study investigated 
the effects of alfentanil on the induction characteristics of 
etomidate it is appropriate to. describe it here, following the 
other etomidate induction studies.
Alfentanil is an intravenous narcotic closely related to 
fentanyl, but with a more rapid onset of action and recovery (Kay 
and Stephenson, 1980; Stanski and Hug, 1982; Sinclair and Cooper, 
1983). The fifth etomidate induction study was carried out mainly 
to assess the effects of an intravenous bolus of alfentanil on the 
quality of induction of anaesthesia with etomidate.
Patients and Methods
Fifty women aged between 18 and 65 years old, who were to 
undergo minor gynaecological surgery, either dilatation and curettage, 
or early termination of pregnancy (of less then ten weeks duration) 
were randomly allocated to one of two groups. One group was to be 
induced with etomidate alone. The other group was to receive 
alfentanil prior to receiving etomidate.
Premedication and preparation of patients for anaesthesia 
were carried out as described in Chapter Two. In this study
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continuous monitoring of the E.C.G. was carried out before and 
during the induction and maintenance of anaesthesia. After the 
measurement of pulse rate and arterial systolic and diastolic 
blood pressures, a 23 S.W.G. cannula (Abbott "Butterfly” , No. 4871) 
was inserted into a vein in the dorsum of the non-dominant hand.
The control group received etomidate 0.3 mg.kg. ^ alone, 
injected over thirty seconds. Anaesthesia was maintained with 
33% oxygen in.nitrous oxide. After a minute, anaesthesia was 
supplemented with halothane 0.5 - 2%. The inspired concentration 
of halothane was altered according to clinical requirements as 
described in Chapter Two.
The alfentanil group received a bolus dose of 8 meg.kg. ^ of 
alfentanil I.V. immediately before induction with etomidate 0.3 mg.kg. 
administered over thirty seconds. Anaesthesia was maintained with 
33% oxygen in nitrous oxide and supplemented with bolus increments 
of etomidate 6 mg. I.V. as required. All patients undergoing 
termination of pregnancy received 0.5 mg. of ergometrine intravenously 
when requested by the surgeon.
Observations of the quality of induction and maintenance of 
anaesthesia were carried out as described in Chapter Two.
Measurements of arterial systolic and diastolic blood pressures 
and pulse rate were made immediately before induction and at one, 
two and five minutes after induction. After being transferred to 
the recovery area, patients breathed air enriched with 4.1 min ^ 
of oxygen via a Hudson mask until recovery was complete. Their
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recovery was supervised as described in Chapter Two. The time 
to early recovery was noted. Patients were seen again in the 
ward some hours after operation and again within the next 24 hours 
whenever this was possible.
Results
Composition of the Groups
Details of the patients and the duration of anaesthesia 
are shown in Table Nine. There were no statistically significant 
differences between the two groups.
Quality of Induction and Maintenance
Anaesthesia was induced successfully in both groups, without 
breath-holding, coughing or apnoea. The effect of alfentanil on 
the incidence of the side-effects of etomidate are shown in Table 
Nine. In particular, there was a statistically significant 
reduction ( p <  0 .0 1 ) in the incidence of pain on injection and 
myoclonic movements. However on questioning after anaesthesia, 
seven patients recalled having pain or being aware of venous sensation 
during injection of etomidate. Five had received alfentanil and 
two were in the control group.
Maintenance of anaesthesia was satisfactory in all 
patients in both groups. An average amount of 25 meg.kg. ^ min ^ 
of etomidate was required to maintain anaesthesia in the patients 
in the alfentanil group.
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No patient in either group showed any evidence of histamine 
release.
Cardiovascular Changes
The mean values of the measurements of the systemic arterial 
systolic and diastolic arterial pressures and pulse rates in each 
group with their associated standard errors of the mean are 
shown in Figure Seven. No statistically significant changes from 
the pre-operative values during the induction period were found in 
either group.
Recovery
Early recovery was faster in the group receiving alfentanil 
with a mean time to recovery of 4 +_ 0.5 minutes compared with the 
control mean time of 8 + 0 . 7  minutes. This difference was statistically 
significant (p < 0.01). Two patients in the control group were 
nauseated compared with four in the alfentanil group, one of whom 
was physically sick. This difference was not statistically 
significant.
Conclusions
The conclusions of this study were that the use of alfentanil 
greatly reduced the incidence of pain and myoclonic movement 
without reduction of cardiovascular stability or the speed of 
recovery.
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Although carried out on a very limited scale and with the 
addition of nitrous oxide, it appeared that the combination of 
etomidate and alfentanil was potentially suitable for further 
evaluation as a total intravenous anaesthetic technique.
CHAPTER SIX
STUDY SIX
PROPOFOL FOR THE INDUCTION OF ANAESTHESIA
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Introduction
The aim of this study was to evaluate the effects of the injection 
of propofol into a small vein (dorsum of the hand), a large vein 
with a high blood flow (antecubital fossa) and pretreatment with 
intravenous lignocaine when injected into a small vein, on the 
quality of induction and maintenance of anaesthesia with an intravenous 
injection of propofol and to compare these effects with those of 
thiopentone.
Patients and Methods
One hundred and sixty eligible patients between the ages of 
18 and 65 years, undergoing a variety of minor elective surgical and 
gynaecological procedures were randomly allocated to one of four 
groups. Details of the operations undergone in each group are 
shown in Table Ten.
Premedication and preparation of patients for anaesthesia 
were carried out as described in Chapter Two. In this study continuous 
monitoring of the E.C.G. was carried out before and during the 
induction and maintenance of anaesthesia. After the measurement 
of pulse rate and arterial systolic and diastolic blood pressures 
with a Dinamap 845 (Criticon Inqj, a 23 S.W.G. cannula (Abbott 
"Butterfly". No. 4871) was inserted into a vein in the dorsum 
of the non-dominant hand in all groups, except in Group B where it 
was inserted into a vein in the antecubital fossa of the non-dominant 
arm. Patients in Group A received an induction dose of propofol 
alone via the dorsum of the hand. Patients in Group B received
TABLE TEN
OPERATIONS CARRIED OUT ON 
EACH GROUP IN THE PROPOFOL 
INDUCTION STUDY
OPERATION GROUP A GROUP B GROUP C GROUP D
DILATATION 
AND CURETTAGE
18 17 18 19
BREAST BIOPSY 7 5 8 7
REPAIR OF 
INGUINAL HERNIA
3 3 2 3
LIGATION OF 
VARICOSE VEINS
2 3 4 3
LAPAROSCOPY 8 11 5 4
HAEMORRHOIDECTOMY 2 1 3 4
40 40 40 40
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propofol via the antecubital fossa. Patients in Group C 
received 10 rag. of lignocaine I.V. through the cannula followed 
sixty seconds later by the induction dose of propofol. The 
induction dose of propofol 2.5 mg.kg. ^ was administered over 
twenty seconds in all patients. Patients in Group D (the 
control group) received thiopentone 4.5 mg.kg. ^ also administered 
over twenty seconds.
After the induction of anaesthesia all patients breathed 
33% oxygen in nitrous oxide for a period of two minutes without 
further inhalational or intravenous supplementation. Thereafter 
anaesthesia was supplemented with 0.5 - 2% halothane. The 
inspired concentration of halothane was altered according to clinical 
requirements as described in Chapter Two. Measurements of pulse 
rate and arterial systolic and diastolic blood pressures were made 
immediately before, and at one and two minutes after induction. 
Another measurement was made after surgery had commenced, five 
minutes after induction. Other observations of the quality of 
induction and maintenance of anaesthesia were made as described in 
Chapter Two. Of particular interest was the incidence of pain 
on injection, muscle movement and apnoea.
Immediately after surgery had been completed, patients were 
transferred to a trolley and moved to the recovery area where they 
were supervised as described in Chapter Two. There they breathed 
40% oxygen via a Hudson mask until recovery was complete. Due 
to the differences in the types of operations and their duration, 
the time to recovery was not looked at in detail. All patients 
were visited in the ward some hours after operation and again
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within the next 24 hours when this was possible.
Results
Composition of the Groups
The composition of the groups is shown in Table Eleven.
There were no statistically significant differences between the 
groups.
Quality of Induction and Maintenance
Anaesthesia was successfully induced with propofol or thiopentone 
in all patients. There was no coughing or laryngospasm. The 
incidence of pain on injection is shown in Table Twelve. Propofol 
when injected via a vein in the dorsum of the hand led to a 37.5% 
incidence of pain. The reduction of pain to 17.5% by pre-treatment 
with lignocaine was not statistically significant. Use of a 
larger vein in the antecubital fossa (Group B) reduced the incidence 
to 2.5%. Compared to the incidence of pain when propofol was 
injected alone into a vein in the dorsum of the hand, this difference 
was statistically significant (p < 0.001). The incidence of pain 
during thiopentone injection (7.5%) was similar to that found when 
injecting propofol into a large vein. The incidence of pain during 
the injection of thiopentone was less than that found when propofol 
was administered alone via a vein in the dorsum of the hand. This 
difference was statistically significant (p < 0.01). Other 
sensations such as heat, cold and tingling at the site of injection
TABLE ELEVEN
DETAILS OF PATIENTS IN THE PROPOFOL INDUCTION STUDY.
SUBJECT
NOS.
MEAN AGE 
(YRS.)
+ S.E.M.
MEAN WT. 
(Kg.)
+ S.E.M.
34F
GROUP A 40 35 + 3 59 + 2
6M
35F
GROUP B 40 37 + 4 60 + 3
5M
31F
GROUP C 40 35 + 3 60 + 2
9M
39F
GROUP D 40 32 + 3 62 + 3
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were similar in all groups as shown in Table Twelve. Six 
patients induced with propofol complained of tingling in the neck 
or face.
Six of the patients induced with propofol had spontaneous 
muscle movement of short duration compared with two in the 
thiopentone group. No other side-effects were noted.
Maintenance of anaesthesia was satisfactory in all patients. 
Cardiovascular Changes
The mean values of the measurements of the arterial 
systolic and diastolic blood pressures and the pulse rates in 
each group with their associated standard errors of the mean are 
shown in Figure Eight. The mean systolic and diastolic blood 
pressures and pulse rates before induction were similar in all four 
groups. After induction, all groups showed a small drop in their 
mean arterial systolic pressures. This drop was statistically 
significant in all the groups (p < 0.01). The thiopentone group 
showed a rise in the mean pulse rate at 1, 2 and 5 minutes compared 
with the propofol groups. This difference was statistically 
significant (p <  0.01). There were no statistically significant 
changes in the mean arterial diastolic blood pressures in any 
group.
Respiratory Changes
The incidence of apnoea is shown in Table Twelve. The
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group induced with thiopentone showed a lower overall incidence 
of apnoea compared with the combined propofol groups. This 
difference was statistically significant (p < 0.01). At 60 seconds 
after induction, the incidence of apnoea in all groups was similar, 
ranging from 12 - 20%. All patients who remained apnoeic were 
ventilated manually until spontaneous respiration returned.
Recovery
Recovery was rapid in all patients, but this was not 
investigated in detail due to the variety of operations undergone 
by the patients. One patient felt nauseated for some hours, and 
another had a persistent cough. No patient in any group showed 
any evidence of histamine release. One patient who had received 
propofol via the antecubital fossa had evidence of thrombophlebitis 
at the injection site which disappeared within 48 hours. All 
patients were willing to receive propofol again.
Conclusions
Di-isopropyl phenol in the new emulsified formulation 
(propofol) was found to be an effective short acting hypnotic.
A high incidence of pain on injection, particularly when injected 
via small veins in the dorsum of the hand, and apnoea on induction 
also occurred. There was a modest drop in arterial systolic and 
diastolic pressures in all groups.
CHAPTER SEVEN
STUDIES SEVEN, EIGHT AND NINE 
THE INFUSION OF ETOMIDATE FOR THE MAINTENANCE OF
TOTAL INTRAVENOUS ANAESTHESIA
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Introduction
Because of the cardiovascular and respiratory stability found 
during the induction studies, the potential of etomidate to maintain 
anaesthesia by continuous infusion was investigated. As etomidate 
possesses no analgesic properties, fentanyl was used to provide 
supplementary analgesia.
Preliminary Study
To find out whether the technique was feasible, and acceptable 
to both patients and staff, a preliminary dose finding study was carried 
out. Fifty patients undergoing a variety of minor surgical and 
gynaecological procedures gave informed consent for the administration 
of etomidate and fentanyl for the induction and maintenance of 
anaesthesia. Fentanyl 100 meg. and etomidate 30 mg. in propylene 
glycol, were mixed in a 20 ml. syringe. A 23 S.W.G. cannula 
(Abbott, "Butterfly", No.4871) was inserted into a vein in the dorsum 
of the non-dominant hand,through which all injections were given. 
Patients were induced with etomidate 0.3 mg.kg. ^ in the propylene 
glycol formulation. Bolus increments of the etomidate and fentanyl 
mixture were injected as required to maintain anaesthesia. The 
* results of this study suggested that an average amount of 20 meg.kg. ^ 
min. ^ of etomidate and 0.056 meg.kg. ^ min. ^ of fentanyl was 
adequate to maintain anaesthesia. However to provide adequate 
initial anaesthesia, it was found that an increased induction 
dose of 0.46 mg.kg.  ^ of etomidate was necessary.
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Aims of the Infusion Studies
The aims of the total intravenous anaesthesia studies were to 
improve the intermittent bolus technique and to investigate the 
safety, ease of use, quality of anaesthesia, side-effects and 
possible limitations of the technique and its use in anaesthetic 
practice.
*
97
Study Seven
The First Etomidate Infusion Study
The aim of this study was to assess the feasibility of 
replacing the intermittent bolus technique by a continuous infusion 
of a mixture of etomidate and fentanyl. In particular the effects 
of this technique on cardiovascular and respiratory stability and 
speed of recovery were investigated.
Patients and Methods
One hundred and six eligible patients took part in this study. 
Fifty one patients were to be ventilated and fifty five were to 
breathe spontaneously. The types of surgery carried out are shown 
in Table Thirteen. There were no control patients.
The anaesthetic machine and a combined infusion of etomidate 
and fentanyl were prepared and patients premedicated as described 
in Chapter Two. All patients were attached to an E.C.G. monitor 
and had an oscillotonometer cuff attached on arrival in the 
anaesthetic room. A 500 cc. bag of normal saline (Steriflex, 
Travenol) was connected via a standard fluid administration set 
(C2071 Travenol) and a three-way tap to an 18 S.W.G. cannula 
(Quik - Cath, Travenol) inserted into a vein in the dorsum of the 
non-dominant hand and allowed to flow at 20 - 30 drops per minute.
If required, an arterial blood sample was taken under local 
anaesthesia as described in Chapter Two. The induction of anaesthesia
TABLE THIRTEEN
OPERATIONS CARRIED OUT ON EACH GROUP IN
THE FIRST ETOMIDATE INFUSION STUDY^
VENTILATED CASES NO. SPONTANEOUSLY 
BREATHING CASES
NO.
UPPER ABDOMINAL 9 MASTECTOMY; BREAST 
BIOPSY
15
LOWER ABDOMINAL 16 INGUINAL HERNIA 6
MAJOR GYN. 20 HAEMORRHOIDECTOMY 7
PERIPHERAL VASCULAR 6 VARICOSE VEINS 6
MINOR GYN. 10
ENT 6
ORTHOPAEDIC 5
TOTAL 51 55
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was carried out by the intravenous injection of fentanyl 1.3 meg.kg. ^ 
followed 1 - 2  minutes later by etomidate 0.46 rag.kg. \  Both 
drugs were administered via the free port of the three-way tap.
If endotracheal intubation was required, succinylcholine 100 mg. 
was given intravenously. Immediately after induction, anaesthesia 
was maintained with an infusion of etomidate and fentanyl attached 
to the free port of the three-way tap. The tap was set so that 
both infusions could run concurrently. All patients breathed 100% 
oxygen during the induction period.
Maintenance of anaesthesia was carried out as described in 
Chapter Two. Measurements of pulse rate and arterial systolic and 
diastolic blood pressures were made immediately before induction, 
after induction, at incision and at five minute intervals during 
surgery unless more frequent measurements were clinically indicated. 
Other observations of the quality of induction and maintenance of 
anaesthesia, including arterial blood gas measurements, were carried 
out as described in Chapter Two. Injections of other drugs such as 
tubocurarine, atropine and neostigmine were administered as 
required through the injection port of the fluid administration set.
Recovery from anaesthesia, during which a third arterial 
blood sample was taken^ if required under local analgesia and the 
post-operative visits were carried out as described in Chapter Two.
Results
Composition of the Groups
The composition and physical characteristics of the patients
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are shown in Table Fourteen. Also shown is the mean duration of 
anaesthesia in the two groups.
Quality of Induction and Maintenance
Anaesthesia was successfully induced in most patients. Ten 
patients (9.4%) complained of pain on injection and two had to have 
thiopentone substituted to complete induction. Five patients 
complained of tingling in their hand and arm. The overall incidence 
of venous sensation was 14%. In the spontaneously breathing group, 
severe muscle movement was seen in six patients (11%) delaying the 
start of surgery and mild to moderate muscle movement in another 
eight. The overall incidence of muscle movement was 25%. Anaesthesia 
remained unsatisfactory in three patients due to continued muscle 
movement and supplementation with halothane was required to produce 
satisfactory anaesthesia. There was no evidence of histamine release 
in any of the patients anaesthetised in this study.
Infusion Rates
No significant differences were found in the infusion rates 
between male and female patients in either group. These rates 
were then combined. The mean amounts of etomidate infused 
in the ventilated and spontaneously breathing groups are shown in 
Figure Nine. For clarity, standard error of the mean (S.E.M.) 
values have been shown at 5 minute intervals. The infusion rates 
were statistically significantly different during three periods 
of time. The initial infusion rate from 0 - 1 0  minutes was 
significantly higher in the spontaneously breathing group (p < 0.05).
D
U
R
A
T
I
O
N
 
(
M
I
N
S
.)
+ 
S
.
E
.
M
.
80
 
+ 
1
5
36
 
+ 
5
H S *sf
+ 1 + 1Z • •
< £50 CO n» o
W ^ vO vD
s ^  +|
w
o s 00 <rC z'-s •
• w +  1 + 1Z CO •
< K W CN O
W >H vO
S ^  + 1
CO S Eh S Eh
H CM O CN CO
Eh Z rH CO CN CO
o w
M
• H
O  < rH in
z  cu m in
w
Q
O •
s > •. >• Ph
(X • •
CO P h Eh
W • P h
OcS M CO
o>
d>
Ll
>-
Q
3
H
CO
Z
o
55
3
LL
LU
H
<
D
1
O
H
ll!
H
0 )
QC
E
HI
X
H
0  z
E
3
D
UJ
H
<
Q
1
O
H
LU
Li.
o
CO
LU
H
<
X
z
o
55
3
LL
Z
I- CO
-  o
_ o
_ o
o o
CO
oT**oCM o
04*
C
s
c/>
4-»c
.23
coa
c
CO
0
b.
3
>
w3
o
0c
0
4-*c
oa
CO
l _ . u ! U J | _ 6 > i  6 o l u  ‘ e j e p i u i o ^  
jo uojsnjm jo ejea
V
en
til
at
ed
 
p
at
ie
n
ts
TOO
In the other two periods from'25 - 31 minutes and from 41 minutes 
onwards, the mean infusion rate for the I.P.P.V. group was „ 
statistically significantly higher, the significance values ranging 
from p <  0.05 to p <  0.01. The overall mean infusion rate was 
20.5 + 1.8 meg.kg. ^min. ^ of etomidate and 0.057 HH 0.0055 meg.kg. ^min. 
of fentanyl. The mean coefficient of variation of the infusion rate 
was 33 + 1.2% for the ventilated group and 66 + 1.1% for the 
spontaneously breathing group.
Cardiovascular Changes
The mean values of the measurements of the arterial systolic 
and diastolic blood pressures and pulse rates in each group with 
their associated standard errors of the mean are shown in Figure 
Ten. Both groups showed a statistically non-significant fall in 
the mean systolic and diastolic arterial pressures during the 
induction period. No statistically significant changes were seen 
in the mean pulse rates. Table Fifteen shows the variation in 
cardiovascular parameters during maintenance anaesthesia, expressed 
as the mean coefficient of variation.
Respiratory Changes
During surgery the levels of arterial carbon dioxide tension 
rose from a pre-induction mean value of 5.2 + 0.1 kPa. to a mean 
value of 6.4 + 0.2 kPa. during anaesthesia. This rise was 
statistically highly significant (p <  0.001). The mean level 
fell during the post-operative period to a mean value of 6.1 + 0.2 kPa.,
although still significantly raised from pre-operative levels.
Fig. 10
CARDIOVASCULAR CHANGES DURING THE FIRST 
ETOMIDATE INFUSION STUDY
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TABLE FIFTEEN
COEFFICIENTS OF VARIATION OF THE 
CARDIOVASCULAR PARAMETERS IN THE 
FIRST ETOMIDATE INFUSION STUDY.
RESPIRATORY SYSTOLIC ARTERIAL DIASTOLIC ARTERIAL PULSE RATE
MODE PRESSURE + S.E.M. PRESSURE + S.E.M. + S.E.M.
I.P.P.V. 9.4 + 1.4 9.9 + 1.5 10.6 + 1.5
SPT. V. 5.5 + 0.6 7.9 + 0.8 7.8 + 0.8
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Ventilation was assisted in eight patients whose respiration became 
depressed to a rate of six breaths per minute or less. The infusion 
rate was slowed until spontaneous respiration was restored. The 
levels of arterial carbon dioxide tension were not measured in 
these patients.
Recovery
The median time to recovery was 5 minutes in the ventilated 
group with an interquartile range of 4 - 10 minutes. This was 
lower than the median of 15 minutes with an interquartile range of 
7 - 2 5  minutes for the spontaneously breathing group. This 
difference was statistically significant (p<0.01). Only one 
patient in the ventilated group had not regained consciousness within 
30 minutes compared with 7 in the spontaneously breathing group. 
Nausea and vomiting was seen in 5 patients. - Marked venous 
thrombophlebitis was seen around the infusion site in two patients 
24 - 48 hours after operation. No patient gave any evidence of 
having been aware during the period of anaesthesia.
Conclusions
The conclusions of this study were that total intravenous 
anaesthesia was possible using a mixture of etomidate and fentanyl, 
but several problems were found. These were mainly a high incidence 
of pain on injection and muscle movement. Inadequate anaesthesia, 
prolonged recovery and severe thrombophlebitis also occurred.
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Study Eight
The Second Etomidate Infusion Study
In an attempt to reduce the incidence of some of the complications 
found in the first study, particularly during induction, thiopentone 
was used to induce anaesthesia instead of etomidate. A more detailed 
study of the extent that the degree of venous damage could be 
attributed to the infusion of etomidate was also carried out. The 
infusion anaesthesic techniques were also compared with more 
conventional anaesthetic techniques. Control and infusion patients 
were matched as described in Chapter Two.
Patients and Methods
Two hundred eligible patients were allocated to either the 
infusion or control groups. Fifty patients in each group were to 
be ventilated and fifty to breathe spontaneously. The operations 
carried out are shown in Table Sixteen.
The anaesthetic machine and a combined infusion of etomidate 
and fentanyl were prepared and patients premedicated as described 
in Chapter Two. All patients were attached to an E.C.G. monitor 
and had an oscillotonometer cuff attached on arrival in the 
anaesthetic room. A 23 S.W.G. cannula (Abbott "Butterfly" No. 4871) 
was inserted into a vein in the dorsum of the non-dominant hand.
If required, an arterial blood sample was taken under local 
anaesthesia as described in Chapter Two. The induction of anaesthesia 
was carried out by an intravenous injection of fentanyl 1.3 meg.kg."1
TABLE SIXTEEN
OPERATIONS CARRIED OUT ON EACH GROUP IN
THE SECOND ETOMIDATE INFUSION STUDY^
VENTILATED CASES NO. SPONTANEOUSLY 
BREATHNG CASES
NO.
UPPER ABDOMINAL 14 BREAST BIOPSY; 
MASTECTOMY
15
LOWER ABDOMINAL 16 INGUINAL HERNIA 10
MAJOR GYN. 15 HAEMORRHOIDECTOMY 7
PERIPHERAL VASCULAR 5 VARICOSE VEINS 5
MINOR GYN. 11
E.N.T. 2
TOTAL 50 50
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followed after 1 - 2  minutes by thiopentone 5 mg.kg. injected
through the membrane of the injection port of the cannula. If 
endotracheal intubation was required, succinylcholine 100 mg. 
was injected intravenously. Immediately after induction, 
anaesthesia was maintained with an infusion of etomidate and fentanyl 
via a 21 S.W.G. needle inserted through the membrane of the injection 
port of the 23 S.W.G. cannula. All patients breathed 100% oxygen 
during the induction period.
Maintenance of anaesthesia was carried out as described in 
Chapter Two. An 18 S.W.G. cannula (Quik - Cath, Travenol) was 
inserted into a vein in the dorsum of the opposite hand through 
which blood, saline or dextrose 5% was infused as required during 
anaesthesia. Injections of other drugs required during the operations 
such as tubocurarine, atropine and neostigmine, were administered 
as required through the injection port of the fluid administration 
set.
Patients in the control groups who were to be ventilated or 
to breathe spontaneously were anaesthetised as described in 
Chapter Two. In an attempt to separate the effect of the infusion 
of etomidate from the effects of the infusion of saline alone, the 
control patients had normal saline infused during the operation 
via a 23 S.W.G. cannula inserted into a vein in the dorsum of the 
non-dominant hand at a rate similar to the infusion rate of 
etomidate received by the infusion groups.
Measurements of pulse rate and arterial systolic and diastolic
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blood pressures were made immediately before induction, after 
induction, at incision and at five minute intervals during surgery 
unless more frequent measurements were clinically indicated. Other 
observations of the quality of induction and maintenance of anaesthesia, 
including arterial blood gas measurements, were carried out as 
described in Chapter Two. Recovery from anaesthesia and the post­
operative visits were carried out as described in Chapter Two.
The time to the first administration of intramuscular post­
operative analgesia was noted.
Results
Composition of the Groups
Details of the physical characteristics of the patients and 
the duration of anaesthesia are shown in Table Seventeen. There 
were no statistically significant differences between the demographical 
data of each infusion group and its control group.
Quality of Induction and Maintenance
Anaesthesia was successfully induced and maintained in all 
patients. There were no induction complications such as pain on 
injection and muscle movement. There was no evidence of histamine 
release in any of the patients anaesthetised in this study.
Infusion Rates
There were no statistically significant differences between
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the infusion rates for male and female patients in either group, 
so these infusion rates were combined. The mean amounts of 
etomidate administered in meg.kg. ^ min. ^ in the ventilated 
and spontaneously breathing group are shown in Figure Eleven.
For clarity, the standard error of the mean (S.E.M.) values have 
been shown at 5 minute intervals. The initial rapid infusion rates 
were not statistically significantly different, but the ventilated 
group received a statistically significantly (p < 0 .0 1 ) lower rate 
of infusion for the period 11 - 20 minutes. Thereafter there were 
no statistically significant differences between the two groups.
The overall mean infusion rate was 20 + 1.6 meg.kg. ^ min. ^ of
-1 -i
etomidate and 0.056 _+ 0.0045 meg.kg. min. of fentanyl. The 
coefficient of variation of the infusion rate was 62 + 3.3% for the 
ventilated group and 74 + 3.1% for the spontaneously breathing 
group.
Cardiovascular Changes
The mean values of the measurements of the arterial systolic 
and diastolic blood pressures and pulse rates in each group with 
their associated standard errors of the mean are shown in Figure 
Twelve. Both control groups showed statistically significant 
falls in arterial systolic pressure during the induction period 
(p <  0.05) for the spontaneously breathing group and (p <  0.02) 
for the ventilated group. These changes were not clinically 
significant, neither were measures taken to counteract them.
The changes in the etomidate groups were not significant clinically 
or statistically. The changes which occurred during maintenance 
anaesthesia are shown in Table Eighteen, expressed as the mean
Fig. 11
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coefficients of variation.
Respiratory Changes
Both spontaneously breathing groups showed a statistically 
significant rise (p < 0 .0 0 1) in the mean values of the arterial 
carbon dioxide tension during the course of anaesthesia. The group 
receiving etomidate rose from a mean pre-induction level of 5.2 + 0.1 
kPa. to a mean level of 6.5 + 0.2 kPa. during anaesthesia. The 
control group showed a rise from a mean pre-induction value of 
5.2 + 0.2 kPa. to a mean value of 7.1 + 0.3 kPa. during anaesthesia. 
Post-operatively the level in the etomidate group fell to a mean 
value of 6.1 +_ 0.3 kPa. whereas the level in the control group 
fell to a mean value of 6.2 _+ 0.3 kPa. Severe respiratory 
depression occurred during operation in 1 0 , mainly elderly^ 
patients who were being infused with etomidate and fentanyl.
In these cases the infusion rates were reduced and the patients 
ventilated manually until spontaneous ventilation was resumed. 
Arterial carbon dioxide tension levels were not measured in 
these cases. No patients in the corresponding control group required 
assistance with ventilation.
Recovery
There was no statistically significant difference in the 
recovery times of the ventilated groups. The median value was 
6 minutes in the control group with an interquartile range of 
3 - 1 0  minutes, compared with a median value of 7 minutes with an 
interquartile range of 3 - 17 minutes for the etomidate group.
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Five patients in the infusion group compared with one in the 
control ventilated group had not recovered after 30 minutes.
Recovery of the spontaneously breathing patients was faster in 
the control group with a median time of 18 minutes and an 
interquartile range of 15 - 23 minutes, compared with a median
time of 25 minutes and an interquartile range of 14 - 35 minutes
for the infused group. This difference was statistically 
significant (p <  0.05). However 14 patients in the spontaneous 
breathing group compared with 3 in the control group had not recovered 
within 30 minutes. Six patients in the etomidate infusion groups 
required 0.1 - 0.2 mg. of naloxone I.V. after which recovery
was complete within a few minutes.
The mean time to the first administration of intramuscular 
postoperative analgesia was 6.9 + 0.8 hours in the groups receiving 
etomidate compared with a mean time of 6.4 + 0.9 hours in the 
control groups. This difference was not statistically significant.
The incidence of nausea and vomiting during the recovery period 
was 4% in the etomidate group and 6% in the control group. No 
patient gave any evidence of having been aware during the period of 
anaesthesia.
Venous Damage
Inspection of the infusion site 24 - 48 hours after the 
infusion of etomidate or normal saline showed a 22% incidence 
of thrombosis 1 - 2  cm. long after the infusion of etomidate 
compared with the 10% after the infusion of normal saline in the
108
control group. This difference was statistically significant
(p <  0 .0 2).
Conclusions
The conclusions of this study were that the use of thiopentone 
as the induction agent followed by an infusion of etomidate and 
fentanyl provided an induction of anaesthesia which was free from 
pain and muscle movement whilst maintaining cardiovascular and 
respiratory stability. However problems arose due to delayed recovery. 
The infusion of etomidate appeared to be associated with an increased 
incidence of venous thrombosis. There was no evidence of any 
patient being aware during anaesthesia.
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Study Nine
The Third Etomidate Infusion Study
A two stage infusion of etomidate for the induction and 
maintenance of anaesthesia based on;the known pharmacokinetic 
properties of etomidate has been described (Schuttler et al, 1980, 
b). It was suggested that this infusion scheme could maintain 
satisfactory anaesthesia, but with the infusion of smaller amounts 
of etomidate than that used by earlier techniques (Schwilden et al, 
1981). A third study was carried out to investigate this infusion 
technique and to compare it with standard anaesthetic techniques 
for ventilated and spontaneously breathing patients.
Patients and Methods
Two hundred eligible patients were allocated to either the 
infusion or control groups. Fifty patients in each group were to be 
ventilated and fifty to breath spontaneously. The operations 
carried out are shown in Table Nineteen.
The anaesthetic machine and separate infusions of etomidate 
and fentanyl were prepared and the patients premedicated as 
described in Chapter Two. All patients were attached to an 
E.C.G. monitor and had an oscillotonometer cuff attached on arrival 
in the anaesthetic room. If required, an arterial blood sample 
was taken under local anaesthesia.
A 500 cc. bag of normal saline 0.9% or dextrose 5% was
TABLE NINETEEN
OPERATIONS CARRIED OUT ON EACH GROUP
IN THE THIRD ETOMIDATE INFUSION STUDY.
VENTILATED CASES NO. SPONTANEOUSLY NO.
UPPER ABDOMINAL 13 BREAST BIOPSY; 
MASTECTOMY
18
LOWER ABDOMINAL 17 INGUINAL HERNIA 16
MAJOR GYN. 18 HAEMORRHOIDECTOMY 8
PERIPHERAL VASCULAR 2 VARICOSE VEINS 8
TOTAL 50 50
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connected via two three-way taps to an 18 S.W.G. cannula (Quik - 
Cath, Travenol) inserted into a vein in the dorsum of the non­
dominant hand and allowed to flow at 20 - 40 drops per minute. The 
etomidate and fentanyl infusion sets were connected to the free limbs 
of the three way taps when required. The induction of anaesthesia 
was carried out by an intravenous injection of fentanyl 1.3 meg.kg. ^ 
followed after 1 - 2  minutes by a rapid infusion of etomidate 100 meg.kg. 
min. for ten minutes. If endotracheal intubation was required, 
succinylcholine 100 mg. was administered intravenously via the 
second three-way tap, once the eyelash reflex had disappeared.
During the induction of anaesthesia, all patients breathed 100% 
oxygen.
Maintenance of anaesthesia was carried out as described in 
Chapter Two. After the elapse of 10 minutes the infusion of etomidate 
was reduced to a maintenance infusion rate of 10 meg.kg. ^ min. ^ 
until the end of the operation. Once in the operating theatre, a 
separate infusion of fentanyl was commenced. The rate of the fentanyl 
infusion was altered when necessary as described in Chapter Two.
An 18 S.W.G. cannula (Quik - Cath) was inserted into a vein 
in the dorsum of the opposite hand through which blooci, saline or 
* dextrose 5% was infused as required during anaesthesia. Injections 
of other drugs required during the operation such as tubocurarine, 
atropine and neostigmine, were given through the injection port of 
the fluid administration set.
Measurements of pulse rate and arterial systolic and diastolic
mblood pressures were made immediately before induction, after 
induction, at incision and at five minute intervals during surgery 
unless more frequent measurements were clinically indicated. Other 
observations of the quality of induction and maintenance of anaesthesia, 
including arterial blood gas measurements, were carried out as 
described in Chapter Two. Recovery from anaesthesia and the post­
operative visits were carried out as described in Chapter Two.
The time to the first administration of intramuscular postoperative 
analgesia was noted.
Patients in the control groups were anaesthetised and their 
post-operative progress observed as described in Chapter Two.
Results
Composition of the Groups
The composition, physical characteristics and duration of 
anaesthesia in the groups are shown in Table Twenty. There were no 
statistically significant differences between the groups, except 
that the duration of anaesthesia in the ventilated control group was 
statistically significantly longer (p < 0.02) than the corresponding 
control group.
Quality of Induction and Maintenance
Anaesthesia was successfully induced and maintained in all 
patients. The mean time to loss of the eye-lash reflex in the 
infusion groups was 103 + 3 seconds. Four patients complained 
of pain on injection, and fourteen complained of tingling when the......
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etomidate was infused. In the spontaneously breathing group 
which received etomidate, severe muscle movement was not seen, 
although mild muscle movement was seen in six patients. All patients 
were satisfactorily anaesthetised using this technique. A rapid 
loss of the eye-lash reflex was found in the patients induced with 
thiopentone. No muscle movement or pain on injection occurred 
in these patients. There was no evidence of histamine release in 
any of the patients anaesthetised in this study.
Infusion Rates
The rate of infusion of etomidate was fixed for both groups. 
There were no significant differences between the infusion rates 
of fentanyl for male or female patients in any groupy which were 
then combined. The amounts of fentanyl infused in the ventilated 
and spontaneously breathing groups are shown in Figure Thirteen.
For clarity, the standard error of the mean (S.E.M.) values have 
been shown at 5 minute intervals. The spontaneously breathing 
group received a significantly higher infusion rate of fentanyl in 
the first three minutes (p<0.01 at 1 and 2 minutes and 0.05 at 
three minutes). Thereafter there were no significant differences 
between the two infusion groups. The infusion rates for the 
fentanyl varied considerably between patients, but the mean infusion 
rate was found to be 0.23 0.015 meg.kg. ^ min. ^ for 3 - 4  minutes
followed by 0.1 + 0.005 meg.kg. ^ min. ^ for 8 - 9  minutes and 
0.05 + 0.003 meg.kg. ^ min. * thereafter. The mean coefficient of 
variation of the infusion rates was 54 _+ 1.3% for the ventilated group 
and 51 HH 3.1% for the spontaneously breathing group.
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Cardiovascular Changes
The mean values of the measurements of the arterial systolic 
and diastolic blood pressures and the pulse rates and their 
associated standard errors of the mean for each group are shown in 
Figure Fourteen. There were no statistically significant changes 
in the mean arterial systolic, or diastolic blood pressures, or 
pulse rates in the etomidate groups. In both control groups there 
were statistically significant falls in the mean systolic arterial 
blood pressure^ (p < 0.05) in the ventilated group and (p <  0.01) 
in the spontaneously breathing group during the period of the induction 
of anaesthesia. These changes were not clinically significant and 
no measures were taken to correct them. During maintenance 
anaesthesia these values tended to return to their pre-operative 
levels. There were no statistically significant changes in the 
mean diastolic blood pressures or pulse rates in the control groups.
The changes occurring during maintenance anaesthesia are shown in 
Table Twenty One, expressed as the mean coefficients of variation.
Respiratory Changes
The mean pre-operative values of arterial carbon dioxide 
tension in spontaneously breathing patients were identical in both 
groups with a mean of 5.1 + 0.2 kPa. These values rose significantly 
during anaesthesia (p <  0.001) in both groups. Values in the 
control group rose to a mean value of 6.5 + 0.2 kPa. during anaesthesia 
falling to a mean value of 6.1 + 0.2 kPa during recovery. In the 
etomidate group the arterial carbon dioxide tension rose to a mean 
value of 6.6 + 0.2 kPa. during anaesthesia falling to a mean value
Fig. 14
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of 6.1 0.2 kPa. in the post-operative period. Episodes of severe
respiratory depression occurred in four elderly patients receiving 
etomidate and fentanyl. In these patients, ventilation was 
manually assisted and the infusion rate of fentanyl was slowed.
No such assistance was required in any patient in the corresponding 
control group.
Recovery
The median time to recovery in both ventilated groups was 8 
minutes. The interquartile range was 5 - 1 2  minutes for the etomidate 
group and 2 - 1 0  minutes for the control group. This difference 
was not statistically significant. All ventilated patients were 
awake within 30 minutes.
The infused group who were breathing spontaneously were 
awake in a median time of 15 minutes with an interquartile range 
of 10 - 20 minutes. The control group awoke in a median time of 
23 minutes with an interquartile range of 15 - 32 minutes. This 
difference was statistically significant (p <0.01). Four of the 
patients in the infused group had not recovered within 30 minutes 
compared with six in the control group.
Four female patients, who had been infused with etomidate for 
over an hour showed myoclonic movements in all four limbs for a 
period of 15 - 4 5 *minutes after the end of infusion. These 
movements gradually settled without any treatment.
The mean time to the first administration of post­
operative intramuscular analgesia in the etomidate groups was
115
5.8 +_ 0.6 hours compared with a mean time of 6.2 _+ 0.7 hours in 
the control groups. This difference was not statistically 
significant. The incidence of nausea and vomiting was 5% in the 
etomidate groups compared with 7% in the control groups. No 
patient gave any evidence of having been aware during the period 
of anaesthesia.
Venous Damage
One patient who had been infused with a 0.5% solution instead 
of the standard 0.25% solution of etomidate had a very severe venous 
thrombosis which lasted for several months. Two other patients had 
severe venous thrombosis.
Conclusions
The conclusions of this study were that the use of a fixed 
infusion rate of etomidate provided a good induction and maintenance 
of anaesthesia with rapid recovery, particularly in spontaneously 
breathing patients. The delay in the onset of hypnosis was not 
found to be unpleasant and several patients preferred it to the 
sudden loss of consciousness experienced during previous anaesthetic 
inductions. The incidence of pain on injection and muscle movement 
was reduced. There was no evidence of any patient having been 
aware during the period of anaesthesia. The use of a 0.5% solution 
of etomidate is not recommended.
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CHAPTER EIGHT
STUDY TEN
THE EFFECTS OF THE MAINTENANCE OF 
BY THE INTRAVENOUS INFUSION 
OF ETOMIDATE AND FENTANYL
ANAESTHESIA
ON HEPATIC AND RENAL FUNCTION
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Study Ten
The Fourth Etomidate Infusion Study 
Introduction
The aim of this study, the Fourth Etomidate Infusion Study, 
was to investigate the effects of the infusion techniques used in 
the second and third etomidate infusion studies on hepatic and renal 
function. The results found were compared with those obtained 
using a standard anaesthetic technique including the administration 
of nitrous oxide and morphine.
Patients and Methods
Sixty eligible patients aged from 18 - 65 years who were to 
undergo simple abdominal hysterectomy were randomly allocated to 
one of three groups. The control group (A) received a standard 
anaesthetic sequence of nitrous oxide/oxygen and morphine as 
described in Chapter Two. Patients in Group B received a combined 
infusion of etomidate and fentanyl for the maintenance of anaesthesia 
and patients in Group C were anaesthetised using the Two Stage 
^ Infusion Technique described in Chapter Nine. Any patient who 
showed evidence of pre-operative anaemia, electrolyte or liver 
function abnormality, who was found at operation to have an abdominal 
malignancy, who required rapid infusion of fluid to raise blood 
pressure, or who required blood transfusion at any time during or 
after the operation, was eliminated from the trial and replaced
by the next suitable patient. All operations were carried out
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by the same consultant gynaecologist.
Blood samples for the control measurements of haemoglobin, 
urea and electrolytes and liver function tests were taken two days 
before operation and repeated twenty four hours after operation.
All patients were to be ventilated. The details of the anaesthetic 
techniques used in this study have been previously described in 
Chapter Two and Studies Eight and Nine. The only difference in 
technique between these studies and the techniques used in this 
study was that a fast flowing (30 - AO drops per minute) infusion 
of Ringer Lactate solution was set up via an 18 S.W.G.cannula 
(Quik - Cath, Travenol) inserted into a vein in the dorsum of the 
non-dominant hand. Three-way taps were added in series as required 
for the number of hypnotic and analgesic infusions to be used.
Cardiovascular measurements, continuous E.C.G.- monitoring, 
induction and maintenance of anaesthesia and recovery were carried 
out in all patients as described in Chapter Two and Studies Eight 
and Nine.
All patients had post-operative fluid regimes of 2000 ml. 
of dextrose 5% and 1000 ml. of 0.9% normal saline I.V. for 2A hours 
post-operatively, followed by a normal ward diet.
Biochemical Analysis
Biochemical analyses were carried out by the Biochemistry 
Department, Victoria Infirmary, Glasgow. Serum concentrations 
of sodium, potassium, chloride, urea and creatinine were measured
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using a Sequential Multiple Analyser 6 - 6 0 .  Serum aspartate 
amino-transferase (A.S.T.) and serum alanine amino-transferase (A.L.T.) 
were measured using an L.K.B. Reaction Rate Analyser 2086. Serum 
alkaline phosphatase (A.L.P.), gamma-glutamyl transferase (G.G.T.) 
total bilirubin (T.B.), total protein (T.P.) and serum albumin (S.A.) 
were measured using a Centrifugal Analyser Union Carbide Centrifichem 
400.
Results
Composition of the Groups
Patient details are shown in Table Twenty Two. There 
were no statistically significant differences between the groups.
Liver Function Test Changes
The results for the changes in the liver function tests are 
shown in Table Twenty Three. There were no statistically significant 
differences between the three groups pre-operatively. Both Groups 
A and B showed a statistically significant increase (p < 0.02) in 
G.G.T. post-operatively. The other liver function tests also 
^tended to be elevated. Total protein showed a statistically 
significant fall (p <  0.05) in the control group only and serum 
albumin (p < 0.01) showed a statistically significant fall in Group 
A and B. A.S.T. values showed a statistically significant rise in 
Group C Only (p < 0.02).
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Serum Electrolyte Changes
The changes in serum electrolyte results are shown in Table 
Twenty Four. There were no statistically significant differences 
between the pre-operative concentrations of sodium, potassium, 
creatinine or urea in any group. In all groups there were
statistically significant falls in potassium and urea. In Groups 
A and B there were also statistically significant falls in creatinine 
concentrations post-operatively. The significance values are shown 
in Table 24.
Conclusions
These results suggest that the infusion of moderate amounts 
of etomidate and fentanyl do not cause greater upsets in hepatic 
or renal function than a standard anaesthetic technique including 
morphine and nitrous oxide.
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CHAPTER NINE
STUDIES ELEVEN AND TWELVE
THE INFUSION OF PROPOFOL FOR THE
MAINTENANCE OF TOTAL INTRAVENOUS ANAESTHESIA
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Introduction
The results of the induction study described in Chapter Six 
suggested that propofol might be suitable as the hypnotic component 
of a total intravenous anaesthetic technique. As with etomidate, 
analgesic supplementation was required for which fentanyl was used.
Study Eleven
The First Propofol Infusion Study
The aim of the first infusion study was to evaluate a pre­
determined infusion regime based on pharmacokinetic data and designed 
to establish rapidly a constant blood concentration for operations 
lasting one to two hours (Cockshott 1985).
Patients and Methods
Fifteen patients, seven male and eight female, of mean age 
5 9 + 2  years and mean weight 5 6 + 3  Kg. took part in an open 
uncontrolled study. The operations carried out were three each 
of peripheral vascular, upper abdominal, lower abdominal, orthopaedic 
(hand) or ligation and stripping of varicose veins. All patients 
were to be ventilated except the six patients who were to undergo 
hand operations or ligation and stripping of varicose veins.
The anaesthetic machine and separate infusions of propofol 
and fentanyl were prepared and the patients premedicated, as
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described in Chapter Two. All patients were attached to an 
E.C.G. monitor and had a Dinamap cuff attached on arrival in the 
anaesthetic room. A 23 S.W.G. cannula ("Butterfly", Abbott, No.
4871) was inserted into a vein in.the dorsum of the non-dominant 
hand, through which all injections and infusions of propofol, 
fentanyl and succinylcholine were given.
Induction was carried out by an intravenous injection of 
fentanyl 1.3 meg.kg. ^ followed after 1 - 2  minutes by the 
injection of 2.5 mg.kg. ^ of propofol in all patients. If 
intubation was required, this was facilitated by the injection of 
succinylcholine 1 mg.kg. Propofol was then infused at a rate
of 0.15 mg.kg. ^ min. ^ via a 21 S.W.G. cannula. All patients 
breathed 100% oxygen during the induction of anaesthesia.
Once a patient was positioned on the operating table and 
connected to the anaesthetic equipment and monitors, an infusion of 
fentanyl was connected to the patient by a second 21 S.W.G. needle 
inserted through the injection port of the 23 S.W.G. cannula. The 
infusion rate of fentanyl was altered according to the individual 
patient’s requirements as described in Chapter Two. A fast flowing 
(30 - 40 drops per minute) infusion of dextrose 5% or normal saline 
0.9% was set up and administered to the patient via an 18 S.W.G. 
cannula (Quik - Cath, Travenol) inserted into a vein in the dorsum 
of the opposite hand. Injections of other drugs required during the 
operations such as atracurium, atropine and neostigmine, were given 
through the injection port of the fluid administration set. When 
required, neuromuscular blockade was maintained with an initial
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bolus injection of atracurium 400 meg.kg. ^ followed by further 
bolus increments of 200 meg.kg. ^ administered as described in 
Chapter Two.
After 30 minutes had elapsed, the infusion rate of propofol 
was reduced to 0.075 mg.kg. ^ min. ^ and was continued at that 
rate until the end of the operation.
Measurements of pulse rate and arterial systolic and diastolic 
blood pressures were made immediately before induction, at one, 
two and five minutes after induction and at five minute intervals 
thereafter, unless more frequent measurements were clinically 
indicated. Other observations of the quality of induction and maintenance 
of anaesthesia were carried out as described in Chapter Two. It had 
been intended to measure arterial carbon .dioxide tension levels in 
the spontaneously breathing patients during and after anaesthesia.
This was not carried out due to the difficulty in achieving adequate 
unaided spontaneous respiration in these patients.
The infusion of fentanyl was switched off at the beginning 
of wound closure. The infusion of propofol was switched off at 
the end of wound closure. This latter point was taken to be the 
beginning of the recovery period. Reversal of neuromuscular 
blockade, extubation after the onset of adequate spontaneous respiration 
and then transfer to the recovery area was carried out as described 
in Chapter Two. Further recovery of the patients was supervised 
as described in Chapter Two. In particular, the times the patients 
took to respond to command and to repeat their name and address
were recorded. All patients were seen before their return to the
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ward, and again 24 - 48 hours later, when the infusion site was 
inspected and the patients1 comments about their anaesthetic experience 
elicited.
Results
Quality of Induction and Maintenance
Anaesthesia was successfully induced and maintained in all 
patients. Induction was smooth, there was no evidence of muscle 
movement or anaphylaxis and only one patient complained of pain 
on injection. Maintenance of anaesthesia was achieved without 
difficulty.
There was no evidence of histamine release during any of the 
anaesthetics.
Infusion Rates
Propofol was infused as described and switched off at 
the end of operation once wound suture was complete. The mean 
duration of infusion was 80 + 15 minutes. Fentanyl was infused 
as required to maintain analgesia as shown in Figure Fifteen and 
switched off at a mean time of 15 _+ 2.6 minutes before the end of 
the operation. The S.E.M. values are shown at five minute intervals.
The infusion rate required by the individual patients varied considerably 
but the mean infusion rate was found to be 0 . 1 5 + 0 . 0 2  meg.kg. ^ min. ^ 
for 5 - 6  minutes followed by 0.1 + 0.005 meg.kg. ^ min. ^ for 8 -
10 minutes and 0.05 +_ 0.003 mcg.kg.~l min.~l thereafter. The
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mean coefficient of variation of the infusion rate was 56 + 1.3%.
The cummulative amount of fentanyl infused in the spontaneously 
breathing patients compared with the corresponding two-stage 
etomidate infusion study is shown in Figure Sixteen. The S.E.M. 
values are shown at five minute intervals.
Cardiovascular Changes
The mean values of the measurements of the arterial systolic 
and diastolic blood pressures and pulse rates with their associated 
standard errors of the mean are shown in Figure Seventeen. The 
mean arterial systolic blood pressure fell during the induction 
period. This fall was maximal 5 minutes after induction and was 
statistically significant (p <  0.05). This fall did not cause 
clinical concern and no measures were taken to counteract it.
During maintenance anaesthesia the mean systolic pressure returned 
to pre-induction levels. The mean coefficient of variation for 
systolic pressure was 9 + 2%. There were no significant changes 
in the mean diastolic pressure throughout the duration of anaesthesia. 
The mean coefficient of variation for the diastolic pressure was 
8 + 2 % .  The mean pulse rate tended to rise during the induction 
period and fall again during maintenance anaesthesia, but the changes 
were not significant, either clinically or statistically. The 
mean coefficient of variation was 6 ± 1%.
Respiratory Changes
All six spontaneously breathing patients became apnoeic and 
required manual assistance with ventilation.
Fig. 16
CUMULATIVE AMOUNTS OF FENTANYL INFUSED IN SPONTANEOUSLY 
BREATHING PATIENTS DURING THE FIRST PROPOFOL INFUSION 
STUDY, COMPARED WITH THE AMOUNTS INFUSED DURING THE 
THIRD ETOMIDATE INFUSION STUDY
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Fig. 17
CARDIOVASCULAR CHANGES DURING THE FIRST PROPOFOL INFUSION STUDY
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Recovery
Recovery was rapid. The median time to the patients opening 
their eyes on command after switching off the propofol infusion 
was 8 minutes with an interquartile range of 5 - 10 minutes.
Patients could repeat their date of birth at a median time of 10 
minutes with an interquartile range of 9 - 16 minutes.
Inspection of the infusion site 24 - 48 hours after anaesthesia 
showed no evidence of venous thrombosis or other complications.
No patient gave any evidence of having been aware during the period 
of anaesthesia.
Conclusions
This propofol infusion study showed that propofol could be 
used as the hypnotic component of a total intravenous anaesthetic 
technique. There was little impairment of cardiovascular stability 
and no muscle movement during the induction or maintenance of anaesthesia. 
Pain on injection was seen in only one patient. Maintenance of anaesthesi 
was smooth and recovery was rapid and complete. There was no evidence 
of any patient being aware during anaesthesia. However the technique 
was not suitable for spontaneously breathing patients due to the 
high incidence of apnoea.
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Study Twelve
The Second Propofol Infusion Study
The second propofol infusion study was carried out to investigate 
the effects of an infusion of propofol over a longer period of time.
Of particular interest were the effects of a prolonged infusion of 
propofol on the quality of anaesthesia, the duration of action of 
atracurium and vecuronium, the possible effects on cardiovascular 
stability, and the speed of recovery.
Patients and Methods
Thiry eligible patients who were to undergo prolonged peripheral 
vascular surgery (24), or orthopaedic surgery for the correction 
of Dupuytren’s contracture of the hand (6 ) were randomly allocated 
to one of two groups. The premedication, induction, maintenance and 
monitoring of anaesthesia and the post-operative recovery of the patients 
were carried out as described in Chapter Two and for the ventilated 
patients described in Study Eleven. In particular, the same 
induction dose and infusion rates of propofol were used. As in 
Studies Nine and Eleven, the infusion rate of fentanyl was varied 
* to meet the individual patient’s requirements. The infusions 
of fentanyl and propofol were switched off at the same end points 
as described in Study Eleven.
The two major differences between Study Eleven and Study Twelve 
were the duration of the operations and the administration of
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neuromuscular blocking agents. One group of patients was to receive 
bolus increments of atracurium 190 meg.kg. \  The other group 
was to receive bolus increments of vercuronium 45 meg.kg. These
amounts were chosen as being the E.D. 90 of the drugs (Robertson 
et al, 1983, a). In the atracurium group 11 patients were to undergo 
peripheral vascular surgery and 4 were to undergo hand surgery 
compared with 13 and 2 patients respectively in the vecuronium group.
Neuromuscular blockade was monitored by supramaximal 
stimulation of the ulnar nerve in the forearm, using a Myotest 
Mark Two Peripheral Nerve Stimulator to produce a 'train of four' 
stimuli. The patient's response to the 'train of four' stimuli 
was assessed both visually and by the anaesthetist feeling the 
patient's response with his own fingers.
The initial 'train of four' stimuli was administered after 
the induction of anaesthesia with propofol 2.5 mg.kg. All
patients were then intubated which was facilitated by the injection 
of succinylcholine 1 mg.kg. \  Once the patient's response to 
a 'train of four' stimuli had returned to the level observed and 
felt before the injection of succinylcholine, the first bolus 
injection of the allocated muscle relaxant was administered. When 
a response to the second stimulus of a 'train of four' was observed 
and felt, a further increment of the allocated muscle relaxant was 
administered.
Results
Composition of the Groups
The mean age and weight of the patients and the duration of
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infusion in both groups is shown in Table Twenty Five. There 
were no statistically significant differences between the groups.
The mean duration of infusion was 165 + 19 minutes with a range 
of 90 - 300 minutes.
Quality of Induction and Maintenance
Anaesthesia was successfully induced and maintained in all 
patients. There was no muscle movement, but two patients complained 
of pain on injection. The quality of anaesthesia was good and easily 
maintained.
There was no evidence of histamine release in any of the 
patients anaesthetised during this study.
Infusion Rates
Anaesthesia was successfully maintained in all patients with 
propofol and fentanyl infused separately. As no statistically 
significant differences were found when the infusion rates for the 
two groups were compared, the amounts were combined and are shown 
in Figure Eighteen. The S.E.M. values are shown at five minute 
* intervals. The rate of infusion of fentanyl varied considerably 
between patients. The combined mean infusion rate was found to be
0.17 + 0.006 meg.kg. ^ min. ^ for 4 - 1 0  minutes followed by
0.12 + 0.005 meg.kg. ^ min. ^ for 12 - 20 minutes and 0.06 + 0.005 
meg.kg.  ^min. ^ thereafter. The mean coefficient of variation was 
50 + 1%.
TABLE TWENTY FIVE 
DETAILS OF PATIENTS AND DURATION OF INFUSION
IN THE SECOND PROPOFOL INFUSION STUDY.
AGE (YRS.) 
+ S.E.M.
WT. (Kg.) 
+ S.E.M.
DURATION 
INFUSION 
+ S.E.M.
OF
(MINS.)
ATRACURIUM 62 + 3 65 + 3 156 + 20
VECURONIUM 62 + 2 62 + 4 170 + 20
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Cardiovascular Changes
The cardiovascular changes were similar in each group. The 
combined mean values of the measurements of the arterial systolic 
and diastolic blood pressures and pulse rates with their associated 
standard errors of the mean are shown in Figure Nineteen. The 
value of the mean arterial systolic pressure fell during the 
induction period. This fall was statistically significant (p <  0.01) 
after five minutes and also at incision but did not give rise to 
clinical concern. During maintenance anaesthesia there was a 
gradual return to the pre-induction values. The mean coefficient 
of variation during anaesthesia was 12 + 1%. The value of the 
mean arterial diastolic pressures showed little change during 
induction, but the mean value of the maintenance diastolic pressure 
was significantly higher (p <  0.05) when compared with the pre­
induction value. The mean coefficient of variation of the diastolic 
pressure was 1 1 + 1 % .  The mean pulse rate changed little but 
tended to fall during maintenance anaesthesia. These changes were 
not statistically significant. The mean coefficient of variation 
was 8 _+ 2%.
Requirements for Muscle Relaxant
The duration of action of each increment of muscle relaxant 
is shown in Figure Twenty. The duration of action of atracurium 
was relatively constant, whereas the duration of action of vecuronium 
tended to incease. This increase was only statistically significant 
for the fourth (p < 0 .0 2) and fifth (p < 0 .0 1 ) increments.
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Recovery
The time to recovery was very similar in both groups and 
the difference was not statistically significant. The results 
for both groups were combined. The fentanyl infusion was switched 
off at a mean time of 21 3 minutes before wound closure. The
infusion of propofol was switched off after wound suture had been 
completed. The median time to opening of eyes on command after 
stopping the infusion of propofol was 10 minutes with an interquartile 
range of 6 - 17 minutes. The median time to recall of date of 
birth was 17 minutes with an interquartile range of 12 - 24 minutes.
Inspection of the infusion site 24 - 48 hours after anaesthesia 
showed no evidence of venous thrombosis or other complications 
in any patient. No patient gave any evidence of having been aware 
during the period of anaesthesia.
Conclusions
The infusion scheme of propofol used was effective and easy 
to use, particularly in ventilated patients. Two patients complained 
of pain on injection. Falls in systolic arterial blood pressure did not 
give rise to clinical concern, and readily reversed spontaneously.
There was some evidence that there was progresive prolongation of 
the action of vecuronium compared with that of atracurium. Recovery 
was rapid and uncomplicated. There was no evidence that any patient 
was aware during the period of anaesthesia.
CHAPTER TEN
SUMMARY OF RESULTS
134
Study One
Induction with Etomidate in Phosphate and Water
1. The groups were very similar in weight and sex distribution.
One group was younger than the other two groups. This difference 
was statistically significant (p < 0.02). The mean age of 
the groups was 56.5 years.
2. Anaesthesia was successfully induced in all patients.
3. No clinically or statistically significant changes in mean 
arterial systolic or diastolic blood pressures or pulse rates 
were observed during the induction of anaesthesia.
* 4. No evidence of severe respiratory depression, in particular,
no significant apnoea was observed in any group.
5. There was no evidence of histamine release in any patient
in this study.
Study Two
Comparison of Induction with Etomidate in Phosphate and Water 
with Propanidid
1. There were no statistically significant differences in age,
weight or sex distribution in any group. The mean age of
!
the groups was 56 years.
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2. Anaesthesia was successfully induced in all patients.
3. No clinically or statistically significant changes in the 
mean arterial systolic or diastolic blood pressures or pulse 
rates were observed during the induction period in the 
etomidate groups who had been premedicated with atropine.
There was a statistically significant (p < 0.01) fall in the 
mean arterial systolic blood pressure in the propanidid group 
during induction. No significant changes were observed in 
the mean arterial diastolic pressures or pulse rates in any 
group during induction. The mean pulse rates in the group 
which had not been premedicated with atropine were statistically 
significantly slower than the mean pulse rates in the other 
groups throughout the induction and maintenance of anaesthesia
(p <  0 .0 1 ).
4. There was no evidence of severe respiratory depression, 
in particular, no apnoea was seen in any group.
5. Recovery from anaesthesia was rapid in all groups, with mean 
times ranging from 6 to 8 minutes. There was no difference 
clinically between the groups. The group who had received 
etomidate over 15 seconds and had been premedicated with 
atropine recovered faster than the group who had received 
etomidate over 30 seconds. This difference was^statistically 
significant (p < 0.05).
6 . There was no evidence of histamine release in any patient 
in this study.
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7. The incidence of complications observed during induction 
during both etomidate studies were combined. The overall 
incidence of pain on injection was 24% (37/152) and muscle 
movement was 29% (44/152). Both these results were 
statistically significantly (p < 0 .0001) higher than their 
incidence in the propanidid group which was zero.
Patients who had etomidate injected over 15 seconds 
had an incidence of pain on injection of 13% (8/62) and an 
incidence of muscle movement of 14.5% (9/62). Patients 
who had etomidate injected over 30 seconds had an incidence of 
pain on injection of 33% (19/58) and of muscle movement of 
43% (25/58). Patients who had etomidate injected over 60 
seconds had an incidence of pain on injection of 31% (10/32) 
and muscle movement of 31% (10/32). The incidence of both 
pain on injection and muscle movement were statistically 
significantly lower (p < 0.025) in the group which received 
etomidate over 15 seconds compared with the other two groups 
which had also received etomidate.
8 . The overall incidence of nausea and vomiting was 7.5%. Two 
patients who had received etomidate had hallucinations and 
one had an epileptiform fit.
Study Three
Induction with Etomidate in Polyethylene Glycol
1. There were no statistically significant differences in age,
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weight or sex distribution between the groups. The 
mean age of the groups was 58 years.
2. Anaesthesia was successfully induced in all patients.
3. The incidence of pain on injection was 4% (1/25) in both 
groups. The incidence of muscle movement in the group 
receiving etomidate over 15 seconds was 16% (4/25) compared 
with 20% (5/25) in the group receiving etomidate over 30 
seconds. This difference was not statistically significant.
4. Cardiovascular changes during the induction period were found 
to be minimal in both groups.
5. No evidence of respiratory depression, in particular apnoea, 
was seen in either group.
6 . Recovery was rapid in both groups. The mean time to recovery 
in the group receiving etomidate over 15 seconds was 4.5 
minutes compared with a mean time of 5.0 minutes in the 
group receiving etomidate over 30 seconds. This difference 
was not statistically significant.
7. The overall incidence of nausea and vomiting was 8%.
8 . There was no evidence of histamine release in any patient 
in this study.
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Study Four
Induction with Etomidate in Propylene Glycol compared with
Methohexitone
1. There were no statistically significant differences in age, 
weight, or sex distribution between the groups. The mean 
age of the groups was 56.5 years.
2. Anaesthesia was successfully induced in all patients.
3. The incidence of pain on injection was 4% (2/50) in the 
etomidate group and 6% (3/50) in the methohexitone group.
The incidence of muscle movement was statistically significantly 
higher (p <  0.01) in the etomidate group at 22% (11/50) 
compared with 0% (0/50) in the methohexitone group.
4. Cardiovascular changes during the induction period were found 
to be minimal in both groups.
5. No serious respiratory depression, in particular apnoea, 
was seen in either group.
6 . Recovery was rapid in both groups, the mean time to recovery 
in the etomidate group was 4.5 minutes compared with a mean 
time of 4.0 minutes in the methohexitone group. This 
difference was not statistically significant.
7. The incidence of nausea and vomiting was 6% in the etomidate
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group and 4% in the methohexitone group. This difference 
was not statistically significant.
8 . There was no evidence of histamine release in any patient 
in this study.
Study Five
Induction with Etomidate and Alfentanil
1. There were no statistically significant differences in age 
or weight distribution between the groups. The mean age of 
the groups was 33 years.
2. Anaesthesia was successfully induced in all patients.
3. There was no spontaneous complaint of pain on injection.in
the alfentanil group but the incidence was 48% (12/25)
in the control group. The incidence of muscle movement was 
4% (1/25) in the alfentanil group and 80% (20/25) in the 
control group. Both these differences were statistically 
significant (p <  0 .0 0 1)
4. Cardiovascular changes during the induction period were 
minimal in both groups.
5. Recovery was rapid in both groups, the mean time to
recovery in the control group was 8.0 minutes compared with
4.0 minutes in the alfentanil group. This difference was
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statistically significant (p <  0 .0 1 ).
6 . Eight per cent of patients were nauseated or vomited in the 
control group compared with 16% in the patients who received 
alfentanil. This difference was not statistically 
significant.
7. There was no evidence of histamine release in any patient 
in this study.
Study Six
Induction with Propofol and Comparison with Thiopentone
1. There were no statistically significant differences in age, 
weight, or sex distribution between the groups. The mean 
age of the groups was 35 years.
2. Anaesthesia was successfully induced in all patients.
3. The incidence of pain on injection.when propofol was 
administered via the dorsum of the hand was 37.5% (15/40) and 
22.5% of patients in this group (9/40) had other sensations. 
The overall.incidence of venous sensation was 60% (24/40)
in this group.
When administered via a vein in the antecubital fossa, 
the incidence of pain was statistically significantly reduced
(p < 0.001) to 2.5% (1/40) and the incidence of other
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sensations was reduced to 17.5% (7/40). The overall 
incidence of sensation in this group was 20% (8/40).
When lignocaine was pre-administered into a vein in the 
dorsum of the hand, the incidence of pain was 17.5% (7/40).
This reduction in the incidence of pain of injection was 
not statistically significant when compared with the group 
receiving propofol in the dorsum of the hand. The incidence 
of other sensations in this group was 22.5% (9/40). The 
overall incidence of sensation was 40% (16/40).
In the thiopentone group, the incidence of pain on 
injection was 7.5% (3/40). This was statistically significantl 
less ( p <  0 .0 1 ) than the incidence of pain on injection of 
propofol in the dorsum of the hand. The incidence of other 
sensations was 20% (8/40). The overall incidence of 
venous sensationiin this group was 27.5% (11/40).
The incidence of muscle movement was 10% (4/40) when 
propofol was administered via the dorsum of the hand and 
ranged from 2.5% (1/40) to 5% (2/40) in the other groups.
These differences were not statistically significant.
4. All groups showed a statistically significant fall in the
mean arterial systolic blood pressure during the induction 
period (p <  0.01). The rise in the mean pulse rate during 
the induction period was not statistically significant in the 
propofol groups, but there was a statistically significant
rise in the mean pulse rate in the thiopentone group (p <  0 .0 1 )
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There were no statistically significant changes in the 
mean arterial diastolic pressure in any group after 
induction.
5. A high incidence of apnoea of short duration was seen in the 
propofol groups, ranging from 52.2% (21/40) to 77.5% (31/40) 
compared with 45% (18/40) in the thiopentone group. The 
overall incidence of apnoea in the thiopentone group was 
statistically significantly (p <  0 .0 1) lower compared with 
the overall incidence of apnoea in the groups receiving 
propofol. The incidence of apnoea lasting longer than 60 
seconds was similar in all groups.
6 . There was no evidence of histamine release in any patient 
in this study.
Study Seven
Etomidate Infusion with Bolus Etomidate Induction
1. The mean age of the ventilated group was 62 years and the 
mean age of the spontaneously breathing group was 46 years.
2. Anaesthesia was successfully induced and maintained in 
100 of the 105 patients in this study.
3. The incidence of pain on injection was 9.4% (10/106) and 
4.7% of patients (5/106) had other venous sensations. The
overall incidence of venous sensation was 14% (15/106). The
incidence of severe muscle movement was 11% (6/55) and the 
incidence of mild to moderate muscle movement was 14.5%
(8/55). The overall incidence of muscle movement was 
25% (14/55).
Unsatisfactory anaesthesia occurred in 5.5% (3/55) of patients 
in the spontaneously breathing group due to prolonged muscle 
movement which caused the proposed infusion anaesthetic 
to be abandoned.
-1 -1
The mean infusion rate was 20.5 + 1.8 meg.kg. min. of 
etomidate and 0.057 + 0.0055 meg.kg. ^ min. ^ of fentanyl.
The mean coefficient of variation of the infusion rate was 
33 + 1.2% for the infusion group,, and 66 + 1.1% for the 
spontaneously breathing group.
Cardiovascular changes in both groups were small during the 
induction and maintenance of anaesthesia. Only the mean 
coefficient of variation for the pulse rate in the ventilated 
group was greater than 10% (1 0 .6%).
Manual assistance with ventilation was required by 14.5% 
of patients (8/55) in the spontaneously breathing group.
The mean arterial carbon dioxide tension rose from a pre­
induction mean level of 5.2 kPa to a mean intra-operative 
level of 6.4 kPa. This rise was statistically highly 
significant (p <0.00l). Fifteen minutes after the end 
of operation this value had fallen slightly to a mean level
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8 . The median time to recovery was 5 minutes in the ventilated
group compared with a median time of 15 minutes in the spontaneously 
breathing group. This difference was statistically significant 
(p <  0.01). One (1/51) patient in the ventilated group 
had not recovered within 30 minutes compared with seven 
(7/55) patients in the spontaneously breathing group.
9. There was no evidence of histamine release in any patient.
10. Nause or vomiting occurred in 4.6% (5/105) of patients.
11. Two patients had marked venous thrombophlebitis around the 
infusion site 24 - 48 hours after anaesthesia.
12. No patient appeared to be aware during anaesthesia.
Study Eight
Etomidate Infusion with Bolus Thiopentone Induction
1. The mean age of both groups of the ventilated patients was 55 
years. The mean age of both groups of the spontaneously 
breathing patients was 47 years.
2. Anaesthesia was successfully induced and maintained in all 
patients in this study.
3. Pain on injection and muscle movement was not found in any
group.
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4. The mean infusion rate was 20.0 +_ 1.6 meg.kg. ^ min. ^ of
etomidate and 0.056 0.0045 meg.kg.  ^min. ^ of fentanyl.
The mean coefficient of variation of the infusion rate was 
62 + 3.3% for the ventilated group and 74 _+ 3.1% for the 
spontaneously breathing group.
5. Cardiovascular changes during the induction and maintenance 
of anaesthesia in both etomidate groups were slight.
Statistically significant falls in .the mean arterial systolic 
blood pressure during the induction period were seen in the
I.P.P.V. control group (p<0.02) and in the spontaneously
breathing control group (p <  0.05). There were no statistically
/■
significant changes in the mean arterial diastolic blood pressures 
or pulse rates during the induction and maintenance of anaesthesia 
in the control groups. All mean coefficients of variance 
were less than 11%.
6 . Manual assistance was required by 20% of patients (10/50) 
in the spontaneously breathing group receiving etomidate 
infusion. Such assistance was not required by any patient in 
the corresponding control group. The mean arterial carbon 
dioxide tension rose from a pre-induction mean level of 5.2 kPa 
to a mean intra-operative level of 6.5 kPa in the etomidate 
group and from a mean pre-induction level of 5.2 kPa to a mean 
intra-operative level of 7.1 kPa in the control group. These 
rises were statistically highly significant (p < 0 .0 0l).
Fifteen minutes after the end of operation these values had 
fallen slightly to a mean level of 6.1 kPa. in the etomidate 
group; and to a mean level of 6.2 kPa in the control group.
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7. The median time to recovery was 7 minutes in the ventilated 
etomidate group. In the ventilated control group the median 
time to recovery was 6 minutes. This difference was not 
statistically significant. Five (5/50) patients in the ventilated 
etomidate group had not recovered within 30 minutes compared
with one (1/50) patient in the control group. In the spontaneously 
breathing groups, the median time to recovery was 25 minutes 
in the etomidate group compared with a median time of 18 minutes 
in the control group. This difference was statistically significant] 
different ( p < 0.05). Fourteen (14/50) patients in the spontaneously 
breathing etomidate group had not recovered within 30 minutes 
compared with 3 (3/50) in the spontaneously breathing control 
group.
8 . The incidence of nausea and vomiting was 4% in the etomidate 
groups compared with 6% in the control groups.
9. There was no evidence of histamine release in any patient 
in.this study.
10. The mean time to the first administration of post-operative 
intramuscular analgesia was 6.9 hours in the etomidate groups 
compared with a mean time of 6.4 hours in the control groups.
This difference was not statistically significant.
11. Twenty two percent of patients (22/100) had evidence of 
venous damage 24 - 48 hours after the infusion of etomidate, 
compared with 10% (10/100) in the control group. This difference 
was statistically significant (p <  0 .0 2 ).
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12. No patient appeared to be aware during anaesthesia.
Study Nine
Etomidate Infusion for Induction and Maintenance
1. The mean age of the patients in the ventilated groups was 52 
years. The mean age of the patients in the spontaneously 
breathing groups was 48.5 years.
2. Anaesthesia was successfully induced and maintained in all 
patients in this study.
3. The incidence of pain on injection was 4% (4/100) and
tingling occurred in a further 14. Mild muscle movement 
was seen in 12% (6/50) of patients. No pain on injection or 
muscle movement occurred in any patients in the control groups.
4. The infusion rate of etomidate was 100 meg.kg. ^ min. ^ for
the first 10 minutes followed by 10 meg.kg. ^ min. ^ thereafter. 
The mean time for the onset of hypnosis was 103 + seconds.
The mean infusion rate of fentanyl was found to be 0.23 +
0.015 meg.kg.  ^min. ^ for 3 - 4  minutes followed by 0.1 +
0.005 meg.kg.  ^min. ^ for 8 - 9  minutes and 0.05 0.003
meg.kg. ^ min. ^ thereafter. The mean coefficient of variation 
of the infusion rate was 54 + 1.3% for the ventilated group 
and 51 _+ 3.1% for the spontaneously breathing group.
5. The cardiovascular changes in both etomidate groups were
minimal during the induction and maintenance of anaesthesia.
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Statistically significant falls in .the mean arterial systolic 
blood pressure in the ventilated control group (p <  0.05) and 
in the control spontaneously breathing group (p <  0 .0 1 ) were 
seen during the induction period. There were no significant 
changes in the mean diastolic blood pressures or pulse rates 
in the control groups during the induction period. No significant 
changes in the mean arterial systolic or diastolic blood pressures 
or pulse rates occurred during maintenance anaesthesia in any 
group. All mean coefficients of variance were less than 10%.
6 . Four (4/50) patients required manual assistance in the 
spontaneously breathing group which had received etomidate 
infusion. Such assistance was not required by any patient in 
the corresponding control group. The mean rise in the level
of the arterial carbon dioxide tension was from a pre-induction 
mean of 5.1 kPa to an intra-operative mean level of 6.6 kPa. 
in the etomidate group and from a mean pre-induction level of
5.1 kPa to a mean intra-operative level of 6.5 kPa. in the 
control group. These rises were statistically highly 
significant (p <  0.001). Fifteen minutes after the end 
of operation these values had fallen slightly to a mean of
6.1 kPa. in both groups.
7. The median time to recovery was 8 minutes in both 
ventilated groups. All patients were awake within 30 minutes.
In the spontaneously breathing groups, the median time to 
recovery was 15 minutes in the etomidate group compared with
a median of 23 minutes in the control group. This difference
was statistically significant (p<0.01). Four (4/50) patients
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in the etomidate group and 6 (6/50) patients in the control 
group had not recovered within 30 minutes.
8 . Four patients who had received an infusion of etomidate showed 
the presence of myoclonic movements for up to 45 minutes 
after the end of infusion.
9. The incidence of nausea and vomiting in the etomidate groups 
was 5% compared with 7% in the control groups.
10. There was no evidence of histamine release in any patient 
in this study.
11. The mean time to the first administration of analgesia was
6.2 hours in the control groups compared with a mean time of
5.8 hours in the etomidate infusion groups. This difference
was not statistically significant.
12. Three (3/100) patients in the etomidate groups showed evidence 
of venous damage, one of which lasted for several months. This 
patient had received a 0.5% solution of etomidate
13. No patient appeared to be aware during anaesthesia.
Study Ten
Etomidate Infusion and Hepatic and Renal Function
1. Neither infusion scheme was found to cause adverse effects
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on renal or hepatic function when compared with a standard 
anaesthetic technique.
Study Eleven
The First Propofol Infusion Study
1. The mean age of the group was 59 years.
2. Anaesthesia was successfully induced and maintained in all 
patients in this study.
3. The incidence of pain on injection was 6.7% (1/15).
4. The infusion rate of propofol was initially 150 meg.kg. ^ min.
for 30 minutes followed by 75 meg.kg. ^ min. ^ thereafter. 
Fentanyl was infused separately. The mean infusion rate of 
fentanyl was found to be 0 . 1 5 + 0 . 0 2  meg.kg. ^ min. ^ for 
5 - 6  minutes followed by 0.1 + 0.005 meg.kg. ^ min. ^ for 
8 - 1 0  minutes and 0.05 + 0.003 meg.kg. ^ min. ^ thereafter. 
The mean coefficient of variation of the infusion rate was
56 + 1.3%.
5. The mean arterial systolic blood pressure fell during the
induction period. This fall was statistically significant 
(p <0.05). The mean arterial diastolic blood pressure and 
pulse rate did not change significantly during the induction 
and maintenance of anaesthesia. All the mean coefficients 
of variance were less than 10%.
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6. All six spontaneously breathing patients required manual 
assistance with ventilation.
7. There was no evidence of histamine release in any patient 
in this study.
8. The median time to early recovery was 8 minutes and the 
median time to recall of the date of birth was 10 minutes.
9. No evidence of venous damage was evident 24 - 48 hours after 
infusion.
10. No patient appeared to be aware during anaesthesia.
Study Twelve
The Second Propofol Infusion Study
1. There were no statistically significant differences in age, 
weight, sex distribution or duration of infusion between the
groups. The mean age of the groups was 62 years.
2. Anaesthesia was successfully induced and maintained in all 
patients in this study.
3. The incidence of pain on injection was 6.7% (2/30).
4. The infusion of propofol was initially 150 meg.kg. ^ min. ^
for 30 minutes followed by 75 meg.kg. ^ min. ^ thereafter.
There were no statistically significant differences between
the infusion rates of fentanyl in the two groups. The combined
mean rate of infusion of fentanyl was found to be 0.17 + 0.006
mcg.k. ^ min. ^ for h - 10 minutes followed by 0.12 + 0.005
meg.kg. ^ min. ^ for 12 - 20 minutes and 0.06 + 0.005 meg.kg. ^min 
thereafter. The mean coefficient of variation of the infusion
rate was 50 + 1.0%.
The mean arterial systolic pressure fell after induction.
This fall was statistically significant (p <  0.01). There were 
no significant changes in the mean diastolic blood pressure 
during the induction period of anaesthesia, but the maintenance 
mean of the diastolic pressure was statistically significantly 
higher than the induction levels (p <  0.05), There were no 
statistically significant changes in the mean pulse rate 
during the induction and maintenance of anaesthesia. The 
highest mean coefficient of variation was 12%.
There appeared to be an increase in the duration Of action of 
consecutive bolus increments of vecuronium compared with 
those of atracurium. These differences were statistically 
significant when the fourth (p <  0.02) and fifth (p <  0.01) 
increments of the two drugs were compared.
The times to recovery after the infusions of propofol were 
switched off were very similar in the two groups. The median 
time to early recovery was 10 minutes and to recall of date 
of birth was 17 minutes.
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8. No evidence of venous damage was evident 24 - 48 hours after 
infusion.
9. No patient appeared to be aware during anaesthesia.
CHAPTER ELEVEN
DISCUSSION OF ETOMIDATE AND PROPOFOL 
FOR THE INDUCTION OF ANAESTHESIA
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Introduction
During the induction studies described in Chapters Three,
Four, Five and Six, many of the advantages and disadvantages of 
etomidate and propofol for the induction of anaesthesia became 
apparent.
Etomidate
Induction Dosage
The early German studies (Doenecke et al, 1973; 1974)
suggested that etomidate was a short acting agent with an 
optimum induction dose of 0.3 mg.kg. Early British and American
induction studies (Studies One to Four; Morgan, Lumley and Whitwam,
' 1975; Kay, 1976; Holdcroft et al, 1976; Gooding and Corssen, 1976; 
Fragen, Caldwell and Brunner, 1976; Ghoniem and Yamada, 1977) 
confirmed that this dose was suitable for induction and this has remained 
so despite changes in formulation.
Cardiovascular Changes
The induction studies of etomidate showed it to be cardiovascularl) 
stable using the standard induction dose of 0.3 mg.kg. None of
the patients in any study described in this thesis who were anaesthetised 
with etomidate, regardless of formulation or rate of injection, 
showed a marked drop in arterial pressure. Similar findings of 
cardiovascular stability using the same dose have been described 
by other workers (Brtlckner et al, 1974; Morgan, Lumley and Whitwam, 1975;
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Kay, 1976; Holdcroft et al, '1976; Gooding and Corssen, 1976;
Fragen, Caldwell and Brunner, 1976; Ghoneim and Yamada, 1977).
Invasive studies in fit volunteers (Gooding and Corssen, 1977;
Patsche et al, 1977) and in patients with known cardiac disease 
(Hemplemann et al, 1974, a; Gooding et al, 1979; Tarnow, Hess 
and Klein, 1980) have also reported minimal cardiovascular depression 
with etomidate. In Study Seven, the use of a higher dose, 0.46 mg.kg.  ^
of etomidate showed no adverse effects on cardiovascular stability.
However, some clinical studies have described small negative 
inotropic effects (Rifat, Gamulin and Gemperle, 1975; Colvin et 
al, 1979; Criado et al, 1980) and two cases of severe cardiac 
complications, attributed either to etomidate or to propylene 
glycol, have been reported (Van Den Hurk and Teijen, 1983). A 
negative inotropic effect on papillary muscle both in rabbits 
(Komai, Dewitt and Rusy, 1985) and dogs (Kissen et al, 1983) has 
been demonstrated as well as a direct chronotropic depressent effect 
in cats when the baroreceptors are denervated (Skovsted and Saphavichaik 
1977). The cardiovascular stability of etomidate may be due to the 
lack of inhibition of baroreceptor function (Hughes and McKenzie,
1978; Bernards, Marrone and Priano, 1985). Unlike methohexitone, 
ketamine and althesin, etomidate has not been shown to inhibit 
efferent cardiac vagal drive in cats (Inoue and Arndt, 1982) possibly 
accounting for the lack of tachycardia associated with its use.
Respiratory Changes
Respiratory stability, particularly the short duration of
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any apnoea, was described in Chapters Three and Four. Similar 
findings of respiratory stability have been described by other 
investigators (Morgan, Lumley and Whitwam, 1975; Zacharias et al,
1978; Kay, 1979). Small changes in blood carbon dioxide gas tensions 
have been reported ranging from 5% (Gooding et al,. 1979), 8% Carlos and 
Innerarity, 1979) to 14% (Colvin et al, 1979). This lack of 
respiratory depression maybe due, in part, to carbon dioxide 
independent stimulation of ventilation (Choi et al, 1985).
Anaphylactic Reactions
No patient in any etomidate induction or infusion study 
showed any evidence of histamine release. The reported incidence 
of anaphylactic reactions to etomidate has been very low (Watkins,
1983; 1985). Some histaminoid reactions have occurred in the peri­
operative period with widespread urticaria. Two cases with 
generalised erythema have been reported (Krumholz et al, 1984;
Sold and Rothhammer, 1985). In the second case, skin testing 
was positive for etomidate only. Asthmatic patients have been 
shown to release significantly higher amounts of histamine than 
normal patients after provocation with althesin, but not with 
etomidate (Guldager et al, 1985).
Complications
During the clinical investigations of etomidate, certain 
disadvantages became apparent. The complications which gave 
concern were pain on injection, muscle movement, emergent psychosis 
and venous sequelae.
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Pain on Injection
Pain on injection was a particular problem with the initial 
formulation of etomidate (Studies One and Two). The overall 
incidence of pain on injection was 24%. Other authors found an 
incidence ranging from 15% (Morgan, Lumley, and Whitwam, 1975; 
O fCarroll et al, 1977, a) 40% - 50% (Zacharias et al, 1978), 50% 
(Gooding and Corssen, 1976; Fragen, Caldwell and Brunner, 1976) 
to 81% when injected via the dorsum of the hand (Holdcroft et al, 1976
Reformulation in polyethylene glycol reduced the incidence 
of pain compared with the original formulation. The incidence 
varied from 4% (Study Three), to 6% (Van Dijk, 1978) to 24 - 30% 
(Zacharias et al, 1978). c~
The final formulation in propylene glycol was also found to 
have a 4% incidence of pain on injection compared with 6% for 
methohexitone (Study Four). Fragen and Caldwell (1979) also 
found a marked reduction in the incidence of pain to around 10%.
Higher figures have been reported, 17% (Helmers, Adam and Giezen,
1981); 25% (Van Eeden, 1980); 25 -35% (Zacharias et al, 1978); 
and 68% (Yelavich and Holmes, 1980).
The incidence of pain in the control group of Study Five 
(etomidate and alfentanil) was much greater (48%) than that found in 
the earlier studies, although all the studies were unpremedicated.
The patients in this study were younger with a mean age of 33 years 
compared with a mean age of 60 years in the earlier studies and 
were female compared with the predominately male older groups.
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Mixing lignocaine with etomidate had little effect in 
children (Kay, 1976), but showed some benefit in adults (Brown 
and Moss, 1981). Some authors found that the pain was reduced by 
administration via the antecubital fossa (Holdcroft et al, 1976;
Kay 1976). Increasing of slowing the rate of injection reduced 
both pain and muscle movement (Studies One, Two, Three and Nine). 
Intralipid has been used as a solvent for etomidate with a marked 
reduction in the incidence of pain on injection and venous thrombosis 
to 2% (Gran et al, 1983).
Muscle Movement
The overall incidence of muscle movement using the original 
formulation was 29%. Other estimations of muscle movement have 
ranged from 25% (Morgan, Lumley and Whitwam, 1975; Gooding and 
Corssen, 1976) to 65% (Holdcroft et al, 1976); 70% (Fragen,
Caldwell and Brunner, 1976) and 70 -75% (Zacharias et al, 1978).
Changing the solvent to polyethylene glycol did not significantly 
lower the incidence of muscle movement (16%) compared with the original 
formulation (Study Three). A similar lack of reduction (80%) has 
been reported by;other investigators (Zacharias et al,.1978; Van Dijk, 197
Reformulation in propylene glycol had no effect on the 
incidence of muscle movement (22%), (Study Four). A variable, 
but high incidence of muscle movement has been reported from many 
authors using this formulation. These range from 10% (Fragen and 
Caldwell, 1979), 38% (Helmers, Adam and Giezen, 1981), 50% (Yelavich
and Holmes, 1980), 70% (Copeland, Howell and Ryan, 1981) to 85% - 95%
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(Zacharias et al, 1978). Thus the changes in formulation do not 
apppear to significantly reduce the incidence of involuntary muscle 
movement after bolus injection. Altering the rate of injection had 
little effect on the incidence of muscle movement (Studies One,
Two, Three and Nine). In Study Nine where the induction dose 
was infused, the incidence of muscle movement was reduced to 12%, 
with a lack of severe muscle movement. A similar lack of change with 
different formulations has been reported by Zacharias et al (1978), 
as has the injection of different dosages over a constant period 
of time (Holdcroft et al, 1976).
As with the pain on injection, a very high - 80% incidence 
of muscle movement was seen in the control group of Study Five.
Although the incidence of muscle movement was high, it was not 
found to be dangerous and was easily controlled by the administration 
of halothane.
Movements in the post-operative period after induction with 
etomidate have been reported (McIntosh et al, 1979; Tasch, 1985) 
possibly due to earlier recovery of the extrapyramidal system 
compared with the cerebral cortex (Laughlin and Newberg, 1985).
Recovery
Recovery in the patients receiving etomidate (Studies One 
to Four) was rapid and this has been confirmed by other investigators, 
both in adults (Morgan, Lumley and Whitwam, 1975; Gooding and Corssen, 
1976; Fragen, Caldwell and Brunner, 1976) and in children (Kay, 1976).
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The incidence of nausea and vomiting in these studies was low at 
5%. Higher incidences have been reported varying from 28% (Holdcroft 
et al, 1976); 40% (Yelanovitch and Holmes, 1980)and 40 - 55% regardles
of formulation (Zacharias et al, 1978). Several reports have commented 
on the occurrence of emergent dysphoria or delirium - 12% (Chiu 
and Van, 1978), 25% (Yelavitch and Holmes, 1980).
Long Term Venous Damage
The incidence of venous thrombosis fourteen days after 
etomidate administration has been found to vary from 24% (4% for 
thiopentone) (Schou Olsen, Huttel and Hole, 1984) to 43% (20% for 
thiopentone) (Kortilla and Aromaa, 1980). Although there are no 
figures available in this thesis concerning long term venous damage 
several patients complained of severe prolonged venous thrombosis 
' either after receiving a bolus dose for induction or after prolonged 
infusion, regardless of formulation.
Effect of Premedication
Pain on Injection
After intramuscular opiate premedication and intravenous
fentanyl given immediately before induction, the incidence of pain
in the first etomidate infusion study (Study Seven), using a bolus
-1
injection of etomidate (0.46 mg.kg. ) for induction, increased to 
9%, and a further 5% of patients complained of tingling, compared 
with the 4% incidence of pain described in the fourth induction 
study. Other studies of the influence of premedication have given
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conflicting results. Reduction of the incidence of pain with 
opiates has been described in some studies (Holdcroft et al, 1976;
Kay, 1976; Gooding and Corssen, 1976; Zacharias et al, 1979).
Other studies (Carlos and Innerarity, 1979; Kortilla, Tammisto, 
and Aromaa, 1979; Helmers, Adam and Giezen, 1981) have not.
Using the same premedication as in Study Seven, a rapid infusion 
of etomidate in alcohol and saline (Study Nine) reduced the incidence 
of pain to 4% but there was a higher incidence of tingling of 14%, 
suggesting that infusion of etomidate reduced the intensity of the 
pain rather than the incidence. Intravenous alfentanil significantly 
reduced the spontaneous complaint of pain (Study Five) but no such 
difference was found by Collin, Drummond and Spence (1986).
Muscle Movement
Intravenous fentanyl or diazepam reduced the incidence 
of muscle movement (Gooding and Corssen, 1976; Carlos and 
Innerarity, 1979; Kortilla, Tammisto and Aromaa, 1979; Helmers,
Adam and Giezen, 1981) as did intramuscular pethidine (Zacharias 
et al, 1979). In Study Seven, intramuscular opiate premedication 
and a bolus dose of 1.3 meg.kg. ^ of fentanyl immediately before a 
bolus injection of etomidate (0.46 mg.kg. ^) did not alter the 
incidence of muscle movement. This was 25% compared with the 22% 
described in Study Four. Using a similar premedication, and 
intravenous fentanyl, but inducing anaesthesia with an infusion of 
etomidate in alcohol (Study Nine), the incidence of muscle movement 
was reduced to 12%, none of which was severe. The use of intravenous 
alfentanil (Study Five) reduced the incidence of muscle movement to 4%, 
none of which was severe (Collin, Drummond and Spence, 1986).
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Propofol
Induction Dosage
The induction dose of 2.5 mg.kg. ^ (Cummings et al, 1984) 
was found to be satisfactory in all cases in the induction study 
(Study Six). Other studies using the new formulation (Nightingale 
et al, 1985; Briggs and White, 1985; Noble and Ogg, 1985) also 
found this induction dose to be satisfactory. However^ lower dose 
requirements have been found in the elderly (Dundee et al, 1986).
Cardiovascular Changes
A moderate reduction of systemic arterial blood pressure 
with little change in heart rate following propofol induction was 
described in Study Six and also by other investigators (Cummings 
et al, 1984; Nightingale et al, 1985; Henriksson et al, 1985). 
Speed of injection did not appear to affect cardiovascular stability 
when administered in a dose of 2 mg.kg. ^ (Roily et al, 1985).
Respiratory Changes
Sixty five per cent of propofol induced patients in the 
induction study became apnoeic, 17% lasting over a minute. Using 
the same formulation, an incidence of apnoea of 44% has been
described (Briggs and White, 1985) of which 21% lasted over a
minute. Apnoea was not found when an induction dose of 2 mg.kg. ^
was administered compared with 2.5 mg.kg. ^ (Cummings et al, 1984)e
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Anaphylactic Reactions
In neither the propofol induction nor the infusion studies 
was there any evidence of histamine release. That propofol releases 
little histamine has been shown experimentally (Doenecke et al, 1985).
Pain on Injection
There was a high incidence of pain on injection of 37.5% 
and 60% of patients in this group had some form of venous sensation 
when small veins were used (Study Six). Similar findings were 
reported by other investigators - 25% (Mirakhur and Shepherd, 1985), 
and 30% (Briggs and White, 1985). The use of veins in the ante- 
cubital fossa significantly reduced the incidence of pain (Study 
Sixr Briggs and White, 1985; Cummings et. al, 1984). Pretreatment 
with I.V. lignocaine appeared to have little effect (Study Six) 
although mixing lignocaine with propofol immediately before injection 
reduced the incidence of pain to 4% (Redfern, Stafford and Hull,
1985).
Pain on injection was reduced to 6.7% using intramuscular 
opiate premedication (Studies Eleven and Twelve), compared with 
the 37.5% found in the unpremedicated induction study, although the 
patients tended to be older (the average age was 60 years compared 
with an average age of 35 years in Study Six). A higher incidence 
of 20% (Be Grood et al, 1985, b) and 45% (Uppingham, Kay and Sear, 
1985) despite morphine premedication has been described.
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Muscle Movement
A low incidence of muscle movement has been reported (Chapter 
Nine; Kay and Healy, 1985; Roily et al, 1985) although an incidence 
of 23%, attributed to lightening of anaesthesia, has been reported 
(Cummings et al, 1984).
Comparison of Etomidate and Propofol with other Agents 
Cardiovascular Changes
Various studies comparing etomidate 0.3 mg.kg. ^ with
-1 * 
propanidid 7.0 mg.kg. (Study Two; Bruckner et al, 1974) suggested
that the cardiovascular stability of etomidate was superior to
propanidid. Compared with thiopentone 4 mg.kg. etomidate
0.3 mg.kg. ^ produced a similar degree of cardiovascular depression
(Gooding and Corssen, 1976; Fragen, Caldwell and Brunner, 1976;
McCollum and Dundee, 1986). The cardiovascular depression found
with etomidate 0.4 mg.kg. ^ and thiopentone 4 mg.kg. ^ was also
very similar (Chiu and Van, 1978; Giese et al, 1985). Methohexitone
1.5 mg.kg. ^ produced either a very similar (Study Four; Dubois-Primo
et al, 1976) or slightly greater degree of depression (Vercuysse,
Hanegreefs and Delooz, 1976; Van Eeden, 1980; McCollum and
Dundee, 1986).
In the induction study with propofol (Study Six) the 
changes were similar to those found with thiopentone 4.5 mg.kg. ^ 
except that there was an increase in pulse rate in the thiopentone 
group only. Similar changes comparing propofol 2 mg.kg. ^ (Roily
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and Versichelen, 1985) and 2.5 mg.kg. ^ (Mouton et al, 1985) with 
thiopentone 4 mg.kg. ^ have been described. In contrast a greater 
fall was described with propofol 2.5 mg.kg. ^ compared with 
thiopentone 4 mg.kg. ^ (Grounds et al, 1985) or 5mg.kg. ^ (Fahy,
Van Mourik and Utting, 1985; Mackenzie and Grant, 1985, a;
McCollum and Dundee, 1986). Greater cardiovascular changes with 
propofol 2.5 mg.kg. ^ compared with methohexitone 1.5 mg.kg. ^ were 
found (Mackenzie and Grant, 1985, a; Kay and Healy, 1985).
Respiratory Changes
The respiratory effects of etomidate may be less depressant 
than those found with althesin or thiopentone (Morgan, Lumley and 
Whitwam, 1975) or methohexitone (Kay, 1979). A higher incidence 
of apnoea was found with thiopentone 4 mg.kg. ^ compared with 
etomidate 0.3 mg.kg. ^ (Ghoneim and Yamada, 1977; Chiu and Van,
1978; McCollum and Dundee, 1986).
Propofol 1.5 and 2 mg.kg. ^ produced a similar degree of 
respiratory depression as thiopentone 4 mg.kg. ^ (Roily and 
Versichelen, 1985). Propofol has been shown to have a greater 
degree of respiratory depression compared with thopentone 4 mg.kg. ^ 
(Mouton et al, 1985; Taylor et al, 1986; McCollum and Dundee, 1986)
4.5 mg.kg. ^ (Study Six) and 5mg.kg. ^ (Mackenzie and Grant, 1985, a; 
McCollum and Dundee, 1986) and methohexitone 1.5 mg.kg.  ^ (Mackenzie 
and Grant, 1985, a; McCollum and Dundee, 1986).
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Pain on Injection
Both agents cause pain on injection, but there was a 
wide variation in the incidence reported in different studies.
Muscle Movement
Muscle movement appeared to be less with propofol compared 
with metholiexitone (Mackenzie and Grant, 1985, a) or althesin (Kay 
and Healy, 1985), and is a major advantage compared with etomidate.
Recovery
Recovery from both etomidate and propofol was rapid and 
complete. Emergence phenomena may be a problem with etomidate.
Venous Damage
Although no specific comparisons have been made in these studies, 
venous damage would appear to be much less than that found after 
the injection of etomidate.
Conclusions
The bolus injection of both etomidate and propofol appeared 
to cause only slight physiological changes, except for some 
cardiovascular and respiratory depression by propofol. However, 
their clinical acceptability was reduced by the incidence of pain 
on injection and etomidate also caused muscle movement. Under 
most circumstances when cardiovascular stability is not of paramount 
importance, propofol would appear to be closer to the ideal induction
agent than etomidate. This is mainly due to the lower incidence of 
side effects, particularly muscle |aovement and venous sequelae.
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Etomidate may be more suitable for the elderly and unfit patients 
because of its greater cardiovascular stability.
Compared with thiopentone, propofol may offer advantages 
in outpatient anaesthesia due to its shorter recovery time, provided 
the incidence of pain and apnoea are not found to be too great a 
disadvantage. For inpatient anaesthesia in fit patients, neither 
etomidate or propofol would appear to offer major advantages over 
thiopentone.
Thiopentone has enjoyed extensive use over more than fifty 
years. Its advantages and disadvantages have become well known 
and can usually be compensated for whenever necessary. In contrast, 
etomidate was freely available for nearly ten years before problems 
such as adrenal depression (Fellows et al, 1983) and possible 
generalised epileptiform activity (Krieger, Coppermann and Laxer, 
1985) were reported. A similar period of time elapsed between the 
introduction and withdrawal of althesin. Di-isopropylphenol has 
already required reformulation and was released for general use 
only in June 1986. Caution has be to be expressed concerning 
the relative merits of any new induction agent as long term use 
may reveal unsuspected disadvantages.
Areas for further Investigation
Possible Relationship between the Rate of Injection and the 
Incidence of Complications
There is some evidence that the rate of injection and therefore
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the concentration of the bolus of the drug may influence the 
incidence of side-effects. This may occur before or after the 
drug reaches its main site of action. The minimum therapeutic 
level for etomidate is 0.3 meg.ml. \  the safe maximum level is 
1.0 meg.ml. ^ and the optimum level is 0.5 meg.ml. ^ (Schlittler, 
Schwilden and Stoekel, 1985). A bolus injection of etomidate 
0.3 mg.kg. ^ over 10 seconds can result in a mean plasma 
concentration of 1.59 meg.ml. ^ within a minute and 1.3 meg.ml. ^ 
when injected over sixty seconds (Doenecke et al, 1982).
In the studies reported in Studies One, Two, Three and Nine 
the maximal incidence of side effects, particularly muscle movement, 
occurred when the drug was injected over 30 - 60 seconds.
When the same amount of etomidate was infused over 3 minutes 
(Study Nine; Scorgie, 1983) there was a marked reduction in the
incidence of pain and muscle movement. This could be due to the
blood levels of etomidate failing to reach the levels found during 
rapid injection. In a similar study with disoprofol, fewer 
side-effects were found when disoprofol was injected over three
minutes (Major et al, 1982).
Little difference in the complication rates have been 
described when the induction dose of etomidate was injected over 
10 - 15 seconds or 20 - 30 seconds (Zacharias et al, 1978), or 
when differing amounts were injected over thirty seconds (Holdcroft 
et al, 1976), although a slight decrease in the incidence of pain 
and muscle movement was found in Study Two, when etomidate was
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injected over 15 seconds. One explanation is that such 
differences which might exist, are greatly reduced because etomidate 
is very highly bound to plasma - 90% (Doenecke et al, 1982).
The cardiovascular and respiratory depression described in 
several studies of induction with propofol could also be due to 
its rapid injection, although little change in cardiovascular and 
respiratory depression has been described when propofol was 
injected over 5, 20, or 60 seconds (Roily et al, 1985). A 
wide variation in the sensitivity to propofol and a marked variation 
in incidence of side effects with rapid injection has been described 
(Dundee et al, 1986).
Because such effects may be important particularly in the 
elderly, further investigations of the effects of the rate of 
injection on the incidence of complications are planned.
Possible Relationship between Age or Sex and the Incidence 
of Complications
The differences in the incidence of pain on injection in 
Studies Four and the control group in Study Five have been commented 
upon earlier in this chapter. Methodological changes could account 
for some of this as different observers took part in the two 
studies. Many patients in the Fourth Study had had previous 
experience of anaesthesia which could have influenced their assessment 
of pain.
The incidence of pain in the fifth study was similar to
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that found by Zacharias et al (1978) also in unpremedicated 
patients undergoing minor gynaecological surgery. In contrast, 
a high incidence of pain (68%) was described in patients undergoing 
cystoscopy (Yelavitch and Holmes, 1980). Although no indication of 
age or sex distribution was given, it could be expected that this 
group would be demographically similar to that of Study Four. The 
reasons for these differences are.not clear and will be the subject 
of further investigation.
CHAPTER TWELVE
DISCUSSION OF THE INFUSION OF
ETOMIDATE AND PROPOFOL 
FOR THE MAINTENANCE OF ANAESTHESIA
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Introduction
The induction studies discussed in the previous chapter 
showed that both etomidate and propofol were potent hypnotics 
which were rapid in onset and recovery. These findings have 
been confirmed by formal pharmacokinetic studies of etomidate 
(Van Hamme, Ghoneim and Ambre, 1978; Schdttler et al, a, 1980;
De Ruiter et al, 1981; Doenecke et al, 1982) and propofol (Briggs 
et al, 1985: Kay et al, 1985, a). The infusion studies extended 
the induction studies by investigating the effects of administering 
large amounts of hypnotic over a relatively short period of time.
The studies have allowed the assessment of such techniques for the 
provision of total intravenous anaesthesia and how such techniques 
might be improved. Since neither etomidate nor propofol have any 
analgesic activity, supplementation was provided with intravenous 
fentanyl.
Infusion of Etomidate
The infusion rates of etomidate in the earliest studies were 
derived empirically. Rates in adults ranged from 20 - 50mcg,Jcg. ^min. 
(Kay and Roily, a, 1977; O ’Carroll et al, 1977, b; Van Dijk, 1979; 
Gepts and Camu, 1981) and similar amounts were infused in children 
(Kay, 1977, a; b). These high rates of infusion were associated 
with high complication rates (O’Carroll et al, 1977, b; Kay 1977, a; 
Kay and Roily, a, 1977).
Lower infusion rates of around 20 meg.kg. ^min. ^supplemented
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with either fentanyl or nitroys oxide were used to maintain 
anaesthesia for both spontaneously breathing and ventilated patients 
(Studies Seven, Eight and Nine; Van Dijk, 1979; Booij, Rutten 
and Crul, 1978).
The relationship between blood levels of etomidate, and the 
degree of hypnosis was investigated (SchUttler et al, 1980, b;
/
Doenecke et al, 1982) using :power spectral analysis of the E.E.G.
The former group described a simple two stage infusion regime which 
rapidly achieved an adequate, steady blood level of etomidate.
Computer simulation using the available pharmacokinetic data suggested 
that this infusion scheme would provide better conditions with 
lower etomidate blood levels compared with the earlier empirical 
regimes (Schwilden et al, 1981). Study Nine was carried out to 
investigate this suggestion.
The differences in the amounts of etomidate administered 
using this two stage infusion regime are shown in Figure Twenty 
One. This shows the cumulative amounts of etomidate administered 
in the three ventilated groups in Studies Seven, Eight and Nine.
The differences in the amounts administered to Studies Seven and 
Eight are not significant and are due mainly to the initial bolus 
of etomidate given for induction in Study Seven.
The contrast between the amounts of etomidate administered 
with the two stage infusion technique and the empirical infusion 
rates is best seen comparing the amounts administered during the 
Seventh and Ninth Studies as both studies were induced with etomidate.
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After 50 minutes Study Nine had received significantly less 
etomidate than Study Seven. This difference was also statistically 
significant (p < 0.01). Compared with Study Eight where 
thiopentone was used for induction significantly less etomidate 
was administered to patients in Study Nine after 105 minutes.
Analgesic Supplementation
Etomidate has no analgesic action and an antanalgesic action 
has been described in rats (Kissen, Green and Reeves, 1984). 
Investigation of etomidate and fentanyl in dogs (Erhardt et al,
1978; Arndt and Mameghani, 1980; Renemans, 1981) and humans 
(Hempleman, Seitz and Piepenbrock, 1977) have shown that the 
combination of etomidate and fentanyl has little effect on cardio­
vascular parameters except for a slowing in pulse rate and some 
depression of respiration (Schockenhoff, Hoffman and Plantiko,
1980). Baroreceptor function, in particular, appears to remain 
unaltered.
The amounts of fentanyl infused in the ventilated patients 
in the three studies are shown in Figure Twenty Two. Statistically 
significant differences are seen within the first 40 minutes between 
the groups. Thereafter there were no statistically significant 
differences between the three studies, although the mean amounts 
of fentanyl infused were lower in the third.
Cardiovascular Changes
In animal studies, doses of etomidate varying from 0.1 mg.kg.
Fig. 22
CUMULATIVE AMOUNTS OF FENTANYL INFUSED IN VENTILATED 
PATIENTS DURING THE THREE ETOMIDATE INFUSION STUDIES
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to 1.6 rag.kg. have been shown to have little cardiovascular
effect (Weymar et al, 1974). Larger doses of etomidate of 2 - 
8 mg.kg. ^ have been shown to have a dose-related central and 
peripheral direct depressant effect on the rabbit myocardium (Hughes 
and McKenzie, 1978). As shown in Figure Twenty One, about 2 mg.kg. ^ 
is administered within 90 -120 minutes depending on the infusion rate. 
The cardiovascular stability found in the induction studies was 
also fqund in the infusion studies, reflected in the low coefficients 
of variation described in Studies Seven, Eight and Nine. This tends 
to confirm the animal work suggesting that either such amounts of 
etomidate do not cause myocardial depression or that the baroreceptor 
reflexes are maintained when etomidate and fentanyl are infused 
together over a period of time. Bradycardia has been described 
(O’Carroll et al^l977, b; Chapter Seven) possibly due to centrally 
mediated bradycardia associated with fentanyl (Eisle et al, 1975; 
Reitan et al, 1978). All episodes reponded to the intravenous 
administration of small amounts of atropine. Induction with 
thiopentone did not appear to affect the cardiovascular stability 
of the infusion of etomidate and fentanyl.
Respiratory Changes
All studies showed rises in arterial carbon dioxide tension, 
comparable to that seen in the control groups. Similar findings 
of respiratory stability have been described in spontaneously 
breathing patients in other studies (Van Dijk, 1979; Van Eeden 
and Leiman, 1980). However, in individual patients, there were 
problems of respiratory depression or apnoea which required manual 
ventilation until spontaneous respiration returned. Such episodes
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frequently occurred after increases in the infusion rate of 
fentanyl or etomidate and fentanyl because of signs of inadequate 
anaesthesia (as defined in Chapter Two). Complications such as 
"stiff chest" and post-operative respiratory depression were not 
seen.
Recovery
Recovery in most patients in Studies Seven and Nine was 
rapid, usually within 12 - 20 minutes. Despite the use of 
differing techniques (Kay, 1977, a, b; O'Carroll et al, 1977, b;
Van Dijk, 1979; Van Eeden and Leiman, 1981; Rocke et al, 1981) 
similar recovery times have been described in those studies.
Recovery could be prolonged in individual patients (O’Carroll 
et al, 1977; Van de Walle et al, 1979). The use of thiopentone
in the second series was associated with prolonged recovery, possibly 
due to the combination of the hypnotic effect of thiopentone and 
the infusion of etomidate. Detailed study of the immediate post­
operative period (Hoffman and Schockenhoff, 1981) showed minimal 
changes in cardiovascular and respiratory systems after the infusion 
of etomidate. The infusion of fentanyl did not appear to influence 
the time interval to the first administration of post-operative 
analgesia in the second or third infusion studies. The occurrence 
of prolonged myoclonus has been reported after the infusion of 
etomidate (Laughlin and Newberg, 1985). Similar effects were seen 
in four patients in Study Nine.
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Liver Function Tests
The problem of which liver function tests should be carried 
out and their significance remains unresolved (Sear et al, 1984). 
Changes in liver function tests occur after routine upper abdominal 
surgery (Clarke, Doggart and Lavery, 1976). In the liver function 
study (Chapter Eight) no clinically significant changes were found. 
Similar small, non-significant changes have been described in other 
studies (Hoffman and Schockenhoff, 1982; Sear et al, 1984). The 
only series where there was a consistent rise in liver enzymes was 
reported by Blunnie et al (1981) using a high infusion rate of 
40 meg.kg.  ^min. These findings suggest that the use of 
moderate infusion rates of etomidate with fentanyl do not upset 
liver function significantly, but that this may not be true of 
higher infusion rates.
Fluid and Electrolyte Balance
The infusion of etomidate and fentanyl (Study Ten) appeared 
to cause little upset in renal function and the results found were 
similar to those found after a standard anaesthetic technique. 
Similar minor changes in serum electrolytes post-operatively after 
the infusion of etomidate have been described (Hoffman and 
Schockenhoff, 1982).
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Infusion of Propofol
The rate of infusion of propofol in Studies Eleven and Twelve 
was initially 150 meg.kg. ^ min. ^ for 30 minutes which was then
reduced to 75 meg.kg. ^ min. Other quoted rates vary from
“1 -1 -1 -1 
72.6 meg.kg. min. (Kay et al, 1985,b), 102.8 meg.kg. min.
(Jessop et al, 1985), and 130 meg.kg. ^ min. ^ (Mackenzie and Grant,
1985,b) used to supplement spinal or epidural analgesia in
spontaneously breathing patients to 160 meg.kg. ^ min. ^ (Hunter,
Spencer and McLaren, 1985), 197 meg.kg. ^ min. ^ (Robinson, 1985)
and 214 meg.kg. ^ min. ^ (McLeod and Boheimer, 1985) infused as
part of intravenous anaesthetic techniques.
Cardiovascular Changes
Cardiovascular changes in the various studies tended to be 
very similar with a drop in arterial pressure, particularly systolic, 
in both fit patients (Coates et al, 1985; Robinson, 1985; Chapter 
Nine) and patients undergoing cardiac operations (Patrick et al,
1985; Stephen et al, 1986) soon returning to pre-operative levels 
during maintenance anaesthesia. Pulse rates tended to remain constant 
(Robinson, 1985; Uppingham, Kay and Sear, 1985). Myocardial 
blood flow may be decreased resulting in possible myocardial 
ischaemia (Stephen et al, 1986).
Respiratory Changes
Apnoea during induction with propofol has been described in
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many studies (Chapter Eleven). Other infusion studies, using 
similar rates of infusion to those described in Chapter Ten, did not 
describe any particular difficulties with apnoea during maintenance 
anaesthesia. This difference may be due to the infusion of fentanyl 
to provide analgesia, causing additional respiratory depression.
The elevation of blood propofol levels associated with the administration 
of fentanyl (Briggs et al, 1985) could also contribute to this effect.
Prolongation of Duration of Action of Muscle Relaxant
In Study Twelve it was suggested that there might be a progressive 
prolongation of the effect of vecuronium compared with that of 
atracurium over a period of 2 - 3 hours. Bolus injections of propofol 
had no effect on the neuromuscular blockade produced by suxamethonium, 
atracurium (Nightingale et al, 1985) or vecuronium (De Grood et al,
1985, a). Disoprofol has been shown to potentiate suxamethonium, 
pancuronium and vecuronium in rats (Fragen et al, 1983, b), and 
atracurium and vecuronium in humans, but without prolonging the 
duration of action (Robertson et al, 1983, b). This finding in 
Study Twelve requires further investigation,but could be due to 
other factors such as alteration of hepatic metabolism, or hepatic 
blood flow, especially as the patients tended to be elderly and 
undergoing prolonged anaesthesia. No such effect was found to 
occur with atracurium, possibly due to its spontaneous degradation.
Recovery
Recovery in the infusion studies was rapid and complete (Studies 
Eleven and Twelve; Upppingham, Kay and Sear, 1985; Jessop et al 1985).
181
The rate of recovery remained rapid even after relatively high 
infusion rates (Mackenzie and Grant, 1985, b; McLeod and Boheimer,
1985), and was comparable with the times found with etomidate.
Venous Damage and other Safety Aspects
The safety aspects of propofol have been extensively investigated. 
The incidence of venous damage in t^e studies- described in - 
Chapters Six and Nine was very low - only one patient had transient 
thrombophlebitis in 120 induction administrations and 45 infusions 
of propofol. Prolonged observation of the administration site after 
the administration of propofol and methohexitone revealed no evidence 
of thrombophlebitis after 14 days (Mattila and Koski, 1985). No 
changes in liver function after doses of 140 to 330 mg. have been 
detected (Robinson and Patterson, 1985).
Quality of Anaesthesia
Although such infusions have been shown to be feasible, the 
question remains as to how effective they are when used clinically.
The results obtained for etomidate varied considerably, 
but its use in paralysed patients was found to be satisfactory in 
Studies Seven, Eight and Nine. Similar findings have been described 
(Booij , Rutter and Crul, 1978; Florence, 1981; Rocke et al, 1981; 
Thomson et al, 1982; Oduro et al, 1983; Carli, Stribley and Clark, 
1983).
Not all studies involving paralysed patients found the
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technique satisfactory. Failure to suppress reflex activity has 
been described (Van de Walle et al, 1979; Gepts and Camu, 1981), 
and much higher infusion rates were found to be necessary for resection 
of abdominal aneurysms and abdoperineal resections (Hutschenreuter 
et al, 1981). One case of awareness has been described (Braude,
Lieman and Galloway, 1985) and several instances of inadequate 
anaesthesia (O’Carroll et al, 1977, b; Van Dijk, 1979).
The lower infusion rate of etomidate described in Study Nine 
appeared to be satisfactory, although one study found that 24% of 
patients required supplementation (Jones, Lawrence and Thornton,
1983). In a large multi-centre trial (Boyes et al, 1981) evaluating 
this infusion scheme, awareness occurred in one patient, and anaesthesia 
was inadequate in another three.
In spontaneously breathing patients the results were more 
variable. Difficulties found in Studies Seven, Eight and Nine 
related to pain on injection, muscle movement and difficulty in 
maintaining respiration when the infusion rates had to be increased.
Pain on injection and muscle movement could be reduced by infusion 
of the induction dose of etomidate (Study Nine) or by the substitution 
of thiopentone for the bolus injection of etomidate (Study Eight), 
but the respiratory problems remained. Good results in spontaneously 
breathing patients have been reported (Booij, Rutten and Crul, 1978;
Van Dijk, 1979; Helmers, Giezen and Adam, 1981).
The two stage infusion scheme has been found to provide 
satisfactory sedation for operations under local anaesthesia (Scorgie, 
1983; Birks, Edbrooke and Munday, 1983). These results are in
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marked contrast to those described in the earlier studies of Kay 
and Roily (1977, a).
Although experience with propofol is much less, problems 
were found during Studies Eleven and Twelve. These were pain on 
injection during induction and the difficulties in maintaining 
spontaneous respiration in Study Eleven.
All the infusion studies showed a very high coefficient of 
variation in the infusion rates required. This high degree of 
variation of infusion rates could create difficulties in spontaneously 
breathing patients when an unprotected airway had to be maintained 
while adjusting the infusion rate.
Comparison between Etomidate and Propofol
Both etomidate and propofol have been found to provide 
satisfactory hypnosis for the induction and maintenance of 
anaesthesia. Etomidate caused less cardiovascular depression 
during the initial infusion period, but during the maintenance of 
anaesthesia, cardiovascular changes were very similar. Predetermined 
infusion rates were found to be successful for both hypnotics, 
except for the spontaneously breathing patients infused with 
propofol. All studies showed a very similar coefficient of variation 
for the infusion rates of fentanyl.
Clinically, the major differences between the two hypnotics
were due to side-effects. The lack of muscle movement with propofol
was a major advantage and the incidence of pain on injection 
in premedicated patients was less. The infusion of etomidate for
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both induction and maintenance of hypnosis reduced the incidence 
of side-effects although they were not abolished. The major 
disadvantages of etomidate are the high incidence of pain, muscle 
movement and venous thrombosis.
Conclusions
The conclusions are that prolonged infusion of etomidate and 
propofol with fentanyl does not affect cardiovascular stability, 
and that recovery is rapid after stopping infusion. There would 
appear to be no adverse effect on hepatic or renal function. However 
several problems remain to be solved before total intravenous 
anaesthesia using these agents becomes practical for routine use.
These are concerned with the adequacy of hypnosis, flexibility of 
analgesic administration without respiratory depression and side- 
effects, particularly pain on injection.
CHAPTER THIRTEEN
GENERAL DISCUSSION OF
TOTAL INTRAVENOUS ANAESTHESIA
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Introduction
Althesin was the first of the new hypnotics used for 
continuous infusion, both for total intravenous anaesthesia (Savage 
et al, 1975; Jago and Restall, 1977), and for supplementation of local 
analgesia (Park and Wilson, 1978). Combined with the development 
of accurate infusion equipment, these advances suggested that total 
intravenous anaesthesia could become an alternative to conventional 
inhalation based anaesthesia. This optimism was illustrated by 
a survey (Wright and Dundee, 1982) where 92% of anaesthetists 
expressed an interest in using total intravenous anaesthetic 
techniques. Failure to use such techniques were attributed mainly 
to lack of information, equipment, and experience, which could be 
easily corrected. More serious difficulties such as assessing 
depth of anaesthesia, or lack of a suitable agent had caused some 
10% of those who had used such techniques to subsequently abandon 
them.
The conclusions of the previous chapter suggest, that several 
problems remain to be solved. This chapter looks at these problems, 
attempts to assess whether they may be soluble and their implications 
for the continued use of total intravenous techniques and the 
prolonged infusion of hypnotic agents.
Hypnosis
One major problem is how to assess the depth of anaesthesia 
when many of the signs of patient response have been obtunded 
by the administration of other drugs, particularly muscle relaxants
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(Lancet, 1986, a,b). Awareness may be a horrific experience for 
the individual concerned (Anonymous, 1979) and has been described 
as the greatest single potential drawback to intravenous anaesthesia 
(Morgan, 1983). In the studies reported in this thesis, no patient 
gave any indication of awareness when questioned after anaesthesia, 
although this is an extremely crude means of assessment.
Administration of Hypnotics
Cerebral Function Monitors have been used to control the infusion 
of althesin and etomidate (Dubois et al, 1978) and thiopentone 
(Frank et al, 1982). As such machines are not yet widely available, 
other methods have been more commonly used. Early infusion schemes 
were empirical. Advances in pharmacokinetic and pharmacodynamic 
theory and the ability to measure blood levels of drugs, has allowed 
the development of theoretically more rational infusion schemes 
(Norman, 1983; Sear, 1983) such as those described in Chapter 
Twelve for etomidate and propofol. These are based on the premise 
that a constant pre-determined infusion of hypnotic agent results 
in a blood level guaranteed to produce the desired effect, the 
"therapeutic window" (Ausems, Stanski and Hug, 1985). Other 
effects are due to surgical stimulation and can be treated with 
varying amounts of analgesic as required.
Pharmacokinetic modelling cannot be used uncritically. The 
coefficient of variation of pharmacokinetic parameters in fit patients 
may be in the order of 25% (Norman, 1983) and the parameters are 
derived from plasma assays, which have their own inaccuracies 
(Faulding and Hall, 1984). It has been suggested that the
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variability in certain pharmacokinetic parameters may be over­
emphasized (Schwilden, SchUttler and Stoeckel, 1985), but fentanyl 
is an example of how variable such data can be (Reilly, Wood and 
Wood, 1982).
An empirical approach has been developed to allow comparison 
between different hypnotics and infusion rates using an intravenous 
equivalent to the M.A.C. values of the inhalational agents. This 
is the Minimum Infusion Rate (M.I.R.) or E.D.50 (Prys-Roberts,
1980; 1983; Prys-Roberts and Sear, 1984). The technique has
been extended and E.D.95 values can now be obtained as well as the 
E.D.50 (Spelina et al, 1986).
Infusion rates suggested by this method have been found to 
be similar to empirical infusion rates for althesin (Morgan and 
Dawson, 1984). The E.D. 95 values for propofol (Spelina et al,
1986) are very similar to other reported infusion rates (Chapter 
Twelve) although recent studies have suggested a much higher 
E.D.95 for propofol when the pre-medication was changed from 
morphine to I.orazepam (Turtle et al, 1987). The infusion rates 
tend to be lower in the M.I.R. studies due to the use of 67%
nitrous oxide which reduces the required infusion rate by about
30% (Keeri-Szanto, 1980, b) to 40% - 50% (Prys-Roberts, 1983;
Sear et al, 1983). The M.I.R. for etomidate was found to be
much higher than the infusion rates for etomidate derived from a
pharmacokinetic model (Prys-Roberts and Sear, 1984). This was 
possibly caused by the high infusion rate of etomidate in the M.I.R. 
studies causing excessive muscle movement. Thus for althesin 
and propofol, but not for etomidate, the agreement between M.I.R.
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and other regimes are reasonably close. Alterations in M.I.R. 
have been found to be altered by age, premedication, drug therapy 
and pre-existing disease (Prys-Roberts, 1983; Prys-Roberts and 
Sear, 1984).
Pre-determined infusion rates have been used successfully 
in limited clinical circumstances although difficulties have been 
described in some series (Chapter Twelve). To be used in routine 
clinical practice, the underlying assumptions would have to hold for 
a wider patient population varying both in operations undergone and 
the incidence of co-existing disease.
Individual variation is important and may be considerable 
(Keeri-Szanto, 1980, a; b). A wide variation in cumulative dose 
requirements with a right skew has been described for methohexitone 
(Dundee and McMurray, 1985) and for propofol (Wright et al, 1984; 
Robinson, 1985). Other influences include nutrition, (Bowman 
and Rand, 1980), physical fitness, sex (Dundee et al, 1982) and 
the concomitant administration of other drugs, such as nicotine 
(smoking), alcohol and caffeine (Stanley and De Lange, 1984).
Changes occur with age (Greenblatt, Sellers and Shaden, 1982) 
and such changes have been described for thiopentone (Christensen, 
Andreasen and Jansen, 1982; Atkinson and Henthorn, 1985), methohexitone 
(Ghoneim et al, 1985), midazolam (Dundee et al, 1985), etomidate 
(Carlos, Calvo and Erill, 1981; Arden, Holley and Stanski, 1984) 
and propofol (Dundee et al, 1986; Hilton, Dev and Major, 1986).
Many of the reported studies have been carried out on 
volunteers and patients where analgesia has been provided by spinal
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or epidural blockade. In sheep, spinal analgesia has been shown 
to have little effect on cardiac output, hepatic and renal blood flow, 
and drug distribution and metabolism, whereas general anaesthesia 
with halothane may cause substantial variation (Runcieman et al,
1984; 1986; Mather et al, 1986). Thus the results of investigations
of infusion schemes in one clinical situation may not be applicable 
to others. This could account for the differences found when 
comparing the pharmacokinetic and pharmacodynamic results of 
propofol in volunteers and anaesthetised patients (SchUttler,
Stoekel and Schwilden, 1985).
Operative procedures may influence drug action and metabolism 
(Pessayre et al, 1978). Hypovolaemia can also reduce plasma 
clearance, with prolongation of elimination as has been shown for 
midazolam (Adams et al, 1985). Changes occurring during cardiopulmonary 
by-pass are even more complex (Morgan et al, 1986). Parenteral 
nutrition has a marked but variable effect on drug metabolism 
(Vesell and Biebuyck, 1984; Pantuck et al, 1984). There are, 
therefore, many factors which may influence drug handling in apparently 
healthy patients, accounting for instances of awareness which have 
been reported with apparently adequate infusion rates of etomidate 
(Boyes et al, 1981; Braude, Leiman and Galloway, 1985).
Co-existing disease may also cause complications. Hepatic 
disease has been shown to prolong etomidate elimination (Van Beem 
et al, 1983). Respiratory disease may reduce the amount of plasma 
binding of etomidate (Carlos, Calvo and Erill, 1981). Severe 
illness such as sepsis can alter volumes of distribution and hepatic 
clearance (Reitbrook, 1980).
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Drug interaction is an important cause of unexpected 
variation. Nitrous oxide has been shown to reduce hepatic 
blood flow in rats (Seyde, Ellis and Longnecker, 1986) and 
has been found to raise the plasma levels of etomidate in humans, in 
association with a prolongation of recovery time (Sear et al, 1984). 
The infusion of fentanyl has been shown to cause a 2 - 3 fold 
reduction in the volume of distribution and a reduction in the 
plasma clearance of etomidate. This may be due to the displacement 
of etomidate from tissue binding sites by fentanyl or by a reduction 
of liver blood flow (SchUttler et al, 1983). A similar interaction 
between fentanyl and propofol has been described (Briggs et al,
1985).
The consequences appear to depend to some extent on the 
physiological properties of the drugs themselves. The interaction 
between etomidate and fentanyl appeared to cause much less 
respiratory depression (Studies Seven, Eight and Nine) compared 
with propofol and fentanyl (Study Eleven), possibly due to the marked 
respiratory stability of etomidate. With the administration of 
three drugs, the situation becomes even more complex and could 
explain the findings with thiopentone (Study Eight) and vecuronium 
(Study Twelve).
Although not found in the studies reported in this thesis, 
the duration of infusion may also cause important changes in 
kinetic properties. With prolonged administration, fentanyl may 
become more cumulative and its kinetics resemble those of morphine 
and pethidine (Stanski, 1983). It has been suggested that acute
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tolerance may occur with etomidate (Doenecke et al, 1982;
Schllttler, Schwilden and Stoeckel, 1985; Schwilden, Schllttler 
and Stoekel, 1985). Infusion with etomidate caused dose dependent 
changes in cardiovascular dynamics and reduced renal and cerebral 
blood flow in pigs (Prakash et al, 1980), and liver blood flow in 
dogs (Thomson et al, 1986). A similar reduction in liver blood 
flow, associated with a progressive rise in etomidate levels has 
been described in dogs (Van Lambalgen et al, 1982). As the 
clearance of etomidate is sensitive to hepatic blood flow rather 
than hepatic enzymic activity (Hebron et al, 1983), these findings 
could be caused by etomidate impairing its own metabolism. Acute 
tolerance has also been reported to occur with thiopentone (Dundee, 
Price and Dripps, 1956) and morphine (Marshall et al, 1985).
Thus methods based on a ’predicted1 basis may be inherently 
unsatisfactory, although the use of the E.D.95 concept may be 
useful in the quantification of such variation. Comments on the 
limitation of the average rate of infusion as means of providing 
anaesthesia in 100% of patients have also been made by Dundee and 
McMurray (1985). Increasing infusion rates to prevent awareness 
in all patients may produce toxic effects in patients sensitive 
to the affects of the drug (Mather., 1980).
Administration of Analgesia
The other major problem was the administration of 
analgesia. Requirements for analgesia vary throughout an operation, 
being greater during laryngoscopy, (Kay, Healy and Bolder, 1985)
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skin incision and wound closure (Mattilla et al, 1979). A 
fixed infusion rate of fentanyl (0.05 meg.kg. ^min. in patients 
undergoing superficial body surgery showed that 29% of the patients 
required supplementation (Andrews and Prys-Roberts, 1984). A 
high coefficient of variation in the amounts of fentanyl infused 
was found in all the infusion studies described in this thesis, 
whether combined with etomidate or not. Requirements for analgesia 
may also vary for different operations (Ausems et al, 1986). These 
findings suggest that analgesics are best infused as required in 
response to perceived patient need.
In most cases in the infusion studies described in this 
thesis, fentanyl was found to be satisfactory, but it has a slow 
response time of 4 - 7 minutes (Scott, Ponganis and Stanski, 1985). 
This led in some cases to larger amounts than necessary of fentanyl 
being administered in an attempt to increase speed of response.
This resulted in apnoea in several patients. Although not seen 
in these studies, overdosage may result in post-operative respiratory 
depression (Adams and Pybus, 1978) possibly caused by secondary 
plasma peaks (McQuay et al, 1979; Stoeckel et al, 1982) or changes 
in kinetics (Stanski, 1983).
Alfentanil may be a superior analgesic for infusion compared 
with fentanyl because of its faster response time of 1 minute (Scott, 
Ponganis and Stanski, 1985). Alfentanil infusions may therefore 
be easier to control, with rapid response to changes in infusion 
rate. Such findings have been reported clinically (Steegers, Booij 
and Pelgram, 1982; Helmers et al, 1983; Versichelen, Roily and 
Beerens, 1983; Kay, 1984; 1986). However, post-operative
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respiratory depression has been reported with its use (Sebel et 
al, 1984).
Hazards of Intravenous Anaesthesia
Injection and infusion of drugs may be associated with 
hazards such as extravasation, thrombophlebitis, sepsis, the 
presence of particulate material and possible toxicity of plastic 
materials and additive compounds (Woods and Newton, 1978). For 
infusion, the physical properties of the drugs have to be considered 
more carefully than for bolus injection. Water solubility is 
desirable, as large amounts of solvent such as alcohol and intralipid 
may be infused. These may cause problems such as the sub-clinical 
complement activation associated with the continuous infusion of 
cremophor (Benoit et al, 1983). Physical compatibility (Huddy 
and Durcan, 1984), stability on exposure to light and lack of 
absorption to plastics as occurs with insulin, are also important 
(Morgan and Dawson, 1984).
Mechanical problems may also occur. A case has been 
reported of a pump discharging etomidate too quickly although 
without resulting in clinical harm (Calhaem, 1983). Although 
pump malfunctions appear to be uncommon, they present an added 
hazard of the technique.
The techniques are based on the premise that the drugs 
used are safe. Although great care is taken in the evaluation of 
all drugs, unexpected toxicity may occur. Etomidate has been 
shown to cause adrenocortical suppression (Fellows et al, 1983;
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Mehta et al, 1985; Duthie, Fraser and Nimmo; 1985). Caution in 
the use of etomidate, particularly for infusion has been advised 
by the Committee on Safety of Medicines (Goldberg, 1983, a; b).
In contrast, propofol has not been shown to have any delecterious 
effect on adrenal or testicular steroidogenesis (Robertson et al,
1985; Keynon, McNeil and Fraser, 1985; Lambert, Mitchell and 
Robertson,1985).
Comparison of Intravenous and Conventional Anaesthesia
Being volatile, the inhalational agents obey physical laws. 
Increasing the inspired concentration rapidly increases the depth 
of anaesthesia and vice versa. This rapid response to changes 
in alveolar concentration makes the inhalational agents very 
flexible and easily adjusted to individual requirements. Also, there 
are no secondary increases in blood levels once the supply of such 
agents is stopped (Norlander, 1980). This flexibility cannot be 
matched by the intravenous agents where reversal of effects depend 
on metabolism. The problems due to biotransformation are greatly 
reduced by the use of the newer, and much less biometabolised 
agents, ethrane (Chase et al, 1971) and isoflurane (Holaday et 
al, 1975).
To provide anaesthesia for .procedures when patients are breathing 
spontaneously, inhalational agents remain superior. In the infusion 
studies the incidence of transient or prolonged apnoea was much 
higher than in the control groups. One hazard which is of great 
practical importance is the danger of divertion of attention. In 
intravenous anaesthesia, attention has to be divided between the
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airway and the infusion pump. This division of attention is 
potentially very dangerous as unexpected complications such as 
venous extravasation, may occur at any time and require immediate 
attention while the airway may be left unprotected.
The two methods are more comparable when anaesthetised 
patients are being ventilated. Under these circumstances, the airway 
has been secured and often an infusion is required for the 
administration of other drugs and fluids. The lack of nitrous 
oxide make total intravenous techniques particularly valuable 
when the cumulation of nitrous oxide may cause difficulties, as in 
abdominal, thoracic,cardiothoracic, neurosurgical and E.N.T. 
operations. Total intravenous anaesthetic techniques have been 
used in thoracic operations (Carli, Stribley and Clark, 1983) and 
cardiothoracic operations (Oduro et al, 1983). In these situations 
intravenous anaesthesia may offer advantages, particularly when 
post-operative ventilation is required. Sedation and analgesia 
can be continued using the same drugs as used during the operation.
The use of intravenous techniques may also be useful in less 
common situations,such as hyperbaric conditions; where jaundice 
has occurred subsequent to previous anaesthesia; where high 
inspired levels of oxygen are required and possibly in cases of 
malignant hyperpyrexia.
Provision of sedation is an area where intravenous techniques 
may be advantageous. This is best seen when provision of hypnosis 
is the main objective and clinical assessment is available, as when 
providing sedation for operations under local analgesia or sedation
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for ventilated patients in the intensive care (Cohn et al, 1983) 
or neurosurgical unit (Dearden and McDowell, 1985). In these 
circumstances the amount of hypnotic agent required can be judged 
by individual response. Several of the studies quoted in Chapter 
Twelve suggest that propofol would be useful for sedation with local 
analgesia (Mackenzie and Grant, 1987). Its use for sedation in 
the intensive care units is currently being evaluated (Grounds 
et al, 1987 ; Newman et al, 1987).
Conclusions
Although short acting hypnotics and analgesics and the 
means to administer them accurately are now available, total 
intravenous techniques based on their use do not appear to be 
superior to currently available inhalational based techniques at 
the present time. The difficulty of finding the optimum dosage 
for each individual, and the relative lack of flexibility of 
response, places such techniques at a disadvantage unless the 
avoidance of nitrous oxide or other inhalational agents is of 
prime importance.
Possible Future Developments
The current situation could be changed in two ways.
Hypnotic infusions, currently propofol, could be substituted for 
nitrous oxide and the less biometabolised inhalational agents used 
to provide the required flexibility in closed circuit anaesthesia. 
This would eliminate the dangers of hypoxic gas mixtures; allow a
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safer use of closed circuit anaesthesia both for ventilated and 
spontaneously breathing patient^ as well as reducing the hazards 
of theatre pollution.
The use of total intravenous techniques for routine use in 
the longer term could become more popular if better methods of 
assessment of anaesthetic depth were available. The development 
of improved methods of automated analysis of the E.E.G. by the use 
of cerebral function monitors (Maynard and Jenkinson, 1984; Sebel, 
Heneghan, and Ingram, 1985; Scott, Ponganis and Stanski, 1985; 
Jones and Konieczko, 1986) may allow more accurate titration of 
intravenous hypnotics and analgesics to individual requirements. 
This would allow a greater use of such techniques in ventilated 
patients. ■ Such developments could eventually lead to computer 
assisted or controlled schemes as have been described for halothane 
(Chilcoate, Lunn and Mapleson, 1983; Ross et al, 1983; Morris, 
Tatnall and Montgomery, 1983). Such a system using E.E.G. and 
E.M.G. to control infusions of etomidate (Kay, 1984) and propofol 
(Kay, 1986) has already been described.
CHAPTER FOURTEEN
CONCLUSIONS
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The bolus administration of etomidate or propofol 
was not associated with adverse physiological effects. However 
the incidence of side-effects of these drugs was such that for 
the routine induction of anaesthesia in fit patients, neither etomidate 
nor propofol would appear to offer any advantages over thiopentone, 
unless rapid recovery is required. Both may have advantages where 
the barbiturates are contra-indicated, or where histamine release 
is not desirable.
The infusion studies showed that in combination with fentanyl, 
total intravenous anaesthesia with etomidate or propofol was feasible, 
providing satisfactory hypnosis, and cardiovascular stability. Apnoea 
in spontaneously breathing patients was a frequent problem, particularly 
when propofol and fentanyl was infused.
The techniques were generally found easy to use., but in 
spontaneously breathing patients the division of attention between 
maintenance of an unprotected airway and the infusion or infusions, 
was potentially very dangerous. They cannot be recommended for use 
in this situation. The techniques were found to be practical in 
ventilated patients* but not yet superior to inhalational based 
methods for routine use.
This thesis does not support the hypothesis that total 
intravenous techniques can provide equally satisfactory anaesthesia 
for patients either breathing spontaneously or requiring mechanical 
ventilation, compared with the use of inhalational agents.
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